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Abstract (English version)
Computed Tomography perfusion (CTp) is a functional imaging technique
that has aroused a lively interest in oncology in the recent years mainly be-
cause it is a very promising approach for early assessment of the effectiveness
of the new anti-angiogenic therapies for cancer treatment. Nonetheless, some
difficulties to achieve standardized, repeatable and reproducible results have
slowed down its application in the daily clinical practice. This Thesis work ad-
dresses three important issues that needed to be faced to advance CTp towards
standardization: the lack of methods to measure the reliability of results, the
clinical relevance of the global perfusion parameter values commonly utilised,
a critical revision of protocols of the multi-centre studies, essential to assess
CTp reproducibility. In this work, lung and liver CTp examinations have been
considered, since they are among the most studied sites in oncology.
First, through a voxel-based spatio-temporal signal analysis, I set up an
error index capable to measure the quality of perfusion results and validated
it using examinations whose signals was degraded by different patient motion
degrees. After proving the effectiveness of the index to detect unreliable perfu-
sion values on single voxels, structured regions affected by noise (e.g. artefacts)
or representing semantic patterns undesirable in CTp studies (e.g. vessels or
bronchi) have been looked for on whole slices. Exploiting the voxel-based anal-
ysis and the same error index, an adaptive algorithm developed on purpose
has allowed detecting all those regions automatically, and to exclude their per-
fusion values from either any subsequent processing or clinical consideration.
The common practice in CTp perfusion studies is providing one averaged
value only for each perfusion parameter, computed on the whole tumour, with
the main purpose of reducing the effects of data variability, but at the expense
of tumour heterogeneity, a key feature that is neglected. Accordingly, whole
lung lesions were considered to inquire into the clinical representativeness of
global perfusion values. After removing all perfusion errors, and proposing a
statistical index to quantify tumour functional heterogeneity, the use of one
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global value has been proved to even mislead clinical considerations.
The last part of the Thesis regards the activities carried out in the widest
European liver CTp multi-centre study. Some algorithms for signal enhance-
ment to improve the accuracy of perfusion results were developed so as to
make CTp examinations of different Centres more comparable. Some mean-
ingful results regarding baseline and blood flow values of liver are reported
and discussed, highlighting whether and to what extent different CT scanners
affect CTp outcomes. Starting from an extensive analysis regarding the great
number of differences in the actual execution protocols, acquisition parameters
and information storing, tentative guidelines are provided to help considering
all the concealable sources of heterogeneity in advance, before planning the
multi-centre protocols.
Abstract (Italian version)
La Tomografia Computerizzata perfusionale (TCp) e` una tecnica di imaging
funzionale che negli ultimi anni ha suscitato un crescente interesse nel campo
oncologico, in quanto ha dimostrato di essere una tecnica molto promettente
per la valutazione precoce dell’efficacia delle nuove terapie anti-angiogeniche
per il trattamento dei tumori. Cio` nonostante, la sua applicazione nella pratica
clinica e` stata rallentata a causa della difficolta` nel conseguire risultati stan-
dardizzati, ripetibili e riproducibili. Questa Tesi tratta tre importanti aspetti
che dovevano essere affrontati per far avvicinare la TCp alla standardizzazione:
la mancanza di metodi per misurare l’affidabilita` dei risultati, la rilevanza clin-
ica dei parametri perfusionali globali comunemente utilizzati in letteratura ed
una revisione critica dei protocolli degli studi multicentrici, essenziali per la
valutazione della riproducibilita` della tecnica. Questo lavoro tratta esami TCp
polmonari ed epatici in quanto fegato e polmone sono tra gli organi maggior-
mente esposti all’insorgenza dei tumori.
Innanzitutto, attraverso un’analisi spazio temporale del segnale basata su
singolo voxel, e` stato messo a punto un indice di errore in grado di misurare la
qualita` dei risultati perfusionali. Tale indice e` stato inoltre validato utilizzando
esami i cui segnali apparivano alterati da differenti gradi di movimento del
paziente. Dopo aver provato l’efficacia dell’indice nel rilevare singoli voxel
associati a valori perfusionali non affidabili, sono state cercate su intere slice
regioni affette da rumore strutturato, quali artefatti, o rappresentanti strutture
fisiologiche, quali vasi e bronchi, normalmente escluse negli studi perfusionali.
Sfruttando l’analisi orientata al voxel ed il medesimo indice di errore, e` stato
sviluppato un algoritmo adattativo specifico che ha consentito di rilevare tutte
quelle regioni in modo automatico e di escludere i loro valori perfusionali da
qualsiasi successiva elaborazione o considerazione clinica.
E` pratica comune negli studi TCp fornire un unico valore mediato calco-
lato sull’intero tumore per ogni parametro perfusionale con lo scopo principale
di ridurre l’incertezza dei dati ma con l’effetto secondario di trascurare la
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variabilita` dovuta all’eterogeneita` tumorale, che rappresenta un’1importante
caratteristica per ogni valutazione clinica. Quindi, allo scopo di indagare la
rappresentativita` clinica dei valori perfusionali globali, sono state considerate
lesioni tumorali complete ed e` stato proposto un indice statistico in grado di
identificare l’eterogeneita` funzionale. Dopo aver rimosso tutti i valori perfu-
sionali non affidabili, e` stato dimostrato come un unico valore globale non
possa essere rappresentativo ed anzi, possa fuorviare le conclusioni cliniche.
Infine, l’ultima parte della Tesi riguarda le attivita` portate avanti nel con-
testo del piu` ampio studio multicentrico europeo di TCp epatica. Innanzitutto
vengono proposti diversi algoritmi sviluppati per il miglioramento del seg-
nale e dell’accuratezza dei risulti perfusionali, cos`ı da rendere maggiormente
comparabili gli esami TCp effettuati in Centri differenti. In seguito, vengono
riportati e presentati alcuni interessanti risultati riguardanti i valori epatici di
baseline e di blood flow, discutendo quanto diversi scanner TC possano even-
tualmente influenzare la riproducibilita` dei risultati perfusionali. A partire
da un’analisi approfondita riguardante l’elevato numero di differenze riscon-
trate nei protocolli effettivi di esecuzione degli esami TCp nei parametri di
acquisizione e nella memorizzazione dell’informazione sono state infine fornite
delle linee guida preliminari con lo scopo di aiutare a considerare in anticipo,
prima della pianificazione dei protocolli multicentrici, tutte le possibili fonti di
eterogeneita`, comprese quelle implicite.
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Chapter 1
Introduction and Thesis
overview
Cancer is among the leading causes of death worldwide [1]. Only in Italy,
the Italian Association of Cancer Registries (AIRTUM) has forecasted 365000
new tumour diagnoses in 2016 alone (i.e., about 1000 subjects per day) [2]. In
particular, over the world the most common site of diagnosed cancer is lung,
followed by breast and colonrectum [3]. Lung cancer is also the most common
cause of tumour death [4], followed by liver cancer [3]. A peculiarity of this last
kind of tumour is that, in the liver, metastatic cancers are more common than
primary cancers. For instance, the liver is the most common site of metastasis
from colorectal cancer (CRC) [5].
In the last few years, the worldwide risk of dying from cancer is globally
decreased [6]. This improvement is also attributable to the introduction of
the new anti-angiogenic therapies that, administered in combination with con-
ventional chemotherapy (i.e., cytostatic drugs) and radiotherapy, have shown
to increase patients survival in several cancer types [7]. Differently from con-
ventional anti-cancer therapies, the effects of anti-angiogenic treatments are
visible earlier on tissue functional behaviour (i.e., the vascular network of the
tumour) and only later in time on morphology [8]. As a result, a lively interest
has aroused around new perspective biomarkers, useful to monitor the sta-
tus of tissue neovascularization and to evaluate the effects of anti-angiogenic
therapies.
Computed Tomography perfusion (CTp) is an imaging technique that thanks
to its wide availability, low invasivity, and capability to provide images with
a high spatio-temporal resolution, results to be one of the most promising
methodologies for the earlier assessment of the efficacy of the anti-angiogenic
1
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therapies [9]. Through the analysis of the CTp sequences acquired, it is possi-
ble to compute perfusion parameters owing information regarding tissue vas-
cularization. In particular, these perfusion parameters have shown to be useful
to evaluate tumour neovascularization, characterize and differentiate tissues,
monitor anti-angiogenic therapies, and predict patient survival in several can-
cer types [8, 10].
Despite the high potential shown by CTp in both cancer diagnosis and
prognosis, there are still some open issues that have prevented the use of this
technique in the standard clinical practice [8]. In this Thesis, I focus my
attention on three topics related to the keywords reliability, standardization,
and reproducibility of perfusion results. The first issue regards the lack of
methods to evaluate perfusion results’ accuracy and to detect the presence of
non-systematic errors. In the literature, all the perfusion values achieved have
always been considered reliable, even when affected by errors (e.g. caused
by the presence of noise or artefacts), this constituting an obstacle for the
achievement of repeatable perfusion results. The second issue is related to the
low reproducibility of perfusion values, mainly caused by the huge amount of
variability sources affecting CTp data and results. To face this problem, many
authors have used global perfusion parameters, often computed as the average
of voxel-based perfusion values found on a single tumour section or on the
whole tumour. However, the higher reproducibility achieved by global values
with respect to voxel-based ones is due to the averaging operation, that reduces
sensibility of results to all the variability sources, tissue heterogeneity included,
this weakening, if not jeopardizing the clinical relevance of results. The third
and last issue regards the lack of standardization in both the acquisition and
data processing protocols. This problem has been an obstacle to the set-up of
multi-centre studies which are fundamental to introduce an imaging technique
as a standard to be used in the clinical routine. Actually, the huge amount of
inhomogeneities between data has even prevented the evaluation of perfusion
values reproducibility computed on examinations acquired by using different
Computed Tomography (CT) scanners.
The goal of my PhD activities was to face these issues to allow improv-
ing the CTp techniques to come to a more and more quantitative imaging
(Chapter 3). In particular, the first issue has been faced by developing an
automatic method to identify and exclude from the analysis those perfusion
values computed on data particularly affected by noise or artefacts and thus
considered to be unreliable. To this purpose, a fine-to-coarse strategy has been
developed, which starting from the quantitative analysis of the signal coming
2
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from the single voxel, was extended first to the single tumour section (Chap-
ter 4) and finally to the whole lesion (Chapter 5). This technique, that has
been applied to CTp examinations acquired in the same Centre and pertaining
to patients with liver and lung cancer, permitted to obtain better perfusion
results (i.e., more reliable and repeatable) on which drawing clinical evalua-
tions. The second issue has been faced by carrying out a deep analysis about
the representativeness of global perfusion values used in the literature. To
this purpose, a three step statistical analysis has been carried out to evaluate
the representativeness of tumour and single section global perfusion values. In
addition, an indicator of tumour functional heterogeneity has been proposed
to evaluate whether perfusion values equivalences found out with statistical
tests were numerical only or also owned a clinical significance (Chapter 5).
The third issue was faced by deeply analysing data coming from the first
CTp multi-centre study on liver and by carrying out a preliminary perfusion
analysis. Through the analysis of the almost 400 examinations acquired in
15 different Centres, it was possible to identify all the intra- and inter-centre
sources of variability affecting CTp data (and outcomes, accordingly) and to
provide a sort of guidelines to correctly set-up this kind of studies (Chapter 6).
In addition, data of different Centres acquired by using the same acquisition
protocol were analysed to evaluate whether the use of different CT scanners
could affect perfusion results (Chapter 7).
Besides the present introductory Chapter, this Thesis is organized in seven
Chapters, all treating different aspects of the same matter. Accordingly, the
experimental results are presented in Chapters 4, 5, 6, 7, pertaining to the
specific topic of the related Section. The content of this Thesis is organized as
follows:
• Chapter 2 contains the background and the state of the art regarding the
use of CTp in oncology. Starting from the description of angiogenesis
(i.e., the key process driving tumour growth), it is possible to under-
stand the increasing need for the assessment of anti-angiogenic therapies
efficacy and why dynamic contrast enhanced (DCE) imaging techniques
have become so important in oncology. A comparison between different
DCE techniques is carried out to motivate why CTp represents one of
the most suitable techniques for the evaluation of therapies‘ efficacy and
of cancer’s diagnosis and prognosis. Then, a summary of the main clin-
ical results achieved through the analysis of CTp perfusion parameters
is reported, with particular attention to lung cancers and liver tumours.
3
Chapter 1. Introduction and Thesis overview
Finally, the most relevant open issues still delaying the use of CTp in
the clinical practice are discussed.
• Chapter 3 starts going into the matter of this Thesis work and presents
the main methods used to process and analyse temporal tissue signals.
First of all, a discussion about the strategies selected to post-process CTp
images and the extracted voxel-based signal which perfusion parameters
are computed on is reported. Four temporal error indexes to evaluate the
signal quality are then proposed and compared, motivating the reasons
standing behind the choice of the error index selected for our studies.
After that, two different methods to automatically find out a cut-off
value between “good” signals and “bad” signals are presented. Finally,
an index to assess tumour functional heterogeneity is proposed.
• Chapter 4 describes the analysis that has been carried out first on the sig-
nal of single voxels and, subsequently, on tumour sections. In particular,
the temporal error index selected in Chapter 3 is validated as a marker of
perfusion values unreliability. This has been done by exploiting signals
of a different known quality that were achieved by building four different
sequences for each patient, according to as many alignment methods for
motion correction. Therefore, the analysis of CTp voxel-based signals
has been shifted to slice level. The two automatic thresholding methods
presented in Chapter 3 have been applied to the error values computed
on the signals of whole tumour sections so as to find out the unreliable
voxels to be excluded from the analysis. In particular, this procedure has
shown to be able to automatically detect and exclude all those structures
(e.g. bronchi, vessels, and artefacts) usually jeopardizing qualitative and
quantitative perfusion analysis.
• In Chapter 5, the analysis carried out on the single tumour section has
been extended to the whole lesion. A deep study regarding tumour het-
erogeneity representativeness of global and single-slice perfusion values
used in the literature is carried out. In particular, the error and per-
fusion parameters are computed on each slice of the tumour, as well as
the index presented in Chapter 3 and representing the tumour functional
heterogeneity. Then, a three step analysis is carried out. First of all, the
representativeness of the global perfusion values computed on the whole
lesion with respect to those computed on the single slices was evaluated
to verify whether and to what extent, the use of global perfusion values
4
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could be representative of tumour single section. After that, the equiv-
alence between perfusion of different sections of the same tumour was
evaluated to verify to what extent single tumour sections could be rep-
resentative of the whole tumour. Finally, spatial perfusion distribution
is compared in tumours having the same global perfusion value to assess
whether the use of one perfusion value computed over the whole tumour
could be effective in clinical decision making.
• Chapter 6 deals with the analysis of data collected in the first CTp
multi-centre study on liver. All the standardization issues related to the
acquisition protocol are analysed as well as the intra- and inter-centre
variability sources that could affect perfusion analysis. In particular, the
implication of using different CT scanners or the variability introduced
by different operators are discussed. Besides that, a quality image anal-
ysis of the CTp sequences acquired in different Centres is carried out for
an early assessment of the possible inhomogeneities introduced by differ-
ent CT scanners or acquisition parameters. Finally, a draft of possible
guidelines regarding how a CTp multi-centre study should be carried out
is presented.
• Chapter 7 describes all the methods that have been implemented to
improve data and perfusion computation of multi-centre examinations
to evaluate how the use of different CT scanners affect perfusion results.
In particular, the algorithm to compute perfusion has been improved and
adapted to the analysis of CT examinations of normal liver. An algorithm
for liver ROIs registration on CT images has been implemented in its
early stage. In addition, a method to correctly compute baseline values
(i.e., the tissue density value before the arrival of contrast agent), which
are of a fundamental importance to achieve accurate perfusion values
has been developed and tested against the most common methods used
in the literature. After that, baseline values of examinations acquired in
different Centres have been computed and compared to evaluate whether
and to what extent the use of different CT scanners affects baseline
values. Finally, tests on perfusion values computed on patients of a
single Centre and of different Centres have been carried out to assess
and analyse single and dual-input hepatic perfusion values in patients
with CRC and to evaluate whether the use of different CT scanners
affects the computed results.
5
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• Concluding remarks and hints for possible future works are reported and
discussed in Chapter 8.
The work developed in this Thesis has been carried out within the:
• Computer Vision Group (CVG), Advanced Research Center on Elec-
tronic Systems (ARCES), University of Bologna, Italy. Director: Prof. Alessan-
dro Bevilacqua
in partnership with the following institutions:
• Diagnostic Imaging Unit, Istituto Romagnolo per lo Studio e la cura dei
Tumori (IRCCS-IRST), Meldola (Forl´ı-Cesena), Italy. Director: Dr. Domenico
Barone
• Department of Radiology, Beaujon Hospital, Clichy, France, Director:
Prof. Vale´rie Vilgrain
The activities discussed in this Thesis pertain to two projects:
• PERFECT - Automatic analysis of hepatic and lung PERFusion through
the usE of CT-4D image reconstruction
• PIXEL - Perfusion IndeX: Evaluation for Liver metastases
In particular, I spent the first two years to implement and validate the error
indexes and the thresholding methods presented in Chapter 3 and discussed
in Chapter 4 that permitted to achieve reliable perfusion values. During the
second year I also started working on the analysis regarding the representa-
tiveness of global perfusion values often adopted in the literature with respect
to tumour heterogeneity. Instead, during the last year I mainly focused my
attention on data regarding the multi-centre study and carried out analyses
and experiments presented in Chapters 6 and 7 to evaluate whether the use
of different CT scanners affects the outcomes of perfusion examinations. The
methods developed and the results obtained have been partly published in four
scientific journals, five international and four national conference proceedings.
In addition, they have been also presented in three oral communications.
My 3-year PhD programme in Bioengineering was granted by the Italian
Minister of Education, Universities and Research (in Italian, MIUR).
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Background and state of the art
Tumour angiogenesisis is the hallmark of cancer capability to develop and
metastasize. In the last few years, several tumour anti-angiogenic drugs have
been developed, arousing interest around minimally invasive imaging tech-
niques that have shown promising capability to assess the effects of these new
therapies. CTp is one of the imaging techniques mostly investigated to this
purpose. The analysis of the signal that can be extracted from each tissue voxel
of the CT image sequence allows the computation of perfusion parameters con-
nected to tissue angiogenesis. Despite the clinical usefulness of CTp has been
demonstrated in several studies, some open issues prevent its application in
the clinical practice.
In the next paragraphs of this Chapter, all these aspects will be taken
into account and discussed to allow a better understanding of this PhD Thesis
work.
2.1 Tumour angiogenesis and imaging biomark-
ers
The term “angiogenesis” is used to describe the process of new vessels for-
mation that is essential for the embryologic development, the normal tissue
growth, and tissue reparation [11]. Angiogenesis regularization happens at a
molecular level and is driven by several factors, the principal of which is the
vascular endothelial growth factor (VEGF) [12].
Some pathologies, such as cancer, are able to interfere with the cellular an-
giogenesis regularization factors giving origin to abnormal vascular networks.
Gene mutations inside tumour cells indeed, cause the release of new regular-
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ization factors that perturb the regular angiogenesis process [13] entailing the
creation of new vessels that are more dilated, tortuous, and permeable than
the normal ones [14]. Moreover, the coexistence of multiple cancer genetic
subpopulations provokes variable degrees of neovascularization in different tu-
mour types [15]. All these features contribute to improve the degree of tumours
heterogeneity that has a deep influence on lesion’s growth and response to anti-
cancer therapies (i.e., chemotherapy, radiotherapy, and immunotherapy) [14,
16].
Angiogenesis has become the hallmark of tumour capability to develop
and metastasize and the target for the production of new anti-cancer thera-
pies [17]. Anti-angiogenic drugs able to inhibit vascular tumour growth (i.e.,
anti-VEGF) have been then widely developed in the last few decades [7].
The administration of these therapies also in combination with conventional
chemotherapy and radiotherapy have shown to increase patients survival for
several cancer types. A positive impact on patients overall survival (OS)
and progression-free survival (PFS) has indeed been found in cancer of the
lung [18, 19], liver [20, 21], colon-rectum [22, 23], kidney [24, 25], breast [12,
26], and ovary [27, 28]. Despite these encouraging results, there are also some
studies that did not observe any significant improvement in survival due to
anti-angiogenic drugs administration. This is the case of breast cancer [29]
and CRC [30, 31]. Moreover, there are some tumour sites such as pancreas,
prostate, and skin in which anti-angiogenic therapies have only a limited im-
pact on OS [32]. Several studies have thus been carried out to try understand-
ing the mechanism which anti-angiogenic drugs are based on and improving
their efficacy accordingly [33, 34]. At the beginning, it was hypothesized that
anti-angiogenic agents would have destroyed tumour vessels, depriving can-
cer from oxygen and nutrient necessary to its growth [35, 36]. However, this
would have also prevented drugs to reach the tissue, this yielding an increasing
tumour hypoxia, a well-known marker of poor response to therapies [37] and
patient OS [38]. Further on, it was found that anti-angiogenic drugs act as a
vascular normalization factor, remodelling the network of vessels to a normal
vasculature, hence permitting a higher drug delivery [33]. Anyway, the mech-
anism by which the anti-angiogenic therapies are able to improve survival over
chemotherapy alone is still not fully clear [39].
The development of anti-angiogenic drugs brings about the need for biomark-
ers able to evaluating the status of the tissue neovascularization process and
to monitoring the effects of anti-angiogenic therapies. The most widely used
methods to assess the efficacy of chemoterapeutic agents are the Response
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Evaluation Criteria in Solid Tumour (RECIST) [40] and RECIST 1.1 [41], be-
sides the World Health Organization (WHO) criteria [42]. All these criteria
are uniquely based on the evaluation of changes on lesions number and size, by
measuring the long-axis of the lesion in one (in case of RECIST or RECIST 1.1)
or two (in case of WHO) dimension. Anyway, due to their non-cytotoxicity,
the anti-angiogenic drugs aim at normalizing the vascular network of cancers
without necessarily influencing tumour size and affect morphology quite a long
time after functional changes happened [8]. This is the reason why the con-
ventional criteria characterizing treatment response may not be effective and
there is a need for new and more effective biomarkers [15, 43].
The invivo biomarkers that can be used to evaluate angiogenesis can be of
two types: direct or indirect ones [44, 45]. An ideal direct biomarker would
be the microvessel density (MVD) that has shown a good correlation with
poor prognosis and tumour metastases [46]. However, biopsy requires taking a
tissue sample, an invasive procedure of limited applicability and effectiveness
to provide a direct measure of biomarkers. In fact, due to its invasiveness,
biopsy cannot be used with the frequency needed to monitor angiogenesis
and to assess therapies effects [47]. In addition, only a very small portion
of tissue is analysed,thus making biopsy prone to error sampling and inter-
observer variability and not suitable for the analysis of highly heterogeneous
tissues, accordingly [48]. The need of more appropriate and accurate biomark-
ers aroused interest towards indirect biomarkers, in particular derived from
DCE imaging techniques, which are able to provide perfusion parameters cor-
related to the tissue vascular characteristics. DCE imaging techniques are
indeed non-invasive methods able to assess the microcirculatory function of
the investigated tissues [49, 50] and the tumour response to therapies, earlier
than permitted with techniques based on morphological changes only [8]. All
the DCE imaging techniques are based on the same principle, that is the mea-
surement of tissue and vascular enhancement over time obtained by acquiring
images of the same sample before, during, and after the administration of a
contrast agent (CA). Finally, the application of apposite kinetic models, and
methods, on the signal extracted from the images allows computing perfu-
sion parameters [51]. More details regarding the perfusion parameters and
the methods used for their computation are provided in Sects. 2.2.1 and 2.2.2,
respectively.
The main DCE imaging techniques that have been used in the characteri-
zation and assessment of tumour angiogenesis are:
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• DCE CT
• DCE magnetic resonance imaging (MRI)
• DCE ultrasound (US)
• Positron-emission tomography (PET)
The main features of these imaging techniques are resumed in Table 2.1.
Dynamic imaging techniques
Technique
Morphologic Functional
Availability Cost Other features
information information
DCE-CT Very good Very good High Medium
Exposure to ionizing radiation
Toxicity of CA
Attenuation proportional to CA concentration
DCE-MRI Very good Very good Low High Versatility in pulse sequences
DCE-US Medium Good Very high Low
Highly operator dependent
Limited depth of penetration
PET Very bad Good Very low High
Radiation exposure
High toxicity of CA
Emission proportional to CA concentration
Tab. 2.1: Main features characterizing the most used functional imaging tech-
niques.
DCE-CT is undoubtedly one of the most used imaging techniques for an-
giogenesis evaluation. The main strong point of this technique is its capability
of providing high spatial-temporal resolution data, this favouring the achieve-
ment of high quality morphological and functional information [9]. Moreover,
the wide availability and the low-cost of this technique has fostered its spread
and use [49]. Despite its lower availability and higher costs, DCE-MRI is an-
other widely used technique. Similarly to DCE-CT, DCE-MRI provides very
high spatial-temporal data, but without exposing patients to ionizing radia-
tions [52]. Nonetheless, DCE-MRI is a highly versatile technique since it allows
choosing between several pulse sequences. As drawbacks, this methodology re-
sults to be very complex and the signal provided is not directly proportional
to CA concentration inside tissue [9]. Another used imaging technique is the
DCE-US. This low-cost and widely available technique also provides functional
information without releasing any ionizing radiations [52]. However, besides
suffering from intra- and inter-observer variability, DCE-US suffers from tech-
nical limitations such as the low depth of tissue penetration and a lower quality
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of the morphologic information provided [53]. As regards nuclear medicine, one
technique used is PET, that is high sensitive to signal variations even with very
low quantities of CA, is capable to provide metabolic information and provides
a signal that is directly proportional to the concentration of CA inside tissue.
Nevertheless, this technique has many drawbacks such as high cost, radiation
exposure, technical complexity, and lack of morphological information [9]. In
addition, differently from the imaging techniques previously discussed, PET
does not directly investigate the vascular system. This causes in some cases
apparent divergent assessments of tumour physiology with respect to perfu-
sion parameters obtained using DCE-CT, DCE-MRI, or DCE-US [54]. To
overcome some of the above mentioned drawbacks, the use of combined PET
and DCE-CT is discussed in the literature more and more frequently. In fact,
joining together morphological and functional information of DCE-CT with
metabolic one provided by PET, it is possible to gather these complemen-
tary information in one, very effective, tool [55]. However, the very long time
needed for examinations and the extremely high costs [16] limit its use.
2.2 Perfusion parameters in CTp
Perfusion has been defined as the transport of blood to a unit volume of tissue
per unit of time [56]. The first publication regarding the use of DCE-CT to
quantify perfusion (i.e., CTp) dates back to 1980 [57]. In that study, the au-
thor proposed for the first time a method to compute the blood flow (BF ) of
the brain in healthy patients. However, in those years both image acquisition
and data processing were too slow to allow the technique to become widely
accepted. At the beginning, CTp has been used only in perfusion studies of
the myocardial and the kidney [51]. The turning point arrived with the in-
troduction of two technical innovations: the use of multiple detector rows and
of slip rings. The former allowed improving the z -coverage of the analysed
tissue for each gantry rotation [58], while the latter allowed continuous rota-
tion of the x-ray tube by removing all the fixed connections of the rotating
components. These innovations permitted faster image acquisitions and the
introduction of the helical (or spiral) scan mode. Differently from the “classic”
acquisition modality (the axial mode), where the image acquisition occurs in
static conditions, in the helical scan mode the patient table is continuously
moved while the image acquisition goes on, allowing the acquisition of a tis-
sue volume rather than separate tissue slices [59]. The spread of CT systems
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equipped with multiple detector rows and slip rings allowed the diffusion and
the use of CTp in several diseases with particular success in acute stroke and
oncology [54].
To enable the computation of perfusion parameters, CTp relies on four
principles:
• the repetition of image acquisition of the same tissue portion
• the administration of a “short and sharp” bolus of iodinated CA
• the selection of at least one vessel supplying the analysed input
• the application of proper methods and kinetic models to extract signal
and compute perfusion parameters
The repetition of image acquisition of the same tissue portion before, during,
and after the administration of CA shows the attenuation changes caused by
CA arrival which are related to tissue perfusion [60]. In particular, by using
a iodinated CA the tissue attenuation changes are directly proportional to
CA concentration inside tissue that are thus easily measurable [61]. At the
beginning, tissue contrast enhancement is mainly due to the arrival of CA in
the intravascular (IV) space. As time goes on, CA gradually moves by passive
diffusion from the IV to the extravascular (EV) and the extracellular spaces,
and the tissue contrast enhancement is due to the presence of CA within
both the blood vessels and the interstitial space [13]. These two phases can
be observed in the tissue signal that can be extracted from the CTp image
sequences. By placing a region of interest (ROI) on the analysed tissue, it is
then possible to extract a time concentration curve (TCC) from each voxel
of the ROI. Therefore, this time signal is composed by the density values,
expressed in Hounsfield Units (HU), assumed by a specific voxel of the ROI in
different time instants. Since the HU values are directly proportional to the
quantity of CA within the IV and the EV space of a voxel in a specific time
instant, the shape of the TCCs reflects the passage of CA inside tissue [62].
CA has to be administrated in a small quantity and at a high flow rate
in order to obtain a “short and sharp” bolus [63], needed to allow a more
accurate computation of perfusion parameters [61]. Moreover, the increase of
the iodine delivery rate helps reducing the dose and, in case of organs with
a dual blood supply (e.g liver and lung), permits to better identify the two
tissue enhancement portions of the signal caused by CA bolus coming from
the two different vascular input [64].
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The third requirement of CTp is the selection of at least one vessel nour-
ishing the analysed tissue. By placing a ROI inside the selected input vessel
(usually an artery such as the aorta), and by averaging the density values in-
side the ROI of each acquisition time instant, it is possible to obtain a single
TCC that will be “compared” with the tissue TCCs in order to compute perfu-
sion parameters [8]. Several recommendations about the correct choice of the
input vessel and the positioning of the ROI have been made in the literature.
The selection of a feeding vessel big enough to prevent partial volume effects
causing the underestimation of the input signal, is highly recommended [63].
Moreover, originally it was suggested to place the arterial ROI as close as pos-
sible to the analysed tissue in order to reduce time delay effects and achieve
more accurate perfusion parameters. However, recently several algorithms
have been developed in order to correct for this delay and this requirement
is thus not so mandatory [65]. In organs characterized by a dual-input blood
supply such as liver and lung, it is possible to place a ROI on each vascular
input. This means that in the liver it is possible to draw a ROI on the aorta
(or on an hepatic artery) and one on the portal vein [8], while in the lung it
is possible to place one ROI on the aorta and a second one on a pulmonary
artery [66]). In Figure 2.1, there is an example of the ROIs that can be drawn
Fig. 2.1: A liver CTp image with ROIs placed on aorta (in the red colour), portal
vein (in the blue colour), and spleen (in the green colour) (a) and the averaged
TCCs extracted from each ROI (in the same colours) (b).
in the liver in order to consider a dual vascular supply. In these organs, the
use of a single input instead of two means assuming that the tissue vascular
supply is predominantly arterial and accepting that a systematic underesti-
mation of perfusion values occurs (as it is reported in [67] for the lung and
in [68] for the liver). The use of two input allows improving the reproducibil-
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ity of perfusion results, the characterization of tissues, and the assessment of
treatment response. Indeed, in a study of 7 patients with liver tumours it was
observed that perfusion results obtained by using two input were more repro-
ducible than those computed by considering a single input only [68]. Moreover,
the computation of perfusion parameters achievable only by considering two
vascular input allowed to differentiate malignant and benign lung lesions [69]
and to distinguish hepatic tumour from normal liver tissue [70, 71]. Perfusion
parameters achieved with dual-input were also used by Ohno et al. in order
to predict response to chemio and radiotherapeutic treatments and the OS of
53 [72] and 66 [73] patients with non-small cell lung cancer (NSCLC). Or else,
by analysing these parameters, Wei-Fu et al. [74] found a threshold value able
to predict patient survival after therapies administration. However, the possi-
bility to consider a dual-input blood supply in the perfusion analysis strictly
depends on the z -coverage of the CT system and on the acquisition protocol
adopted. Indeed, as reported in [75] for liver and in [76] for lung, by using
a narrow volume coverage or an inappropriate field of view (FOV), it is not
always possible to acquire in the same image both the tissue being studied
and the two vascular input. If the two input vessels are not present in the CT
images, one input only has to be considered.
The last principle which CTp is based on is the application of apposite
kinetic models and methods to the arterial and the tissue TCCs in order to
compute perfusion parameters [52]. All the models applied assume that the
tissue behaves as a linear and time-invariant system. This means that the
output of the system (i.e., the tissue) to multiple stimuli (i.e., the arrival of
CA bolus from different input) is equal to the sum of the tissue response to
the single stimuli separated. Moreover the response of the system is considered
constant in time, independently from the time instant in which the stimulus is
applied. On the base of these assumptions, two different theoretical concepts
on which the models and the methods to compute perfusion parameters are
based, have been developed [61]: the indicator dilution theory (IDT) and the
pharmacokinetics compartment models (PCM).
In the next paragraph (Sect. 2.2.1), a summary of the physical and bio-
logical meaning of the main used perfusion parameters is reported. Instead,
Sects. 2.2.2 and 2.2.3 report the principal methods and models used to compute
perfusion parameters on the base of IDT and of PCM principles.
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2.2.1 The perfusion parameters
CTp permits the calculation of several perfusion parameters, depending on
the kinetic model or method applied to the signal. By assuming that CA does
not diffuse from the IV space (i.e., modelling tissue as a single-compartmental
model) it is possible to measure the BF , the blood volume (BV ), and the
mean transit time (MTT ). On the contrary, by assuming that CA can join
the EV space (i.e., apply a model with more than one compartment) it is
also possible to assess the permeability surface (PS ), the extraction fraction
(EF ), and the ktrans. The way by which each of these parameters is related
to the pathology features of tumour angiogenesis and to the effects that the
anti-angiogenic drugs have on the vascular network is complex [8]. In this
paragraph, the main quantitative perfusion parameters used in literature are
summarized as well as their physical meaning and how they are supposed to
enable the assessment of tumour angiogenesis and the evaluation of tumour
response to therapies.
BF has been defined as the transport of blood to a unit volume of tissue
per unit of time and is expressed in ml/min/100ml or in ml/min/100g [52]. Its
value tends to increase with the increase of MVD [60]. In organs characterized
by a dual vascular supply, it is possible to compute BF values separately for
the two contributions. For instance, in the liver there are the arterial BF
(aBF ) and the portal BF (pBF ) while in the lung there are the bronchial BF
and the arterial BF . The total BF value can then be achieved as the sum of
the two partial BF values and a perfusion index (PI ) can be computed to
quantify the influence of the two blood supplies over the total BF [77].
BV measures the volume of blood flowing in the tissue, including blood in-
side arteries, arterioles, capillaries, venules and veins. BV is usually measured
in ml/100ml or ml/100g [52]. As BF , the BV value increases with higher
MVD [60].
MTT represents the mean time taken by the blood to transit through the
tissue vascular network (from arteries to veins) and it is expressed in seconds
(s) [60]. This parameter is not directly extracted from the kinetic models, but
it is derived from BF and BV values (see Sect. 2.2.2).
PS measures the product between the permeability and the total surface
of the capillary endothelium in a unit mass of the tumour and is expressed in
ml/min/100 ml [78, 79]. As reported in Sect. 2.1, abnormal vessels generated
after a gene mutation show a poorly formed vascular basement membrane
characterized by a high permeability [14].
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EF has the same unit of measure as PS , but it represents the fraction of
CA arriving at the tissue that leaks into EV space in a single passage through
the vasculature. Like PS , EF is directly related to the permeability of the
analysed vessels to CA [78, 79].
Finally, ktrans is the constant flow rate of CA from IV to EV space and is
expressed in min−1 [78, 80].
The combination of these parameters allows making important evaluations
about the analysed tissues. For instance, the increase of BF and BV values can
point out the presence of newly formed vessels if PS assumes high values, or the
presence of mature vasculature if PS value is normal or low. On the contrary,
low BF and BV values can indicate the presence of necrosis or inflammation,
whether they are coupled with low or high PS values, respectively [81].
All these parameters are usually represented through the use of colorimetric
perfusion maps, such as that reported in Figure 2.2 (c) together with a full
Fig. 2.2: Lung CTp image (a), the lesion magnified (b), and relative BF colori-
metric map (c).
slice (a) and the magnified lung lesion (b). Here, blue colours are used to
highlight the regions with the lowest perfusion while red colours indicate the
highest perfused areas. Instead, the pink colour is used to point out unreliable
BF values (Sect 4.2). This way of visualizing results is particularly useful since
it permits a first visual analysis of the perfusion parameters and the assessment
of spatial correlation and functional heterogeneity.
Another category of perfusion parameters providing semi-quantitative mea-
sures exists and are sometimes adopted in perfusion studies. For instance, the
“area under the curve” (AUC) is related to BF and the quantity of CA admin-
istered, and it is computed as the integral of the tissue TCC. Also, the “peak
enhancement” is connected to BV and corresponds to the peak of the tissue
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TCC, while the “time to peak” is related to BF and represents the lag between
CA administration and the peak enhancement [82]. However, these measure-
ments are very sensible to differences in iodine sensitivity of CT systems and
depends upon several factors such as the arterial input function, patient’s cen-
tral hemodynamics, and their weight [83]. Quantitative measurements such as
those discussed above are consequently often preferred.
2.2.2 Methods based on IDT
IDT considers tissue as a “black box” and consequently analyse the system
without making any morphological or physiological assumption [84, 85]. In
general, the output of a system can be described by the convolution between
the input function and the impulse response function of that system. By con-
sidering the organ or the tissue investigated as the system, its input and output
functions correspond to the concentration of CA in the arterial inflow Ca(t) (in
mg/ml) and the venous outflow Cv(t) (in mg/ml), respectively. Instead, h(t)
is the probability density function of CA particles and, in practice, represents
the distribution of transit times required by the molecules of CA to move from
the entrance to the exit of the system, by whatever path. The relation between
Cv(t) and Ca(t) can thus be described as in Eq. 2.1:
Cv (t) = h (t)⊗ Ca (t) =
∫ ∞
0
h (t− τ)Ca (τ) dτ (2.1)
Since, for the principle of mass conservation, all tracer particles entering the
system sooner or later leave it, the AUC of h(t) is unitary, as reported in
Eq. 2.2: ∫ ∞
0
h (t) dt = 1 (2.2)
Moreover, since h(t) is the frequency function of transit times, by definition,
MTT is given as its first moment, as described in Eq. 2.3 [61]:
MTT =
∫ ∞
0
th (t) dt (2.3)
However, since usually there are no a-priori information about the vascular
network, h(t) is unknown andMTT cannot be computed directly from Eq. 2.3.
In the particular case of a system with a single input and a single output, as
that depicted in Figure 2.3, it is possible to apply the Fick principle, describing
the law of mass conservation. In particular, the Fick principle states that Q(t),
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Ca(t) Cv(t)
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Fig. 2.3: Outline of a single input and single output mono-compartmental model.
the rate at which the quantity of CA (expressed in mg) accumulating in an
organ at any time t, depends on the organ BF , Ca(t) and Cv(t) [47], and it is
described by Eq 2.4:
dQ (t)
dt
= BF · Ca (t)−BF · Cv (t) (2.4)
However, venous outflow cannot be correctly measured by DCE imaging tech-
niques since the outflow vessels are too small if compared with the spatial
resolution of CT scanners. The measurement of Cv(t) would then be an un-
derestimation of its true value, due to partial volume effect [61, 86]. Therefore,
since the use of DCE imaging techniques only permits to measure regional BF
within a tissue or an organ, the Fick principle has to be reinterpreted. In par-
ticular, Q(t) is the mass concentration of CA in tissue (expressed as percentage
in mg/g) and BF is the specific BF of that tissue (in ml/min/g).
In order to compute BF parameters, two methods exist. While the first
one is based on the use of an additional assumption, the second one directly
faces the convolution problem through the use of Eq. 2.1. Both these methods
are presented below.
After the injection of CA, there is a period of time during which CA remains
inside tissue. During this period, it is possible to make the assumption of no
venous outflow (i.e., Cv(t) = 0), and this is the assumption which the first
method is based on to compute perfusion parameters. Hence, Eq. 2.4 can be
rewritten as follows:
dQ (t)
dt
= BF · Ca (t) (2.5)
and consequently, assuming that the rate of tracer accumulation is maximal
when the arterial concentration is maximal, we can write Eq. 2.6:[
dQ (t)
dt
]
Max
= BF · [Ca (t)]Max (2.6)
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With the acquisition of rapid series of CT images, it is possible to extract BF
from Eq. 2.6 and compute it as the rate between the maximum slope of the
tissue TCC (computed on the increasing portion of the TCC identified during
the first pass phase) and the peak height of the arterial TCC as shown in
Eq. 2.7 [61]:
BF =
[
dQ(t)
dt
]
Max
[Ca (t)]Max
(2.7)
This method to compute BF is known as the maximum slope method
(MSM) or simply slope method and has been validated in liver [87, 88],
kidney [89], pancreas [90], and brain [91, 92]. Figure 2.4 shows ideal aortic
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Fig. 2.4: Representation of the aortic TCC (in the red colour) and of a tissue
TCC (in the blue colour). The red star indicates the aortic peak while the blue
circle highlights the point of maximum slope of the tissue TCC.
and tissue TCCs with two markers in correspondence of the time points where
the parameters needed by the MSM (i.e., the aortic peak and the maximum
slope) have to be computed. The MSM can be applied also in biological
systems with a dual-input supply as the one schematized in Figure 2.5. In
these cases, the MSM is applied two times, by considering the contribution
of the two input functions separately. For instance, as regards the hepatic
district, while CA brought by the arterial input directly flows into the liver,
CA arriving through the portal vein arrives later, since it passes through the
spleen first. Therefore, usually the peak time of the splenic TCC is considered
as the separating time threshold between the two different TCC portions.
Indeed, while the enhancement of the tissue TCC before the splenic peak is
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Fig. 2.5: Representation of a dual-input and a single-output mono-compartmental
model.
considered to be caused predominantly by the arterial input, the part after is
mainly attributed to the portal vein. MSM is then applied twice according to
what depict in Figure 2.6. The first time, it is carried out on the first part of
Fig. 2.6: Typical tissue TCC of a dual-input system with the two portions sepa-
rated by the dotted vertical line and the two maximum slopes highlighted by the
red lines.
the tissue TCC by using the aorta or an hepatic artery as the vascular input,
and the second time on the second part of the tissue TCC using the portal
vein as the vascular input [8]. The same procedure can be used in the lung by
considering the left atrium peak as the time separator of the two tissue TCC
portions: the pulmonary portion before the peak, and the bronchial portion
after [76].
The main strong points of MSM are the mathematical, numerical and con-
ceptual simplicity. Nevertheless, the assumption of no venous washout does
not hold any more at the time instant when the tissue maximum slope is com-
puted. In fact, in some cases where the tissue is highly perfused and lowly
vascularized or the administered bolus of CA is not “short and sharp”, it may
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happen that part of CA starts leaking from the tissue before the maximum
slope time instant. In these cases, if the venous outflow is relevant, BF will be
underestimated [61, 86]. However, thanks to its easy implementation and to
its versatility, this method has been implemented in several commercial soft-
ware [52] and it is currently widely applied to several body districts such as
lung [73], liver [93], kidney [94], and pancreas [95].
The second method based on IDT and known as deconvolution method,
avoids the assumption of no venous outflow by solving the inverse process of
convolution. To well understand this method, the impulse residual function
R(t) has to be introduced. R(t) (represented in Figure 2.7) is a function
Time (s)
R
(t)
Fig. 2.7: Input residual function R(t).
describing the quantity of CA still inside tissue at time t and can be written
through Eq. 2.8:
R(t) = 1−
∫ t
0
h (τ) dτ (2.8)
By considering Eqs. 2.1 and 2.4 and thanks to R(t), it is possible to express
the relation between Ca(t) and the tissue concentration Ct(t) through Eq. 2.9
(see Appendix 8 for more details):
Ct (t) = BF ·R (t)⊗ Ca (t) (2.9)
When CA is still in the IV network it is possible to solve the deconvolution
problem and extract the flow-scaled R(t), that is the product BF ·R(t) [47].
The value of BV and BF can be extracted as the area and the maximum height
of the kernel BF ·R(t), respectively [61, 86]. By applying the central volume
21
Chapter 2. Background and state of the art
2.2. Perfusion parameters in CTp
principle [84], it is finally possible to compute MTT as the rate between the
area and the maximum height of the flow scaled R(t):
MTT =
BV
BF
(2.10)
Like MSM, the deconvolution technique allows considering the dual vascular
input. This can be done by describing the vascular input as the combination
between the two blood supplies. In particular, by introducing PI , the total
input of the system BF · Ca(t) can be written as described in Eq. 2.11:
BF · Ca(t) = PI · Ca (t) + (1− PI) · Cp (t) (2.11)
Therefore, Eq. 2.9 can be rewritten as in Eq. 2.12:
Ct (t) = [PI · Ca (t) + (1− PI) · Cp (t)]⊗R(t) (2.12)
where Cp(t) is the concentration of the second vascular input [77].
Although the deconvolution method has been validated in cerebral stud-
ies both against microspheres [96] and stable xenon [96, 97], it presents sev-
eral drawbacks due to its numerical properties. Indeed, while the convolution
operation gives a unique result, the inverse problem is ill-posed and returns
multiple solutions, all mathematically approximating the result of the convo-
lution between Ct(t) and Ca(t), but with some of them having no physiological
meaning and without knowing the right one [86]. To solve this problem, ad-
ditional assumptions on the shape of R(t) or correction methods have to be
applied. Several methods have indeed been proposed to achieve more cor-
rect results [98, 99]. The most spread in literature include the use of Wiener
filter on the Fourier transform of the deconvolution problem [100] and the
application of regularization methods such as the truncated singular value de-
composition [101, 102] and the Tikhonov regularization method [102, 103]. A
further problem of deconvolution is due to its sensitivity to bolus dispersion
and delay. Indeed, to reach the tissue analysed, CA has to pass through vessels
and microvessels of different dimension and length, this causing a delay and
a dispersion of the bolus measured inside the arterial input. Therefore, since
the shape of the function R(t) extracted from deconvolution reflects properties
of both vasculature and tissue, CA delay and dispersion will affect R(t) shape
and in turn the obtained perfusion values [104, 105]. Many studies have thus
been conducted in order to reduce the side effects of this issue and to permit
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a more accurate estimation of perfusion parameters [106, 107]. Despite decon-
volution approach is complex and still shows some limitations, this technique
has been widely implemented and it is currently adopted in several perfusion
studies [108, 109, 110].
2.2.3 Methods based on the PCM
The alternative method to IDT to analyse the tracer kinetic is PCM. While in
IDT the tissue is considered as a black box, in PCM, some assumptions about
the physiology of the analysed tissues are taken into account.
To better understand this part and the terminology used, it is important to
have clear in one’s mind the tissue physiological fluids and their classification,
represented in Figure 2.8. Indeed, fluids can be subdivided in the two macro-
Intra-cellular
space
Extra-cellular space
Extra-vascular space
Intra-vascular space
Interstitial space
Transcellular space
TISSUE
Fig. 2.8: Classification of the fluids inside a physiological tissue.
categories of intra- and extra-cellular fluids. Moreover, the extra-cellular fluids
in their turn can be subdivided in IV and EV fluids. IV fluid is constituted by
blood plasma, while EV fluid is made of the interstitial and the transcellular
fluids. However, since the volume of the transcellular fluid is very low and
often negligible, EV space can be considered as made by the interstitial fluid
only. For this reason, EV is often called interstitial space.
Differently from IDT, in PCM tissue is described by several interacting
compartments, each reflecting a different state of the administered CA. Each
compartment is characterized by the same kinetic status as CA [105] and it
can be assumed as being either well-mixed or plug-flow. In the first case, the
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concentration within the compartment is assumed to be spatially uniform at
any given time (Figure 2.9 (a)), meaning that CA spreads and diffuses inside
(a) (b)
x
0 L
x
0 L
(c)
x
0 L
dx dx dx dx dxdx dx
Fig. 2.9: Example of a well-mixed (a) and a plug-flow (b) compartment, referred
to a generic time instant ti where CA is distributed uniformly and following a
gradient (from x = 0 to x = L), respectively. Finally, the plug-flow compartment
in (b) has been further subdivided in infinite single compartments, each having a
different constant spatial concentration (c).
the compartment instantaneously. On the contrary, in case of a plug-flow
compartment, the concentration of CA is considered to be spatio-temporally
variant, following a gradient (Figure 2.9 (b)). In particular, it is assumed
that CA is carried on through a tube, whose length is parametrised by x
(i.e., ranging from x = 0 to x = L). For instance, this assumption may hold
when describing the status of CA inside the capillary bed, whose diffusion from
arteriole to venule takes a finite time and is not uniform immediately along the
whole vessels path [62, 111]. The concentration inside the compartment is both
temporally and spatially-dependent. Therefore, in order to mathematically
describe the system, the tube is subdivided into a series of small cylindrical
sections discs with infinitesimal height dx → 0, that are rings with an inner
constant spatial concentration (i.e., practically discs), so as that each disc can
be considered as a single compartment (Figure 2.9 (c)) [111].
In the following paragraphs, the main PCM used in the literature to eval-
uate perfusion parameters are briefly described. Starting from the single-
compartment model, the next paragraphs consider models composed by even
more compartments, up to four. However, this section is mainly focused on
the single- and two-compartment models which are those mostly used in the
literature.
The dual-input single-compartment model (2I1CM) is characterized
by one well-mixed compartment, two vascular input and a single output (Fig-
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ure 2.5). This model can be described by the following differential equation:
dCt (t)
dt
= k1a · Ca (t) + k1p · Cp (t)− k2 · Ct (t) (2.13)
where the parameters k1a and k1p represent the arterial and the portal inflow
rate constant, respectively, and k2 is the outflow rate constant of the system.
By solving Eq. 2.13 for Ct(t), it is possible to write Eq. 2.14:
Ct (t) =
∫ t
0
[k1a · Ca (T − τa) + k1p · Cp (T − τp)] · e−k2·Ct(t−T )dT (2.14)
where τa and τp are the delay parameters representing the transit time of CA
from aorta and portal vein to the tissue, respectively. By fitting tissue TCCs
with the model described in Eq. 2.14 and exploiting a minimization of the
fitting errors to achieve the best fitting, it is possible to compute the values
of the parameters k1a, k1p and k2 for that fitting curve. aBF , pBF , and MTT
can thus be achieved according to Eqs. 2.15, 2.16, and 2.17:
aBF =
k1a
EF
(2.15)
pBF =
k1p
EF
(2.16)
MTT =
1
MTT
(2.17)
Since EF in the liver can be assumed as being unitary [112], aBF and pBF
correspond to k1a and k1p, respectively. This model has been validated against
microspheres by Materne et al. [112] in the liver and has been used in several
hepatic perfusion studies, such as [113, 114]. However, 2I1CM could be used
also in case of a single vascular input, by assuming k1p = 0. Therefore, starting
from Eq. 2.14, it is possible to obtain the following model:
Ct (t) =
∫ t
0
k1a · Ca (T − τa) · e−k2·Ct(t−T )dT (2.18)
Therefore, in this case, aBF represents the total BF value of the organ and
corresponds is equal to k1a. Nevertheless, this model has been mainly applied
to dual input systems.
The two-compartment exchange model (2CXM) describes the plasma
and the interstitial spaces as two well-mixed compartments (Figure 2.10).
Since it is assumed that EV exchanges CA with IV only, to fulfil the mass
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Fiv
PS
viv
vev
Fig. 2.10: Schematic representation of 2CXM, where Fiv is the plasma flow, viv
and vev are the volume of the plasma and the interstitial space, respectively and
PS is the permeability surface between the two compartments.
conservation principle (stating that no CA accumulates in the system), the
exchange of CA between the two compartments is the same in both directions.
The equation of the model can be then written according to Eq. 2.19:
vev · dCev (t)
dt
= PS · Civ (t)− PS · Cev (t) (2.19)
where Cev and Civ represent CA concentration in EV and IV, respectively,
and vev is the EV volume. This model has been first applied to CT perfusion
studies [115], but recently its application has been extended to MRI perfusion
studies [116, 117].
The tissue homogeneity model (THM) is similar to 2CXM, but it de-
scribes the plasma space as a plug-flow system (Figure 2.11). However, this
model has not been widely adopted since the differential equations defining the
model does not have a time-domain solution [111]. To solve this problem, the
adiabatic approximation to the tissue homogeneity model (AATHM)
has been proposed by Lee [118]. The only difference between this model and
THM is the assumption that CA cannot pass through the capillary walls (i.e.,
PS = 0) in all spatial points other than x = L (as shown in Figure 2.12). IV
and EV can thus be respectively described by the two following differential
equations (Eq. 2.20 and Eq. 2.21):
viv
L
∂Civ (x, t)
∂t
= −Fiv · ∂Civ (x, t)
∂x
(2.20)
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Fiv
PS
viv
vev
Fig. 2.11: Schematic representation of THM. Here, the plasma compartment is
represented as a plug-flow system.
Fiv
PS
viv
vev
x
0 L
Fig. 2.12: Schematic representation of AATHM. The plasma compartment is
represented as a plug-flow system and CA exchange occurs only at x = L.
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vev
dCev (t)
dt
= PS · Cv (t)− PS · Cev (t) (2.21)
where viv is the IV volume, Cv(t) is the plasma concentration at the venous
outlet, supposed to be equal to Civ(L, t), and Fiv is the plasma flow (i.e., the
volume of plasma entering a unit of tissue volume per unit of time, expressed
in ml/min/ml). AATHM has been implemented in commercial software [52]
and, as such, it has been widely used [119, 120].
The distributed parameter model (DPM) assumes that both the com-
partments are plug-flow (Figure 2.13). The interstitial space is thus modelled
Fiv
PS
viv
vev
Fig. 2.13: Schematic representation of DPM. Here, both plasma and interstitial
compartment are represented as plug-flow systems.
as a series of infinitesimal compartments which interact only with the neigh-
bouring capillary walls. Consequently, in this model both Civ and Cev depend
on the spatial position where they are measured. DPM is described by Eq. 2.22:
vev
dCe (t)
dt
= PS · Civ (x, t)− PS · Cev (x, t) (2.22)
DPM has been validated with microspheres [121] and it has been recently
applied mainly for the evaluation of liver perfusion [122, 123].
The two-compartment models presented above permit to evaluate the value
of four parameters: Fiv, PS , viv, and vev. However, due to their complexity, the
use of simpler models with two- or three-parameters has been often preferred.
These simpler models are derived from the four-parameter two-compartmental
models described above through the formulation of further assumptions on at
least one of the four parameters [82]. The three simplified two-compartment
models mainly used in the literature are presented below.
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The Tofts Model (TM) [124] assumes that the IV space is negligible (i.e.,
viv = 0) and can be described as in Eq. 2.23:
Ct (t) = k
trans · e− k
trans
vevt ⊗ Ca (t) (2.23)
An extension of TM is the extended Tofts Model (eTM) that can be de-
rived by the compartmental model discussed above, through the assumption of
infinite Fiv (i.e., highly perfused tissues). This assumption allows considering
Ca(t) equals to Civ(t) and k
trans equals to PS . The eTM can be described by
Eq. 2.24 :
Ct (t) = viv · Civ (t) + ktrans · e−
ktrans
vevt ⊗ Ca (t) (2.24)
In TM, only ktrans and vev can be assessed, while in eTM it is also possible to
evaluate the viv value. Despite the accuracy of these parameters highly depend
on the tissue hemodynamic status, that is often unknown in advance [125], both
these two- and three-parameter models are often currently applied [116, 126,
127, 128].
On the contrary, the uptake model is based on the assumption that due
to high vev or low PS , Cev(t) is much lower than Civ(t) and hence the outflow
from the interstitial space is negligible. This model can be derived from any
of the four-parameter models previously discussed by imposing the condition
Cev = 0. This three-parameter model allowing to evaluate Fiv, PS , and viv [82]
is not so diffused in CTp. However, the Patlak model that can be derived
by the uptake model, assuming Fiv as an infinity quantity, has been widely
adopted. In Patlak model, Civ(t) is considered equal to Ca(t), while k
trans is
equal to PS . From Eq. 2.25:
Ct (t) = viv · Civ(t) + ktrans ⊗ Ca (t) (2.25)
it is thus possible to extract viv and k
trans [129, 130]. By imposing X (t) =∫∞
0 Ca(τ)dτ
Ca(t)
, and Y (t) = Ct(t)
Ca(t)
it is possible to rewrite Eq. 2.25 in the simpler
form:
Y (t) = viv + k
trans ·X (t) (2.26)
Thanks to the possibility of linearise Eq. 2.25 and thus to solve the problem
graphically [129, 130], Patlak model is highly attractive. Indeed, this model
has been implemented both in in-house and commercial software and widely
adopted in several perfusion studies [131, 132, 133].
Some few perfusion studies using three [134, 135] and four [135] compart-
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mental model have been proposed in the literature. However, due to their
complexity caused by the high number of compartments and of parameters
considered, the use of these models have still not gain a wide success in CTp
perfusion studies.
Table 2.2 presents a brief summary of the main features regarding the
discussed methods to compute perfusion parameters.
Kinetic models and methods used to compute perfusion parameters
Principle Method/Model NC Parameters Assumptions Complexity
IDT
MSM 1 BF No venous outflow Low
Deconvolution 1 BF , BV , MTT Assumptions about the shape of R(t) High
PCM
2I1CM 1 aBF and pBF well-mixed compartment Medium
2CXM 2 Fiv, PS , viv, vev IV and EV are well-mixed Medium
THM 2 Fiv, PS , viv, vev IV is plug-flow and EV is well-mixed High
AATHM 2 Fiv, PS , viv, vev
IV is plug-flow, EV is well-mixed, and the
High
exchange of CA occurs only at venous end
DPM 2 Fiv, PS , viv, vev IV and EV are plug-flow High
TM 2 ktrans, viv, vev Fiv ≈ ∞ and viv ≈ 0 Low
eTM 2 ktrans, vev Fiv ≈ ∞ or viv ≈ 0 Medium
Patlak model 2 ktrans, viv Cev<Civ Low
Tab. 2.2: Main features of the most commonly used methods and models: the
principle on which they are based on, the number of compartments (NC) they
consider, the perfusion parameters they yield, the assumptions which they are
based on, and their complexity level.
2.3 Clinical Application of CT perfusion in on-
cology
CTp has proved to be a very useful tool in several clinical applications. Sev-
eral very recent reviews [10, 136, 137, 138, 139, 140, 141], have been indeed
published gathering clinical results obtained through the use of CTp. This
paragraph resumes the main clinical results achieved by exploiting CTp pa-
rameters in several body districts, with a special focus on lung and liver, which
are the two organs dealt with in this Thesis.
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2.3.1 Correlation of CTp parameters with tissue angio-
genesis
One of the main reasons for which DCE imaging techniques were introduced in
the oncology research is the needs for tools able to assess tumour angiogenesis.
To this purpose, CTp parameters showed to be well correlate with several an-
giogenesis biomarkers (e.g. MVD or VEGF) in cancer of lung [142], liver [143],
prostate [144], kidney [145], head and neck [146], and soft tissues [147]. In par-
ticular, in the lung cancer a significant correlation between MVD and BV [142,
148] and also between MVD and BV [149] was found in patients with several
tumour subtypes. In two more studies on the lung cancer carried out by Ma
et al., a correlation between MVD and the perfusion parameters was found
also for PS [150] and MTT [151]. Moreover, in this last work a great correla-
tion between VEGF and BF , BV , PS , and MTT was also reported [151]. As
regards liver tumours, a significant correlation was observed between VEGF
receptor 2 and BF , BV , and the hepatic PI (HPI ) [143]. The arterial and the
total BF instead, resulted to be correlated with both MVD [71] and the level
of circulating IL-8 [152]. However, discrepancies between results were found in
CRC. Indeed, while Goh et al. [153] found correlation between PS , BV , and
MVD, in two more recent works [154, 155] no significant correlations could be
found between MVD and BF , BV , MTT , PS , and ktrans. A possible reason
why these results do not agree can be found in [155]. In this work, Dighe et
al. suggest that while CTp parameters aim at measuring tumour functional
characteristics, the MVD is based on the morphological count of all vessels,
some of which could not even be perfused.
2.3.2 The use of CTp parameters in diagnosis
Cancer diagnosis and therapeutic decision making strictly depend on the in-
formation that a clinician is able to achieve as regards extension, stage, grade,
and stratification of tumours. By using conventional imaging techniques, can-
cer tissue often does not show features allowing distinguishing it from healthy
tissues. Detection and assessment of tumour extension is consequently rarely
possible with conventional imaging techniques and, when so, it is often not
possible to characterize the tissue as benign or malign. Of course, assessing
both tumour grade and stage that have shown to be correlated with tumour
aggressiveness and prognosis, and that are therefore fundamental for the choice
of the therapy on the decision making process, is quite impossible with the use
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of conventional imaging [82]. On the contrary, CTp has shown to be effective
in characterization, differentiation, and estimation of tumour grade and stage.
Several perfusion parameters have indeed shown to be significantly different if
measured in the tumour or in the normal tissue. For instance, BF and PS in
the prostate [156] and BF , BV , and PS in the kidney [157] showed to be signif-
icantly higher in tumour than in the surrounding tissue. Moreover, BF , BV ,
PS , and MTT were found to be significantly different in the pancreas [133]
and in the colon-rectum [158]. In the liver, things are more complicated due to
the effects that tumour progression has on liver blood supply. It is well-known
indeed that the evolution of hepatocellular nodules in hepatocellular cancer
(HCC) cause a decrease in the pBF and an increase in the aBF and in the
HPI [8]. This was observed in several studies comparing normal liver with
metastases from CRC [70] and normal liver with HCC [71, 159]. Opposite
results were obtained for the global BF value in the comparison between HCC
and normal tissue. Indeed, while Yang et al. [71] found global BF value lower
in HCC than in normal liver, Ippolito et al. [159] found the global BF value
higher. Anyway, BF value is not the only marker that have been identified
to characterize liver tumours. Indeed, by analysing liver metastases from en-
docrine tumours, Lefort et al. [160] found that BF was significantly higher
and MTT was significantly lower in metastatic tissue that in normal liver.
Also Frampas et al. [161] observed a significant difference between MTT val-
ues computed in HCC and in the surrounding normal parenchyma. Wang et
al. [123] instead, found as a characterization marker the PS value that resulted
to be significantly higher in the metastases from neuroendocrine tumours than
in the normal liver.
Completely different is the case of lung nodules detection. Thanks to the
high density difference between lung normal tissue (that typically ranges be-
tween −700 and -900HU [162]) and lung nodules (usually between −200 and
200HU [163]) it is not so difficult to detect the presence of abnormal tissue
mass even with conventional imaging techniques. However, density alone can-
not allow differentiating between benign and malignant lung nodules [164]. To
this purpose, CTp has shown to be very useful by proving that benign and
malignant nodules are characterized by significantly different perfusion values.
This was demonstrated for BF , BV , EF in [165, 166], for BF , BV , PS in [167],
and for the pulmonary PI in [76]. Further studies also taken into account the
inflamed tissue were carried out by Li et al. [168] and Ma et al. [151]. Both
the authors found that BF and BV were able to discriminate benign nod-
ules from inflamed tissue and malignant nodules. However, none of these two
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parameters was significantly different to enable a differentiation between the
inflamed tissue and the malignant nodules. A solution to this issue was pro-
posed by Li [168], that also investigated PS . This last perfusion parameter
indeed, showed significant differences between inflamed tissue and malignant
nodules, thus enabling their discrimination. The combined use of BF and
PS , or of BV and PS can thus yielding a complete discrimination between
inflamed tissue, benign and malignant solitary lung nodules. CTp parameters
have also shown a great differentiation capability in the colon-rectum to dis-
tinguish between cancer and diverticulitis [158] and in pancreas to differentiate
adenocarcinomas and masses forming pancreatitis [133].
Another important feature necessary to make a correct diagnosis is the
knowledge of tumour subtypes. In this way, CTp has also shown good perfor-
mance in kidney to identify papillary renal cell carcinoma, chromophobe renal
cell carcinoma and angiomyolipoma [157], and in the liver to discriminating be-
tween HCC, hypo-vascularized, and hyper-vascularized metastases [169]. Het-
erogeneous results were instead found as far as the differentiation of lung cancer
subtypes was concerned. Li et al. [148] did not find any significant differences
between BV values computed in adenocarcinomas, squamous cell carcinomas,
large cell carcinomas and small cell carcinomas. Similar results were obtained
by Spira et al. [149], that analysed BF and BV in adenocarcinomas, squamous
cell, and small cell lung cancers. On the contrary, a more recent research of
Nguyen-Kim et al. [170] addressing dual vascular supply pointed out a signifi-
cant difference of BF values in some tumour subtypes. In particular, BF was
found to be lower in adenocarcinomas than in squamous cell carcinomas and
large-cell carcinomas, while in large-cell carcinomas the bronchial BF resulted
to be significantly higher than in adenocarcinomas. Instead, Fraioli et al. [171]
by using a single vascular input, found significant differences in BV values of
large cell carcinoma, adenocarcinoma and squamous cell carcinoma.
Other two information needed to make a correct and accurate diagnosis are
tumour staging and grading. Capability of CTp to assess tumour staging has
been drawn in prostate [172] and in head and neck [173] cancer. On the con-
trary, the study by Reiner et al. [145] on renal cell carcinoma did not show any
correlation between tumour stage and BF , BV , and ktrans. As regards tumour
grading, a good efficacy of CTp was observed in colorectal [154], prostate [172],
brain [174], and pancreas [175] cancer. Worse results were instead obtained
for kidney, liver, and lung cancer. In particular, the results obtained in kidney
varied based on tumour types. In the same year, Reiner et al. [145] did not
obtain any correlation between renal cell carcinoma grade and BF , BV , and
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ktrans, while Zhang et al. [176] shown the capability of BV to differentiate be-
tween high and low grade of clear cell carcinoma. In the liver, a study enrolling
52 patients with HCC did not found any correlation between tumour grading
and aBF , pBF , total BF , HPI , and BV . In lung, both Nguyen-Kim et al. [170]
and Li et al. [148] did not found any correlation between tumour grading and
the perfusion parameters being tested (i.e., PI in [170], and BF , BV , MTT
in [148]). However, opposite results were achieved in a larger study carried
out by Spira et al. [149] that observed a correlation between lung cancer grade
and BF values in 72 patients with several different subtypes of lung cancer. In
this study indeed, lower values of BF corresponded to a higher tumour grade.
2.3.3 The use of CTp in therapy monitoring and sur-
vival predicting
Another important issue for which DCE imaging techniques have been intro-
duced is the assessment of anti-angiogenic drugs efficacy and the early pre-
diction of their outcome. In a recent work, Prezzi et al. [177] report how the
effects of anti-cancer therapies can be evaluated by using BF , BV , PS , and
EF . Indeed, the standard chemotherapy and the vascular disrupting agents,
provoke the reduction of BF , BV , PS , and EF values, while the administra-
tion of radiotherapy produces their reduction only after an initial increase.
The administration of angiogenesis inhibitor only affects the values of PS and
BF , which first increase and then diminish. All these effects have been ob-
served in several studies regarding different body districts. For instance, the
administration of Bevacizumab and radiotherapy has been found to cause a
reduction in BF , BV , and PS values of the soft tissues sarcomas [147]. A
decrease of BF values was observed in neuroendocrine tumours after the ad-
ministration of Bevacizumab and Everolimus [178], in esophageal cancer after
chemoradiation therapy [179] and in chest and abdomen after the administra-
tion of a combination of AZD2171 and gefitinib [180]. In a study regarding
advanced HCC a decrease of BF , BV , and PS was observed after the adminis-
tration of bevacizumab in combination with gemcitabine and oxaliplatin [181].
In NSCLC, the administration of sorafenib and erlotinib caused a decrease of
BF value [182], while the use of chemotherapy combined with anti-angiogenic
drugs (e.g. paclitaxel and bevacizumab) caused a significant reduction of BF
and PS values in advanced lung adenocarcinoma [183], large cell carcinoma,
adenocarcinoma, and squamous cell carcinoma [171].
CTp has also shown to have a great prediction capability of patient survival
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with cancer in several body districts. Perfusion parameters have been capable
of discerning the patients responding to therapy from those who did not in
soft tissues sarcomas [147], in esophageal [179, 184], oropharynx [185], and
lung cancer. In particular, in NSCLC BF was significantly different between
responders and non responders in [73, 182, 186], while the total tumour BV
was identified as the most effective indicator in [187]. Instead, significant
differences in both BF , BV , and PS values were found in the advanced lung
adenocarcinoma between responders and non-responders patients [183]. As
regards the liver, different results were achieved by Frampas et al. [161] and
Jiang et al. [181] through the analysis of different perfusion parameters. In 11
patients with advanced HCC, treated with sorafenib and suritinib, Frampas
did not find any significant differences at baseline between BF , BV , MTT ,
and PS values between RECIST progressors and non-progressors (measured
at month one and two). On the contrary, Jiang et al. [181] found that the
ktrans value measured in 23 patients with HCC and treated with bevacizumab
and GEMOX-B was significantly different in responders and non-responders.
In that case, ktrans could be considered as a biomarker predicting patients
response.
CTp parameters also showed to correlate with OS in cancer of esopha-
gus [179, 184], colon-rectum [188], rectum [189], pancreas [190], brain [191],
liver [74], and lung [39, 72]. The relation between CTp parameters and PFS
was demonstrated in oropharynx [185], liver [181] and lung [182] cancer. As
regards the lung, in a recent study Hayano et al. [192] did not notice any cor-
relation between OS or PFS and BF , BV , and MTT values computed in 35
patients with NSCLC. These results are at the opposite of those obtained in
the two studies on NSCLC found in by Wang et al. [186] and Li et al. [193],
which confirmed the capability of CTp parameters to predict both patient OS
and PFS. The main difference between these studies is in the perfusion param-
eters considered. In the work of Wang et al., PS was the marker of survival,
which was not computed by Hayano et al.. Differently, Li et al. considered
a dual vascular supply and identified the marker of survival in the bronchial
BF , while Hayano computed perfusion values by using a single input only.
A further final improvement brought by the use of CTp is the assessment
of perfusion parameters’ capability to predict the development of metastases,
as it was shown in two studies on CRC [194] and rectal cancer [189].
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2.4 Open issues in CTp
Despite CTp has shown to be a very promising technique in the oncological
field for its capability to assess angiogenesis, characterizing and differentiating
tissues, monitoring therapies, and predicting survival of tumours in several
body districts (Sect. 2.3), it has not been applied in the clinical practice yet.
Several issues concerning the CTp examinations are still open and needs to be
dealt with. These issues regard different phases of the process involved in the
achievement of correct perfusion results, from CT images acquisition till the
computation of perfusion parameters. Some of the steps have already been
faced in literature, some at last partially, while some others have still to be
addressed. The main ones are:
• the lack of standardization in both acquisition and data analysis proto-
cols
• the definition of the acquisition parameters in function of the radiation
dose
• the lack of repeatability and reproducibility of perfusion results
• the presence of patient motion
• the application of the most correct post-processing procedure
• the selection of methods and models to compute perfusion parameters
• the way to analyse the reliability of perfusion results
All these issues are discussed in the following subsections.
2.4.1 Lack of standardization
One of the most critical issues of CTp is the lack of standardization in both ac-
quisition and data analysis protocols. In fact, this issue prevents the widespread
use of CTp [8], the comparison of results obtained in different clinical stud-
ies [111], and the implementation of multi-centre studies [111, 195].
The problem of the lack of standardization has been addressed by Miles
et al. in [83]. The Delphi process involving several DCE-CT experts allowed
the development of guidelines addressing various aspects of the acquisition and
the data analysis protocols. The first issue that has been faced regards CT
scanner requirements. Indeed, the limited z -coverage has been one of the many
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limitations of CTp up to the recent advances of CT systems. In fact, until a
few years ago the need of examinations with a high temporal resolution limited
the width of the studied volume, that had to be limited to a single section, or
a few sections, only [63, 54]. The introduction of CT machines endowed with
256 or 320 detector rows and capable to acquire images at a high temporal
resolution in both axial and helical modalities, allowed achieving a wider z -
coverage and performing the analysis of the whole tumour or of multiple lesions
present inside an organ [81]. In addition to the indications on CT scanner
requirements, the work in [83] also returns recommendations regarding the
acquisition protocol to be followed, the CT system quality assurance (that
should be carried out on phantoms before beginning each clinical trial), and
the results that should be presented in a CTp study.
Despite the useful recommendation given in [83], several aspects of CTp
acquisition and processing protocols still needs to be faced. Indeed, without
knowing exactly the effects that a variation of acquisition parameters would
cause on results, the use of different acquisition protocols would prevent the
comparison of results obtained in different CTp studies and the set-up of multi-
centre studies. In particular, multi-centre studies are essential before introduc-
ing an imaging technique as a standard to be used in the clinical routine. This
issue is addressed in Chapter 6, where through the analysis of data coming
from a CTp multi-centre study on liver, it has been possible to draw some
preliminary guidelines about the set-up of multi-centre studies.
2.4.2 Radiation dose and Acquisition parameters
The reduction of radiation dose is one of the main challenges of CTp. Due to
the cancer risk associated to radiation exposure, the dose delivered to patients
should be decreased as much as possible, without compromising the quality
of the achieved perfusion results [83]. The radiation burden is associated to
the CT tube current and voltage (and finally to mAs), and to the number of
“volumes” acquired. The decrease of tube current and voltage allows reducing
the radiation dose administered to the patient [131] at the expense of the
quality of results [8]. The reduction of detected signal results in increased
noise levels [64] and in artefacts from beam hardening [8] that can significantly
affect the quality of the computed perfusion values. A possibility to face this
problem and reduce image noise is increasing the slice thickness and lowering
the resolution of the reconstruction filters. However, this would lower the
image spatial resolution [196]. Another possible solution to reduce the overall
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radiation dose is to diminish the number of images acquired by shortening the
duration of the examination or by decreasing the sampling frequency. However,
the diffusion of CA inside tissue and its spread out of the IV space take a
finite time and the use of too short duration acquisition sequences could not
allow monitoring these events, hence yielding possibly misleading perfusion
values. This is yet more true for those perfusion parameters such as PS and
EF describing CA exchange between two or more compartments [54]. On the
other hand, the radiation dose reduction by decreasing the sampling frequency
leads to a poorer image temporal resolution, this affecting the accuracy of the
computed perfusion parameters. This is particularly true for those perfusion
parameters computed by using methods based on the IDT, such as MSM, for
which having a high temporal resolution is of fundamental importance [197].
However, independently from the method adopted, the exposure reduction has
unavoidable consequences on the acquired image quality and on the accuracy
of perfusion results computed on those data. A trade off between heavily side
effects associated to the received radiation dose and benefits deriving from the
clinical information coming from CTp thus needs to be found [81]. Actually,
several perfusion studies have been carried out in order to estimate perfusion
parameters quality achieved by using low-dose acquisition protocols [131, 198,
199]. However, at present there are no precise guidelines about the exact
method to adjust acquisition parameters in order to guarantee a satisfying
image quality and a “low” radiation dose for each patient [83].
2.4.3 Repeatability and reproducibility
Repeatability and reproducibility of perfusion parameters are mandatory pre-
requisites of CTp technique to enable its use in the clinical practice. In the last
few years, some studies have been carried out to this purpose. For instance,
Sahani et al. [200] found a high correlation and a low variability between BF ,
BV , MTT , and PS values computed on two consecutive CTp image sequences
acquired at 30 hours time distance in 4 patients with HCC. Low differences
between BF , BV , MTT , and PS values were also found by Goh et al. [201]
in two consecutive CTp examinations performed in 48 hours on ten patients
with CRC. Two different studies were instead carried out on lung to assess
perfusion parameters reproducibility by using different z -coverage [202, 203].
In both these works, ten patients with lung cancer underwent two consecutive
CTp scans (repeated within 24 hours) and the median BF and PS values were
computed on both a single slice and four adjacent tumour sections. A greater
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reproducibility of perfusion parameters was achieved by computing them on
analysing a wider volume coverage. Two more studies [204, 205] were finally
performed to assess reproducibility of perfusion parameters with respect to the
acquisition time length of the examination and the application of motion cor-
rection methods. Seven patients with liver tumour [204] and 10 patients with
lung cancer [205] underwent CTp examination. In both the studies, results
obtained in lung cancer, in tumour liver, and in normal tissue resulted to be
more reproducible by using longer acquisition scan and by applying the motion
correction algorithm. These findings were particularly true for PS . Indeed, as
discussed in Sect. 2.4.3, to achieve a correct value, PS has to be computed
on long acquisition sequences. Of course, using long acquisition time results
in unavoidable patients respiratory motion, this requiring motion correction
algorithms to reduce data variability.
Despite the encouraging results obtained in the studies discussed above,
a lot of work still needs to be carried out. The activities can be resumed
in two main tasks. First of all, it is important to analyse repeatability and
reproducibility in a wider number of patients to achieve a higher statistical
significance of results. Thereafter, it is necessary to carry out multi-centre
studies that use examinations acquired in different Centres and therefore with
different CT scanners, which can propagate differences on protocols and so
on [8, 83]. These two tasks have been partly addressed in Chapter 7, where
almost 400 liver CTp examinations acquired in 19 different Centres have been
considered for perfusion analysis, although 87 examinations have been analysed
at the end.
In addition, in order to achieve a correct and effective assessment of re-
peatability and reproducibility of perfusion results, it is also necessary to con-
sider voxel-based perfusion values, instead of global ones (used in the works
discussed above). Employing mean or median operators allows obtaining more
repeatable and reproducible results that, however, cannot take into account
local spatial heterogeneity of tissues analysed (see also Sect. 2.4.7). To also con-
sider tissue’s spatial features, it is therefore necessary to perform a voxel-based
analysis, that however is much more sensible to the presence of random and
systematic errors caused by both image acquisition and data analysis [206]. In-
deed, the presence of noise, artefacts, and anatomical structures (i.e., bronchi
and vessels) can jeopardize the reliability of the computed perfusion parame-
ters and, in turn, their repeatability. The fact that in the literature, all the
perfusion values achieved have always been considered reliable, disregarding
the presence of model or numerical errors, has represented a huge obstacle
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to the achievement of repeatable perfusion results. Consequently, the lack of
indexes to assess perfusion results accuracy and to detect and quantify at least
the non-systematic errors is a crucial point for the achievement of repeatable
results. Developing tools to assess results reliability is thus necessary in order
to go towards large-scale trials [195]. This issue is faced in Chapter 4.
2.4.4 The problem of motion
Motion has always represented a great issue to be faced in CTp studies. Both
voluntary (e.g. respiratory motion) and non-voluntary (e.g. peristaltic mo-
tion) motion can bring to voxel-based TCCs composed by signals coming from
different tissue portion and consequently lead to incorrect perfusion results.
Respiratory motions are those causing the most significant consequences on
TCCs’ quality and mainly affect tissues of the upper abdomen and thorax [81].
This issue has ever been very challenging, especially in those studies using CT
scanners permitting a narrow z -coverage only. In these cases, indeed, the mo-
tion of tissue out of the FOV causes data loss [63]. Several approaches have
been proposed in the literature to cope with this issue, the principals of which
are: the use of immobilization devices and hypotonic agents, the acquisition
of images in breath-hold conditions (that anyway can be limited in time), and
the adoption of motion correction methods [52]. The use of motion correc-
tion algorithm has shown to yield more reproducible perfusion results [204,
205] and to be necessary to achieve reliable results, otherwise the examina-
tions should have to be discarded [207]. Also the guidelines in [83] suggest
the use of motion correction algorithms and recommend to exclude from the
analysis those images particularly affected by patient motion. This issue has
been partly faced in Sect. 7.2, dealing with the early prototypic algorithm for
automatic motion correction of liver CTp images I have developed.
2.4.5 Signal post-processing
The application of spatio-temporal filters to the CT images and to the TCCs
allows correcting for the presence of acquisition noise, discretization errors,
and motion artefacts. However, the lack of guidelines about their application
can cause variability in the results obtained through the use of different post-
processing procedures [83]. As regards the spatial domain, the median filters
with kernels of size 3 [208] or 5 [209, 210] are the most used, since they are ef-
fective on removing noise while preserving geometric structures present in the
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images. However, the literature also reports the use of smoothing filters, such
as the weighted means [211, 212], that cannot preserve edges as median filters
do. Instead, as for the time domain, smoothing filters and fitting methods are
often applied to the TCCs. To this purpose, Moreira et al. [213] proposed the
use of a 7-point moving average filter to analyse cerebral CTp images. This
temporal filter was selected between the moving average, the moving median,
and the smoothing filter as the one showing the best trade-off between appli-
cation simplicity and goodness of results achieved. Instead, 3-point moving
average filters were adopted in CTp studies of the myocardium [211] and on
simulated liver TCCs [214]. In particular, in the work of Romano et al. [214]
the aBF values were computed by using three different methods of temporal
smoothing. The moving average method applied to the simulated TCCs re-
sulted to be superior to the other two methods based on parametric fitting
strategy. To achieve denoised signal indeed, it is also possible to apply para-
metric and non-parametric fitting techniques. The former relies on assump-
tions regarding the diffusion model of CA inside the tissue voxel analysed and
returns a signal reflecting these assumptions. The latter yields resulting TCCs
that are more faithful to the original signal, meanwhile being more affected
by the presence of outliers and noise. In [215], both non-parametric spline fit-
ting method and the parametric Gamma-variate model are successfully used to
compute aBF in 8 patients with HCC. The Gamma model described in [216,
217] has been widely adopted in perfusion studies [119]. However, by changing
the assumption on the kinetic diffusion of CA inside the analysed tissue, it is
also possible to apply other models such as the Weibull [218] or the Hill [219]
ones. In particular, the Hill’s model fits the assumption of no venous outflow,
since its increasing sigmoidal shape well describes the arrival of the bolus of
CA inside tissue, but not its flowing out. A family of curves for the Gamma-
variate, Weibull, and Hill models are represented in Figure 2.14.
2.4.6 Methods and models to compute perfusion pa-
rameters
The choice of the best model or method to compute perfusion parameters is still
widely debated. Each technique relies on different assumptions regarding CA
distribution inside tissue, this leading to the computation of different perfusion
parameters (as reported in Table 2.2). Moreover, the adequacy of methods or
models to compute perfusion parameters may depend on the acquisition proto-
col used. A short acquisition protocol, ending before CA flowing out from IV
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(a) (b) (c)
Fig. 2.14: Gamma-variate (a), Weibull (b), and Hill (c) model are represented.
space, can indeed be suitable to methods based on a single compartment. On
the contrary, longer acquisition protocols allow assessing also the vascular per-
meability of the analysed tissue by computing perfusion parameters such as PS
or ktrans through the application of two, or more, compartment models [54]. In
case of retrospective studies, the selection of the method or model that has to
be applied must take into account the limitations imposed by the acquisition
protocol applied (such as duration and sample frequency). On the contrary,
in case of a perspective study it is possible to decide a-priori which perfusion
parameters to study, which method or model to apply to achieve those param-
eters, and which acquisition protocol, accordingly [64]. However, at present
there is not any established agreement yet, regarding which parameters should
be considered and, consequently, which model and acquisition protocol should
be applied in the various perfusion studies [83].
Currently, only few studies exist that have compared perfusion parame-
ters obtained with different kinetic models applied on human tumour tissues.
Kanda et al. proposed two studies that compared perfusion parameters com-
puted using different methods, based on the assumption of a single compart-
ment. In [113], the mean values of aBF , pBF , and HPI were computed in 109
patients with a high risk of malignant liver tumour by using the dual-input
maximum slope (DIMS) method and the 2I1CM. Results of statistical tests
pointed out the differences between parameters obtained with the two meth-
ods and highlighted the fact that they are not directly comparable. The same
results were obtained in [114], where aBF , pBF , and HPI were computed
in 88 patients with liver metastases by using the MSM, the single compart-
ment model, and the deconvolution method. Perfusion results computed by
using the various methods and models were again hardly comparable. In-
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stead, three more works compared perfusion parameters obtained by using
two-compartment models. In particular, in [220] the values of BF , BV , MTT ,
and PS were computed in 19 patients with advanced HCC by using 2CM,
TM, eTM, AATHM, and DPM. The study was repeated after 10-12 days from
the administration of the anti-angiogenic treatment since its aim was to study
whether any parameter could be a predictor of 6-month PFS. The results
highlighted that both the absolute values of each perfusion parameter and
the differences measured in the two examinations were significantly different
among the models applied. Similar results were obtained in [188] in the evalu-
ation of the capability of perfusion parameters to predict the 5-year OS in 46
patients with primary CRC. The value of BF , BV , MTT , PS , EF , vev, and
ktrans computed by using four different models (2CM, eTM, AATHM, DPM)
resulted to be significantly different. Instead, another study [221] carried out
on 44 patients with CRC, compared ktrans and BV values achieved by applying
AATHM and Patlak model. Also in this case, the perfusion results achieved
with the two models were significantly different and could not be directly com-
pared. Anyway, it is important to remark that in this last study, the use of
different commercial software might have affected the obtained results. Indeed,
in [222] the use of the same commercial software before and after the upgrade
on the same datasets of 30 patients with suspected CRC, leads to significantly
different values of BF , BV , MTT , and PS . This study demonstrates that also
the use of different commercial software (even if produced by the same ven-
dor) can deeply affect perfusion results and prevent comparison of parameters
computed in different studies.
2.4.7 The analysis of results
Another source of inhomogeneity that could lead to different clinical consider-
ation is the modality used to analyse perfusion results. To this purpose, it is
possible to subdivide the problematic into three main issues, which regard the
ROIs selection, the method of analysis used (global or voxel-based), and the
number of tumour sections considered.
The first issue regards the lack of consensus on how the tissue ROIs should
be drawn [83]. Due to tumour heterogeneity, the analysis of data coming from
different tissue portion could yield different clinical consideration. In a re-
cent study involving 27 patients with lung cancer indeed, the mean BF and
BV values were computed in several ROIs of different size and placed in dif-
ferent position of the same tumour section. The results of statistical tests
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highlighted that the computed perfusion parameters showed a high variability
between ROIs of different size and position and that the highest reproducibil-
ity of results was achieved using the ROI encompassing the whole tumour
surface [110].
The second issue regards the selection of one of the two methods that can
be used to analyse perfusion parameters [223]. The first one is based on the use
of statistical indexes (e.g. mean or median value of the perfusion parameters)
that allows obtaining a unique perfusion value aiming at being representative
of the whole ROI, or the whole tumour. This method permits a simple and
fast analysis of perfusion results [223] and generates perfusion parameters with
a great intra-observer and inter-observer reproducibility, whether global values
are computed on a single slice [201] or on a number of tumour sections [200]. In
any case, this method does not bring any information about the spatial distri-
bution of perfusion patterns and masks the local tissue variability that are the
characteristic feature of tumours (i.e., tumour heterogeneity) [60]. The second
method to be used consists in a voxel-based perfusion analysis. This method
enables the study of local perfusion heterogeneity and the detection of hypo-
and hyper-vascularized areas [223]. As reported by Petralia et al. in [52, 60],
the voxel-by-voxel analysis can be done both qualitatively, by visually assess-
ing perfusion maps, and quantitatively by analysing histograms of perfusion
values [224] or by adopting fractal analysis [225, 226]. However, voxel-based
analysis requires longer and more complex computational techniques [223] and
the use of global perfusion parameters is still often preferred.
The third issue regards the selection of the number of tumour sections on
which perfusion parameters have to be computed. Due to tissue heterogeneity,
perfusion of a single slice may not reflect perfusion of the whole tumour [8].
More reproducible perfusion results were achieved in two studies of lung can-
cer [202] and CRC [203] by using a greater z -coverage. However, both these
studies have been conducted by using global values that cannot take into ac-
count tumour heterogeneity. Also in this case, the lack of guidelines facilitates
the spread of different, and sometimes not appropriate, solutions. Despite the
knowledge that tumour heterogeneity can highly affect perfusion parameters
computed on a single slice, there are still several studies that currently com-
pute perfusion parameters on a single tumour section only [192, 227, 228]. In
order to evaluate the representativeness of global and voxel-based perfusion
results computed on the whole tumour and on a single slice with respect to
tissue heterogeneity, a deep analysis has been carried out in Chapter 5.
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In this Chapter, the methods and the indicators that have been defined, im-
plemented, and tested during my PhD activities are presented and discussed.
First of all, the pre-processing techniques applied to the CTp data of each
examination and the methods used to compute perfusion parameters are pre-
sented (Sect. 3.1). Then, a series of error indexes is taken into account in
order to evaluate the quality of the signal on which the perfusion parameters
are computed. Four temporal indexes of goodness of fit are indeed investigated
and compared to find out the most suitable one to evaluate TCCs’ quality and
to assess the reliability of the perfusion values computed. A couple of spatio-
temporal indexes able to evaluate the evolution over time of tumour spatial
heterogeneity is also presented (Sect. 3.2). In order to establish which perfusion
values were characterized by the highest errors and hence had to be considered
as being unreliable and excluded from the analysis, two automatic thresholding
methods of the error index distribution are proposed (Sect. 3.3). Finally, two
indicators used to evaluate local spatial coherence of perfusion maps (Sect. 3.4)
and tumour functional heterogeneity are introduced (Sect. 3.5).
3.1 From image sequence to TCC
In this section, the pre-processing techniques applied to CTp images and to
TCCs are presented. The liver and lung CTp image sequences studied in this
manuscript have all been acquired in axial scan mode. Indeed, despite using
an helical acquisition would allow obtaining a more accurate registration [183]
and covering a wider volume coverage [229, 203], the improvement brought by
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the “spiral” scan mode is light in case of hidden tumours or lesions extending
for few slices only [230]. Moreover, the fact that the axial scan mode allows
acquiring images at a higher temporal resolution meanwhile delivering a lower
radiation dose to patients, makes this technique the most preferable one [60].
In the next paragraphs, the denoising methods applied to the CTp images
and to the TCCs (Sect. 3.1.1) are presented as well as the method selected to
compute perfusion parameters (Sect. 3.1.2), and the model chosen to fit the
resulting TCCs (Sect. 3.1.3).
3.1.1 Denoising methods
In order to remove noise from the acquired images and from the TCCs, a cou-
ple of filters have been applied. The techniques presented have been selected
in preliminary studies among several methods. The criterion applied to select
these techniques was related to the achievement of the best trade-off between
signal denoising and preservation of data information content. The first denois-
ing step is applied to the sequence images and is implemented through the use
of a median filter with a 5-pixel kernel size, that allows removing noise while
preserving edges. The very small dimension of this filter allows to achieve an
effective denoising that removes the bigger outliers mainly due to acquisition
noise without loosing the image information content. Subsequently, an autore-
gressive (AR) filter is applied to the TCCs in order to further reduce the effects
of noise, motion artefacts and discretization. The application of this method
is based on the assumption that the signal can be modelled as a sequence of
correlated samples affected by random noise. This assumption hods in case
of TCCs since they are characterised by a common trend that consists in a
first increase due to CA uptake inside tissue, followed by a very slowly decay
caused by the CA outflow. Each TCC can thus be described through the use
of the AR process shown in Eq. 3.1:
yAR(m) =
p∑
k=1
a(k)yAR(m− k) + η(m) (3.1)
where yAR is the signal described through autoregression, a(k) represents the
generic AR coefficient, p is the order of the AR model and η(m) is the white
noise process. Both the coefficients and the order of the AR model are esti-
mated by using the Yule-Walker method [231, 232]. This procedure permits
to capture temporally local correlation between consecutive samples and to
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denoise the signal, accordingly.
3.1.2 Perfusion values computation
Since the main goal of this Thesis is to provide methods allowing clinicians
to make more correct and more aware clinical decisions, independently from
the parameters that are computed and from the methods used to compute
their values, I decided to work on BF values computed by using the MSM. As
discussed in Sect. 2.3, BF has shown to be a multi-purpose parameter since
it is one of the most versatile and useful. It can indeed be applied also to
organs characterised by a dual vascular input, such as liver and lung, where
it has shown to be correlated with tumour angiogenesis [143, 149] and to be
very useful for the formulation of a correct diagnosis [167, 169] and progno-
sis [73, 74]. Despite the BF value can be computed by using several methods
and models, I decided to use the MSM since it is robust (Sect. 2.2.2) and it
does not need any prior assumption about the investigated tissue [84], thus
allowing to preserve the generic purpose of this research work. Moreover, the
mathematical simplicity of the MSM [52] permits to keep under control all the
possible error sources related to the model. Indeed, the use of more complex
methods or models can introduce a bias in the perfusion results computed.
For instance, the deconvolution method leads to results whose robustness and
precision strongly depend on the regularization methods applied [98]. Instead,
the compartmental models, are based on the assumption that are made on
the tissue vascular system and that consequently affect the value of the com-
puted perfusion parameters [62]. On the contrary, the use of a simple and
robust method free from any assumption about the analysed tissue permits
to directly evaluate the efficacy of the algorithm applied without introducing
further sources of uncertainty and instability. For these reasons, the MSM
resulted to be the most suitable for our purpose.
3.1.3 The fitting model
Despite the application of spatio-temporal data denoising methods, TCCs can
still remain very noisy and show an oscillating behaviour. Since to compute
perfusion parameters we decided to use the MSM, we can focus our atten-
tion on the first portion of the TCCs (i.e., the one before CA recirculation).
Figure 3.1 (a) reports an example of liver TCC together with the curve interpo-
lating its data points. For obvious reason, here the application of the MSM and
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Fig. 3.1: Liver TCCs’ data points (the black markers) are reported together with
their linearly interpolating curve (in the blue colour) (a), non-parametric fitting
curve (obtained with spline, in the green colour) (b), and parametric fitting curve
(achieved with Hill’s equation, in the red colour) (c).
the computation of the maximum slope value cannot be done directly on the
interpolant curve. In fact, due to the presence of non filtered noise or artefacts
affecting data, it is possible to incur in incorrect solutions that would bring to a
wrong estimation of the BF value. Consequently, in the presence of noisy data,
the use of fitting methods becomes indispensable. As discussed in Sect 2.4.5,
it is possible to adopt both non-parametric (e.g. that of Figure 3.1 (b)) and
parametric fitting strategies (e.g. that of Figure 3.1 (c)). However, in the pres-
ence of highly oscillatory tissue TCCs also the use of non-parametric fitting
can be misleading, since TCCs may adapt to signal oscillations. Instead, the
use of a parametric fitting method allows achieving as the best signal as pos-
sible describing the expected global behaviour of the tissue TCCs, thus being
less sensible to the presence of noise and outliers. Since the MSM is based
on the assumption of no venous outflow and the only portion of the tissue
curve needed to compute the BF value is the increasing one, it is possible to
choose the Hill’s model as the parametric fitting [219]. This sigmoidal-shape
parametric model permits to correctly describe the enhancement phase of the
TCC caused by the arrival of CA. The Hill’s equation indeed, has been often
used to describe the non-linear drug response in pharmacodynamics models,
but is also suited to model CA pharmacokinetics [233]. The Hill’s equation
can be described by Eq. 3.2:
y(t) = E0 + (Emax − E0) t
α
(EC50 + t)α
(3.2)
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where E0 is the baseline concentration value of the tissue before CA arrival,
Emax is the saturation value of tissue concentration, EC50 is the time instant
of half-maximum response concentration of the curve, and α is the non-linear
parameter that mostly affect the slope of the curve. A representation of these
parameters can be find in Figure 3.2.
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Fig. 3.2: Liver TCC’s data points (the blue markers), their fitted version through
the Hill’s equation (the red line), and its parameters E0, Emax, and EC50.
Figure 3.3 reports three liver TCCs pertaining to different voxels of the
(a) (b) (c)
Fig. 3.3: Examples of liver TCCs (the black markers) with increasing noise level
from left to right and their interpolating piecewise curve (in the blue colour),
non-parametric fitting spline curve (in the green colour), and parametric fitting
sigmoidal curve (in the red colour).
same CTp examinations with different noise levels. Each TCC is represented
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together with its interpolating piecewise linear curve, its non-parametric fitting
curve based on the spline model, and its parametric fitting curve achieved by
using the Hill’s equation. In Table 3.1, the values of the maximum derivative
Maximum first derivative and BF values in interpolating and fitting TCCs
TCC Type of curve
Maximum first BF value
derivative (HU/s) (ml/min/100g)
Fig. 3.3 (a)
Interpolating 5.13 61.5
Spline 5.11 61.3
Hill’s equation 5.24 62.8
Fig. 3.3 (b)
Interpolating 5.30 63.6
Spline 2.27 27.2
Hill’s equation 1.84 22.1
Fig. 3.3 (c)
Interpolating 8.73 104.8
Spline 2.56 30.7
Hill’s equation 1.21 14.5
Tab. 3.1: Maximum value of the first derivative and consequent BF value achieved
using interpolation (a), non-parametric fitting spline (b), and parametric fitting
with Hill’s equation (c).
and of BF computed on the enhanced phase of the curves are reported for
each TCC and for each type of fitting or interpolating curve. In the first TCC
(Figure 3.3 (a)) the noise characterizing the enhancement portion of the curve
is negligible and the three curves (the interpolating, the non-parametric fitting,
and the parametric fitting ones) similarly describe the evolution of the TCC’s
increasing portion. Indeed, the maximum value of the first derivative computed
on the enhancement part of the three curves and BF values, accordingly are
almost equivalent. Instead, the second TCC (Figure 3.3 (b)) is characterized
by a little more noise in its enhancement part. In this case, the interpolating
curve remarks each oscillation of the TCC, leading to an overestimated BF
value. On the contrary, the global trend of the TCC that is clearly identifiable
by visual evaluation is well represented by the two fitting methods yielding very
similar BF values. Finally, the third TCC (Figure 3.3 (c)) is characterized by
the widest oscillations. Also in this case, computing the maximum slope on an
interpolating curve would lead to unrealistic BF values, very far from those
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achievable through a fitting approach. Yet more, in this case the oscillations are
so heavy that the use of non-parametric fitting would be unsuitable. In fact, the
presence of strong noise in the enhancement part of the curve affects the non-
parametric fitted curve that tends to adapt to the local trend of the TCC data
points. In this case, the maximum first derivative value (and, consequently
BF ) is twice as big as that achieved through the parametric fitting. The
model based fitting is the only one capable to follow the global trend of the
TCC even with a high presence of noise, thus yielding more robust results.
In conclusion, the results achieved with a model based fitting in case of
low noise are similar to those obtained with the other two methods. On the
contrary, in case of a high noise level, the parametric model based fitting is the
only one preventing BF computation from falling in local minima solutions.
This approach, based on the Hill’s equation has shown to be well suited to the
MSM and it has been chosen in my Thesis to fit the TCCs. It is worth noting
that all the results published in [230, 234, 235, 236, 237] rely on this method.
3.2 Goodness of fit: some error indexes
The quality of the data acquired can be affected by several factors (Sect. 2.4),
such as CTp acquisition parameters, noise, and artefacts (in particular those
coming from respiratory motion), that can have a strong influence on the
shape and the smoothness of the TCCs and, consequently, on the perfusion
parameters estimated. In the literature several attempts to reduce the impact
of these error sources have been carried out, starting from the application of
motion correction methods [238, 239] to the improvement of TCCs quality by
removing outliers. In particular, these last types of method can be based on
several principles such as the qualitative assessment [212], or the quantitative
estimation of the degree of motion that can affect an image sequence [126], or
the quantitative evaluation of the noise affecting each TCC [215, 234, 229].
In order to evaluate image quality some methods have been proposed in
the literature. In [240] and [241] for instance, image quality is qualitatively
evaluated by expert readers. Instead, in other works quantitative assessments
of image quality are made through the measurement of tissue standard devi-
ation std [242] and of the contrast-to-noise ratio [243]. Despite these efforts,
the work of Miles et al. [83] highlights the need of quantitative indicators of
signal and fitting quality (e.g. signal to noise ratio (SNR) and goodness of
fit respectively) which the reliability of the computed perfusion parameters
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depends on. By providing clinicians with goodness-of-fit indexes would make
it possible for them to have an indicator of perfusion values’ reliability, this
helping them to make more aware clinical decisions.
To this purpose, I analysed and evaluated the capability of several temporal
(Chapter3Section2Sub1) and spatio-temporal (Chapter3Section2Sub2) indexes
to assess the consistency of the fitted curves with the original data and the
evolution over time of the local spatial tissue features.
3.2.1 Temporal error indexes
This section is dedicated to the temporal quantitative indexes that have been
tested to evaluate TCCs’ quality. All these indexes are based on the analysis
of residuals ϵ defined as the distance, measured at the time instant i between
the observed TCC data points Yi and the computed value Yˆi referring to the
curve fitting the TCC (Eq. 3.3):
ϵi =
∣∣∣Yi − Yˆi∣∣∣ (3.3)
Therefore, the higher the value of residuals, the worse the fitting model repre-
sents the original data. An example of the residuals of a TCC is reported in
Figure 3.4, where each blue vertical bar represents a residual ϵi of the signal.
Fig. 3.4: The original TCC (represented with the black stars) is fitted by using
the Hill’s equation and the vertical blue bars are the residuals ϵ.
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Four temporal indexes aiming at measuring the goodness of fit were eval-
uated:
• the residual’s standard deviation (σϵ)
• the residual’s sum of squared errors (SSE )
• the coefficient of determination (R2)
• the mean of the absolute value of residuals (µϵ)
To allow a better understanding of the main strength and weakness points
of the error indexes that are going to be discussed, let us refer to the synthetic
TCCs represented in Figure 3.5. The TCCs of Figure 3.5 (a)-(c) (referred to
(a) (b) (c)
(d) (e)
Fig. 3.5: Synthetic TCCs characterized by different noise levels and trends. TCCs
A (a), B (b), and C (c) are characterized by a very low noise with TCC B having
the fewest data-points and TCC C the lowest contrast enhancement. TCC D (d)
is characterized by the presence of some outliers, thus having a noise higher than
TCC A, B, and C. TCC E (e) instead, is the one with the highest noise level.
as TCC A, TCC B, TCC C respectively) are all characterized by a low noise
level. In these three curves we have the same ϵ values in every time instant, but
while TCC B has fewer data points than TCCs A and C, TCC C presents the
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lowest concentration enhancement. In addition, with respect to TCC A, TCCs
D (Figure 3.5 (d)) and TCC E (Figure 3.5 (e)) have the same number of data
points, show a comparable concentration enhancement, but are characterized
by a higher noise levels. Indeed, differently from TCC A, TCC D presents
some outliers, while TCC E (Figure 3.5 (e)) show the highest noise level with
high residuals almost equally distributed all over the time instants.
Table 3.2 reports the values of the four error indexes (σϵ, SSE, R
2, and µϵ)
Temporal error indexes
Error index TCC A TCC B TCC C TCC D TCC E
σϵ 0.69 0.85 0.69 1.24 0.83
SSE 30.66 20.55 30.66 70.78 519.50
R2 0.995 0.994 0.989 0.989 0.923
µϵ 0.80 0.86 0.80 1.02 4.23
Tab. 3.2: σϵ, SSE, R
2, µϵ values computed on the TCCs of Figure 3.5.
computed on the five TCCs of Figure 3.5 that are going to be discussed.
In many perfusion studies the first and often the only one statistical pa-
rameter that is evaluated to assess the presence of irregularities, and thus
considered as a marker of noise is the standard deviation. To this purpose,
I have analysed σϵ whose value is computed as the standard deviation of ϵ,
according to Eq. 3.5:
σϵ =
√∑N−1
i=0 (ϵi − ϵ¯)2
N
(3.4)
where N is the number of TCC’s data points considered and ϵ¯ is the mean
value of the residuals ϵ (Eq. 3.5):
ϵ¯ =
1
N
N−1∑
i=0
ϵi (3.5)
In particular, σϵ is an index that is very sensible to the presence of outliers
in the TCC. Indeed, comparing TCC A (or TCC C, that have the same residual
distribution) with TCC D (that is the one with some outliers), in Table 3.2
we can see high differences in the values of σϵ. A small difference of this error
index between TCCs A and B can be observed due to the lower number of
samples composing the TCC B. However, the main drawback of this index can
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be noted by comparing TCCs A, D and E. Indeed, the value of σϵ in TCC E
is higher than that of TCC A, but is much lower than that of TCC D, that
is much less noisy. This is because the presence of high, but almost uniform
residuals is not detected by σϵ aims at revealing the inhomogeneities between
the residual values. Therefore, σϵ results to be inappropriate to measure the
TCC’s quality.
The SSE, also known as the residual sum of squares or sum of squared
residuals, is another error index that is often adopted to analyse the goodness
of a regression. This indicator is computed according to Eq. 3.6:
SSE =
N−1∑
i=0
(ϵi)
2 (3.6)
As we can see from Table 3.2, the SSE is able to correctly detect the
increasing presence of noise in TCCs. Indeed, this index has low values in
the TCCs A, B, and C that are characterized by a low noise level, higher
in TCC D, and yet more in TCC E. However, the value of SSE depends on
the number of data points constituting the TCC. In fact, TCC B has the
same noise level as TCC A, but has fewer data points and is consequently
characterized by a much lower value of SSE. In this case, TCC B erroneously
seems to have a much better fitting quality with respect to TCC A. This aspect
can be particularly awkward if a method to remove outliers is applied to the
TCCs before fitting [234]. Indeed, since in this case it is possible to have
TCCs characterized by different number of data points (e.g. in case of random
sampling [234]), the use of SSE would be misleading. TCCs with the same
noise level (and the same fitting quality), but with different number of data
points, would indeed differ by SSE and the perfusion parameters computed on
TCCs having less data points would be considered as being more reliable.
Another goodness-of-fit index that has been widely used in regression anal-
ysis is R2. Its value ranges from 0 (bad fit) to 1 (good fit) and is computed as
the rate between the total sum of data squares SStot and the SSE (Eq. 3.7):
R2 =
SStot
SSE
(3.7)
where SStot is calculated in Eq. 3.8 as:
SStot =
N−1∑
i=0
(Yi − Y¯ )2 (3.8)
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and Y¯ is the mean value of the TCC data points (Eq. 3.9):
Y¯ =
1
N
N−1∑
i=0
Yi (3.9)
R2 has shown to be able to well detect the differences of noise level in TCCs A,
D, and E. In addition, by comparing its value in TCCs A and B (Table 3.2),
it is possible to see that the presence of a lower number of data points does
not affect its value. However, R2 has a drawback that needs to be considered.
In fact, its value directly depends on SStot that in its turn varies according to
the range of the TCC’s concentration values. In case of high perfused tissues,
there is a greater enhancement than that occurring in low perfused tissues.
On the other hand, a higher enhancement results in a higher SStot, and R
2
values, accordingly. Consequently, by comparing TCCs A and C (Table 3.2)
that are characterized by the same residual values, but a different contrast
enhancement, one can see a lower value of R2 in the TCC with the narrower
range of concentration values (i.e., TCC C). TCC C would then be erroneously
considered as the one with the worst fit quality and the one yielding the less
reliable perfusion values, accordingly. Because tumours are usually affected by
high morphological and functional tumour heterogeneity, the use of R2 is not
appropriate for the evaluation of TCCs’ quality.
µϵ is an index that evaluates TCC residual values directly. This indicator
is computed as the mean value of the absolute residuals, as follows:
µϵ =
1
N
N−1∑
i=0
|ϵi| (3.10)
µϵ has shown to be able to correctly estimate the TCC’s quality. Indeed, by
comparing TCC A, D, and E, it is possible to note that the value of µϵ is
directly proportional to the noise level. Indeed, in TCC D where there are
only few outliers, µϵ value is only a little greater than that assumed in TCC
A. On the contrary, in TCC E that is characterized by high residual values in
every time instant, the value of µϵ is much higher than that in TCCs A and
D. Moreover, this error index, being averaged is independent from the number
of TCC’s samples and from the range covered by the concentration values of
the curve, thus resulting in comparable values between TCCs A, B, and C.
Thanks to its capability, µϵ is the temporal index that have been selected
to assess TCC’s quality. Its use in perfusion studies has been validated in [230]
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(Sect. 4.2) while its usefulness in clinical studies has been demonstrated in [236]
(Sect. 4.3).
3.2.2 Spatio-temporal error indexes
Two spatio-temporal indexes have been studied in order to investigate the
temporal evolution of the local (image-based) spatial features of a group of
TCCs:
• the mean of the local standard deviation (MS )
• the variability of the local standard deviation (SS )
Given a window W (x, y) of dimension w × w and centred in the voxel with
coordinate (x, y), it is possible to achieve for the image acquired in the time in-
stant i a group of concentration values ΩW (i) with standard deviation σi(ΩW ).
Low values of σi(ΩW ) point out a local homogeneity, while high σi(ΩW ) values
hint at a region of the image analysed containing tissue with heterogeneous
density values. Figure 3.6 reports two 9 × 9 windows W (x, y) taken on the
same tumour sections. While the upper window (with the red border, (b)) con-
tains a more homogeneous tissue portion (σi(ΩW ) = 10.9), the lower one (with
the green border, (c)) contains density values more spatially heterogeneous
(σi(ΩW ) = 20.2). This difference is even more evident in the related his-
tograms of density values reported in Figure 3.7. Indeed, while the histogram
of the tissue region characterized by the lowest σi(ΩW ) value is narrower (Fig-
ure 3.7 (a)), the other one (Figure 3.7 (b)) spans over a wider (nearly twice)
range of bins.
The index MS is computed for each voxel (x, y) according to Eq. 3.11:
MS =
1
N
N−1∑
i=0
σi(ΩW ) (3.11)
as the mean of the values assumed by σi(ΩW ) in each time instant i by the voxel
(x, y) in the centre of the windowW (x, y). This spatio-temporal index has been
conceived to estimate the mean degree of spatial homogeneity over time in the
local neighbourhoods of (x, y). Accordingly, a low MS value corresponds to
tissue regions that remains locally homogeneous over the acquisition period,
independently from the variations of ΩW intensity values.
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(b)
(c)
(a)
Fig. 3.6: An unenhanced lesion (a) and two 9 × 9 windows W (x, y) related to
tissue portions with different local density heterogeneity degrees (b,c).
(a) (b)
Fig. 3.7: Histograms of density values (a,b) of the two tissue regions shown in
Figure 3.6 (b) and (c), respectively.
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The index SS computed for each voxel (x, y) according to Eq. 3.12:
SS =
√∑N−1
i=0 (σi(ΩW )−MS)2
N
(3.12)
as the standard deviation of the values assumed by σi(ΩW ) in each time in-
stant i. This second index aims at monitoring the temporal variations of the
texture range for neighbour voxels. Accordingly, SS presents a low value if
the variability of spatial characteristics of the TCCs pertaining to ΩW (i) are
kept constant over time. For instance, this happens in case of uniform spatial
enhancement. On the contrary, SS assumes high values when the local range
of density values is not preserved over time. For instance, this can happen
in case of not negligible motion, when voxels belonging to structures with a
different tracer response fall in different time instants into the same window
W (x, y), or in the unusual case of neighbour tissue voxels with a markedly
different tracer dynamics.
Both MS and SS can be represented through the use of colorimetric maps
that can be very useful for radiologists and clinicians. Indeed, the combination
of this two spatio-temporal indexes can allow drawing several considerations
about the analysed tissue. For instance, low values of both MS and SS may
indicate homogeneous regions undergoing a uniform enhancement. Instead,
high values of MS associated with low values of SS point out heterogeneous
tissue regions that keep their heterogeneity constant during the whole exam-
ination. On the contrary, high values of both MS and SS could represent
heterogeneous regions with a heterogeneity varying over time.
The use of these two indexes that in the context of preliminary studies have
shown to be good indicator of spatial homogeneity and temporal uniformity,
has been deepened in a CTp study of the CVG [235].
3.3 Automatic error thresholding
In Sect. 3.2.1, a temporal index able to effectively evaluate the fit quality of the
TCCs has been presented. The use of µϵ colorimetric maps can allow clinicians
to make more correct and aware clinical evaluation by weighing BF values
visible inside the colorimetric maps. For instance, a tissue region characterized
by very high perfusion values can be correctly considered as a hyper-perfused
area if the values of the error index regarding that region are low. On the
contrary, if the µϵ values of that area are high, the corresponding perfusion
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values should not be included in the analysis, since computed on TCCs that has
been wrongly fitted. High µϵ values are due to the presence of high residuals,
that is, the TCC is far from the fitted curve and accordingly from the ideal
model that has been adopted to describe the kinetic of CA inside the tissue.
This may occur in the presence of noise and artefacts affecting TCCs’ data
points, or in cases of anatomical structures (e.g. as vessels or bronchi) that
are functionally different from the tissue analysed. However, the use of µϵ maps
to evaluate the reliability of the corresponding BF values may be influenced
by inter-observer variability. Indeed, without a cutoff value pointing out which
BF values should be considered in the analysis and which one should be not,
different clinicians could subjectively decide to consider or not the presence of
tissue regions that could make the difference in the ultimate clinical decision
making (e.g. hyper- or hypo-perfused areas). Moreover, the greatest part of
CTp studies are based on global values computed as the mean or the median
perfusion values achieved in one or more tumour sections. By considering
all the perfusion values, without excluding those highly affected by errors,
the resulting global perfusion value might be significantly different from the
correct one, thus leading to different clinical conclusion. Therefore, the lack
of a threshold value for the error indexes prevents clinicians from correctly
deciding which perfusion values should be considered in the decision making
process.
To this purpose, I studied some solutions permitting to automatically find
out a cutoff value for µϵ that could be specific for each CTp examination.
First of all, I analysed the distribution of the µϵ values of several examinations
in order to take advantage from the statistical indexes, such as the mean
(E[µϵ]) and the standard deviation (σµϵ) of µϵ. An example of histograms and
colorimetric maps of µϵ values achieved in healthy liver and lung cancer tissues
are reported in Figure 3.8. Here, the healthy liver tissue is not particularly
affected by artefacts or noise and does not contain any big vessels. Its µϵ
histogram (Figure 3.8 (a)) has a Gaussian-like shape and it is spread over a very
narrow range of values (2− 5HU). On the contrary, the lung tumour tissue
is much more heterogeneous and affected by partial volume effect (Sect. 4.3).
In this case, the error index histogram is characterized by an unimodal bell-
shaped curve with a long right tale (Figure 3.8 (c)). The right portion of
the histogram, and especially its right tail, retains the highest error values
corresponding to the voxels of the colorimetric map represented with the hotter
colours (i.e., those affected by partial volume effect). In order to automatically
find out a threshold value able to identify the TCCs mostly affected by noise
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(a) (b) (c) (d)
Fig. 3.8: Histograms and colorimetric maps of µϵ values computed in healthy
liver (a,b) and NSCLC (c,d).
(i.e., those in the right tale of µϵ histogram) that expectedly would have given
rise to the most unreliable BF values, I tested two thresholding approaches
that could be applied to µϵ histogram:
• the 2σ method
• the triangle method
The first method is based on the 2− σ rule stating that “for many reason-
ably symmetric unimodal distributions, approximately 95% of the population
lies within two standard deviation of the mean” [244]. In particular, if x is
an observation and µ and σ are respectively the mean and the standard de-
viation of the distribution, the 2 − σ rule can be described by the following
mathematical notation:
Pr(µ− 2σ ≤ x ≤ µ+ 2σ) ≈ 0.9545 (3.13)
However, since the hypothesis of Gaussianity does not perfectly hold, this
approach just detects the voxels with a very high error only. This implicitly
means accepting that high error could anyway returns reliable perfusion values.
In our case, samples with a low µϵ value point out a good fit and hence have
not to be removed. A threshold value T2σ to be applied to the µϵ histogram
can thus be defined as:
T2σ = E[µϵ] + 2σµϵ (3.14)
By applying the 2− σ rule to the µϵ histogram of Figure 3.8 (c) it is possible
to achieve the result represented in Figure 3.9. The bins of Figure 3.8 (a)
represented in the blue colour are those with over-threshold error values and
correspond to perfusion values that can be considered unreliable. In particular,
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Fig. 3.9: Histogram (a) and TEM (b) pertaining to the same patient of Fig-
ure 3.8 (c), (d). The voxels and the bin in the cyan colour are those characterised
by a µϵ value lower than T2σ while those in the blue colour have an over threshold
error value.
these bins correspond to those voxels that have been represented in the blue
colour inside the thresholded error map (TEM) of Figure 3.9 (b). On the
contrary, the bins of the histogram and the voxel of the TEM represented in
the cyan colour are those with a µϵ value lower than the threshold T2σ and
that should be considered for the perfusion analysis.
Since the histogram has only positive values and is usually characterized by
a long right tale, the exclusion from the analysis of µϵ values greater than T2σ
results to be a method quite conservative, tending to exclude very high values
only. Therefore, in order to exclude the errors so to achieve a more simmetrical
distribution, another well-established and more aggressive method was consid-
ered. Indeed, the triangle method has been conceived for removing tails in
unimodal distributions [245]. The threshold TT that can be found by applying
the triangle method corresponds to the bin of the histogram whose top has the
maximum perpendicular distance to the straight line joining the mode and the
last bin of the distribution. This geometric method is less conservative than
the 2 − σ rule and consequently the relation TT < T2σ ever holds. However,
due to the high risk to incur in local minima solutions, the application of the
triangle method cannot be done directly on the raw histogram. Therefore, it
is necessary to follow a two-step pre-processing procedure. First of all, it is
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appropriate to remove the farthest outliers by cutting the 2.5% of voxels with
the highest error values. This step needs to be done in order to avoid that
the presence of few bins placed very far from the mode can cause an incorrect
selection of the TT value, greater than the correct one. For instance, Fig-
ure 3.10 shows an histogram of µϵ values thresholded with the triangle method
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Fig. 3.10: Histogram of µϵ with TT value (the red vertical line) found by applying
the triangle method on all data (a) and after having excluded voxels with the
highest error (i.e., those after the green vertical line) (b).
by considering all the values (Figure 3.10 (a)) or by excluding those voxels
characterized by the highest errors (Figure 3.10 (b)). The second step to be
performed is the application of a moving average filter to the bin values of the
µϵ histogram. The local inhomogeneity among bins and the accidental presence
of a bin particularly high could indeed lead to the selection of an incorrect TT
value too. The size of the moving average filter is selected through the use of
an adaptive algorithm that automatically chose the best window for each CTp
examination in order to gain the best trade-off between histogram smoothness
and preservation of data content. Figure 3.11 shows how the application of a
moving average filter can affect the selected TT value.
Finally, in Figure 3.12 a comparison between the two automatic threshold
methods analysed is reported. In the histogram and in the corresponding TEM,
the two different threshold values that can be chosen accordingly with the 2−σ
rule and the triangle method are visible. In the cyan colour are represented
those voxels characterized by low error values (µϵ < TT ). In the red colour
are represented those voxels whose BF values would be considered as being
unreliable only by the triangle method (TT ≤ µϵ < T2σ). The blue colour,
instead, points out those voxels that would be excluded from the analysis by
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Fig. 3.11: Histogram of µϵ with TT value (the red vertical line) found by applying
the triangle method to the original data (a) or to data filtered with a moving
average filter (b).
Fig. 3.12: Histogram (a) and TEM (b) pertaining to the same patient of Fig-
ure 3.8 (c), (d) and 3.9. The voxels and the bin in the cyan colour are those
characterised by a µϵ value lower than TT . The red bins and voxels are associated
to those TCCs having error index between TT and T2σ. The blue colour instead,
is used for those bins and voxels with very high error value (greater than both TT
and T2σ).
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both thresholding methods (µϵ ≥ T2σ).
The 2 − σ rule has been used for the first time to remove outliers from
lung and liver CTp examinations in the study [230] carried out by the CVG.
Moreover, its clinical usefulness has been proved and compared with that of
the triangle method in [236], using several CTp examinations pertaining to
patients with primary lung cancer. Finally, triangle method, that has shown
to be the most effective ones, has been selected and applied in other recent
CVG studies [235, 237].
3.4 Quantitative assessment of perfusion local
spatial coherence
An important feature that has to be taken into account to evaluate the good-
ness of the algorithm applied to compute perfusion parameters is the spatial
coherence of the results obtained. All the methods and models discussed in
Sect. 2.2 permits the computation of perfusion parameters by evaluating the
signal coming from a single voxel without taking into account the trend of
the neighbour TCCs. Since tissue TCCs pertaining to a small window should
usually tend to follow quite gradual and coherent transitions instead of un-
dergoing abrupt changes from voxel to voxel, the measure of spatial coherence
can provide information regarding the reliability of the estimated perfusion
maps. An index that can be used to assess the dispersion of a distribution
of values around their mean is the coefficient of variation (CV ). For instance,
considering all the BF values of a ROI, the CV (expressed in arbitrary units)
can be computed as the rate between the BF standard deviation σBF and the
BF mean µBF , according to Eq. 3.15:
CV =
σBF
µBF
(3.15)
This index has been adopted in CTp studies in order to assess the perfusion
uncertainty and variability of BF values [209, 246]. However, by using the
CV on the whole ROI, it is not possible to take into account the spatial
relations of perfusion values. Accordingly, in order to achieve a measure of
the local spatial perfusion coherence, the local CV (lCV ) has been proposed.
This index is computed for each voxel (x, y) as the CV of the window of
dimension w × w centred on (x, y). The colorimetric map of lCV that can
be achieved allows to visually evaluate the spatial coherence of BF values.
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Furthermore, by computing the mean and the standard deviation of all the
lCV values (µlCV and σlCV , respectively) it is possible to achieve a measure of
the global spatial coherence of the analysed tissue. For instance, Figure 3.13
reports four colorimetric maps of the same section of a lung lesion computed
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Fig. 3.13: BF (a,c) and lCV (b,d) maps of a lung lesion computed on TCCs
before (a,b) and after (c,d) considering motion correction. The pink colour is used
to represent unreliable BF values and those voxels where the lCV values cannot be
computed because there are not enough reliable BF values in the adjacent voxels.
on TCCs of different qualities1. In the first row the BF (Figure 3.13 (a))
and the lCV (Figure 3.13 (b)) colorimetric maps computed on TCCs affected
1Credits to Eng. Serena Baiocco for providing these data.
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by motion are represented. Instead, in the second row (Figure 3.13 (c), (d))
the same colorimetric maps are computed on TCCs that have been corrected
through the use of a motion correction method. As one can see, the BF
map (Figure 3.13 (c)) computed on the motion corrected data is locally more
homogeneous than the other BF map (Figure 3.13 (a)). However, while µlCV
values well describe this feature by decreasing from 47.91 to 42.12, as the TCCs
quality improves, the CV computed on the whole ROI increases from 68.06 to
75.33, showing not to be able to capture the local map coherence.
The lCV has been adopted in two studies carried out by the CVG. In par-
ticular, in the first one [234] an algorithm based on random sample selection
(RANSAC) to remove outliers from the TCCs was proposed. Thanks to the
capability of this algorithm to provide better TCCs on which computing perfu-
sion parameters it was possible to achieve BF colorimetric maps with a higher
spatial coherence. The improvement brought by the use of this algorithm of
outlier removal was tested on 14 examinations pertaining to as many patients
with NSCLC and verified both qualitatively and quantitatively through the use
of lCV. In the second work [237], the use of lCV was deepened and validated in
15 patients with primary lung cancer. In this study, lCV proved its capability
to provide information about tissue local heterogeneity independently from the
amount of noise affecting images.
3.5 Quantitative measurement of functional het-
erogeneity
Despite heterogeneity is one of the main features of tumour tissue and can be
present both at morphological and at functional level (Sect. 2.1), it has often
been neglected (Sect. 2.4.7). Since CTp aims at giving the possibility to assess
the functional characteristics of the analysed tissue, I looked for an index that
could allow the quantification of tissue hemodynamic heterogeneity.
The Shannon entropy (or briefly, Entropy) constitutes a well-known mea-
sure of data information content [247]. This parameter was introduced in the
information theory in the late 1948 [248] and since then it has been applied in
several fields, image analysis included. The Entropy (E) is computed as
E = −
k−1∑
i=0
p(vi)log2p(vi) (3.16)
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where k is the number of the possible outcomes and p(vi) is the frequency of
the ith outcome. Entropy measures are reported in arbitrary units (a.u.).
In Figure 3.14 there is an example of three photo sorted by increasing
Fig. 3.14: Three photographs depicting different landscapes are sorted from left
to right by increasing Entropy values.
Entropy values. The landscape with the lowest Entropy value (E=5.97, Fig-
ure 3.14 (a)) is indeed the one containing fewer details, while the one with
the highest Entropy value (E=7.83, Figure 3.14 (c)) is the one showing more
elements, most of which introduced by human beings. Instead, the photograph
in the middle (Figure 3.14 (b)) is the one with an intermediate complexity and
consequently is also characterized by a mid Entropy value (E=6.50).
The Entropy has been often used in texture analysis and it has also been
applied in oncology. For instance, it has been used to evaluate texture ir-
regularities [249], and have proved to provide important information for the
formulation of tumour diagnosis [250, 251] and prognosis [192, 252]. How-
ever, to the best of our knowledge, Entropy has never been applied to the
colorimetric maps of perfusion parameters. In order to achieve a measure of
tissue hemodynamic heterogeneity I computed Entropy on the BF colorimet-
ric maps. In this case, the p(vi) of Eq. 3.16 represents the frequency of BF
values inside the BF map. Figure 3.15 reports the BF colorimetric maps per-
taining to five adjacent sections of the same tumour, sorted from left to right
by increasing Entropy values. As in the example of the landscape photos,
Entropy has shown to be once again able to detect the information content
of the BF maps that here is the functional heterogeneity. The colorimetric
maps related to the second level of the tumour is the most homogeneous one
(Figure 3.15) (a) and presents the lowest Entropy (E = 7.43). Its adjacent
slice at level 3 instead, is the colorimetric map of the tumour with the highest
heterogeneity (Figure 3.15) (e) and consequently is characterized by the high-
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Fig. 3.15: Five CT images (first row) and BF colorimetric maps (second row)
pertaining to consecutive sections of the same tumour and sorted from left to
right by increasing Entropy values: the slice at level 2 (E = 7.07) (a), level 1
(E = 7.43) (b), level 5 (E = 7.62) (c), level 4 (E = 7.92) (d), level 3 (E = 8.10) (e).
The BF values represented in the pink colour are those considered as non-reliable
and are not included in the computation of the Entropy value.
est Entropy value (E = 8.10). An intermediate functional heterogeneity can
instead be observed in the more external sections of the lesion that accordingly
present mid Entropy values with respect to sections 2 and 3. Indeed, levels 1
(Figure 3.15) (b), 4 (Figure 3.15) (d), and 5 (Figure 3.15) (c) are characterized
by Entropy values of E = 7.43, E = 7.92, and E = 7.62 respectively.
The use of Entropy on BF values has been applied for the first time in [253]
to quantify the functional heterogeneity of different sections of the same tu-
mour or of different lesions (Chapter 5).
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Chapter 4
A method to assess perfusion
values reliability
In this Chapter, the issue of the lack of indexes capable to assess the reliability
of perfusion results described in Sect. 2.4.3 is faced. In particular, in Sect. 4.1,
a specific background regarding issues related to respiratory motion and the
presence of noise and artefact in CT images is reported. In Sect 4.2, the
validation of the temporal index µϵ presented in Sect. 3.2.1 as an indicator
of signal quality and of perfusion values reliability is carried out. After that,
an automatic method employing µϵ values to automatically detect unreliable
perfusion values is presented and compared with the manual method used in
literature to exclude perfusion values apparently out of the physiological range
(Sect 4.3).
4.1 Background
As discussed in Sect. 2.4.3, reliability and reproducibility of the functional
results still represent open issues. Among the factors affecting the outcomes of
CTp examinations, three of the most relevant ones are the presence of motion,
noise, and acquisition artefacts in the CT images. In addition, the presence of
anatomical structures, such as vessels and bronchi, can further affect reliability
of the obtained results and jeopardize perfusion maps. In this section, all these
aspects are discussed.
As regards motion, it has been proved that respiratory movements induce
artefacts that can break the spatial fidelity of the imaged structures, caus-
ing inconsistent intensity trends for the generic spatial location of interest.
Figure 4.1 depicts a clear example of motion artefacts found in a liver CTp
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Fig. 4.1: Liver CTp image deeply affected by motion artefacts.
image of a patient with CRC. In addition, respiratory movements and tu-
mour spatial heterogeneity can lead to mis-registrations in both transverse
(x-y plane) and craniocaudal (z axis) directions and yield misleading rapid
or slow inflow/outflow patterns, affecting reliability of the resulting perfusion
parameters.
Many methods to reduce and to compensate for patient motion have been
proposed in the literature (Sect. 2.4.5). However, here I want to draw reader’s
attention on the alignment methods applied to the acquired CT images and
on their effects on TCCs and on perfusion values, accordingly. In the litera-
ture, erroneous estimations of perfusion parameters for a single tumour level
analysis (i.e., fixed slice at z -location) have been reported in [212, 254] for
liver CTp, so that multi-level methods, based upon retrospective visual selec-
tion of image sets contiguous to a reference z -axis position, are suggested [202,
254]. Manual translation of ROIs [208] as well as manual and anatomic-based
image registration with respect to a reference slice are applied in lung [255]
and liver [239] CTp, where motion effects can be even more evident. However,
only few methods take into account x-y misalignments jointly with z -axis mis-
alignments, meaning that a specific assessment of 3D manual registration is
absent [255]. As a matter of fact, recent clinical studies are still conducted em-
ploying x-y or craniocaudal compensation only [210], or not even that [159].
Some registration methods aim at assessing the effectiveness of image align-
ment only [255, 239], or the reproducibility of perfusion parameters [204, 205],
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while none of them, to our best knowledge, measure the effect of motion on
TCC signal, also correlating these measures with the reliability of perfusion
analyses. In fact, the impact of motion artefacts on CTp reproducibility for
such methods is discussed for liver and lung tumours in [204, 205], emphasizing
how variability in the estimation of perfusion parameters can reach 70%− 90%
in the absence of any kind of compensation, while decreasing to relatively lower
values (10%− 20%) when data registration is applied. However, these works
do not mention the reliability of perfusion patterns, which were not even sub-
mitted for evaluation to radiologists.
The study and the measurement of the effects of motion artefacts on TCCs
and on perfusion values reliability is carried out in Sect. 4.2.
Another issue hampering the achievement of reliable and reproducible re-
sults is the presence of noise and acquisition artefacts in CT images. Despite
software embedded in CT scanner are capable to reduce their presence, streaks
and dark bands are often well visible on CT images, sometimes so heavily as
to impede the use of CT examinations [256].
Image noise (also known as Poisson noise) is an effect caused by the statis-
tical error of low photon counts that can be seen on CT images in the form of
bright and dark streaks mainly in direction of the greatest attenuation. Noise
presence can be reduced only with the use of CT system’s reconstruction al-
gorithm [257]. Figure 4.2 reports an example of liver CTp image affected by
Fig. 4.2: Liver CTp image affected by Poisson noise.
Poisson noise.
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CT artefacts can be grouped into three categories:
• physics-based artefacts, resulting from the physical processes involved in
the data acquisition
• patient-based artefacts, strictly related to the patient such as those due
to motion or to presence of metallic materials
• scanner-based artefacts, due to hold ups of some scanner components
Examples of physics-based artefacts are the well-known beam hardening effect,
the partial volume effect, the photon starvation, and the undersampling. Beam
hardening is caused by the passage of x-ray beam through a tissue. Low-
energy photons are absorbed by the tissue more than high-energy photons and
accordingly, the mean energy value of the beam leaving the tissue increases
(i.e., the beam becomes “harder”). This would results in artefacts, such as
streaks and dark bands appearing between two dense objects, and in cupping
artefacts, consisting in different attenuation of the photon beam when crossing
tissue middle portion and edges [258]. Beam hardening artefacts, such as
those represented in Figure 4.3, could also arise in the presence of a high
(a) (b)
Fig. 4.3: Lung CTp images affected by beam hardening causing dark bands (a)
and streaks (b).
CA concentration. The effects of this type of artefacts can be reduced by
using iterative reconstruction and by combining data from multiple scans [257].
Partial volume instead, is an effect related to spatial resolution and is caused
by the loss occurring when an object partially occupies the sensitive volume
(i.e., the volume from which emitted photons would be detected at a given
detector location) of the imaging instrument [259]. For instance, when the
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tissue analysed is affected by rapid motion or when there are inconsistencies
between two views (i.e., the detectors see an object from one angle of view,
but not from the others), partial volume artefacts will occur. An example of
inconsistencies between two views is represented in Figure 4.4. This effect can
Fig. 4.4: Inconsistency between two views: only one of the two detectors see the
object in the green colour.
be reduced by using thinner acquisition sections [256]. Photon starvation is
an effects occurring when a too low number of photons reach the detector,
leading to heavy streaking artefacts. This effect is often visible at pelvis or
shoulder level (Figure 4.5) where several attenuating anatomical structures
are present [260]. Photon starvation can be reduced by using methods of tube
current modulation and algorithm of active filtration. The increase of tube
current indeed, allows reducing the effects of the problem, but at the expense
of a higher radiation dose delivered to the patient [256]. Finally, undersampling
occurs when few projections are used to reconstruct a CT image (view aliasing)
or when few detectors are used within a projection (ray aliasing). This effect
is very important in pixel-based analysis where fine details are important and
can be solved by using high resolution acquisition techniques [256].
As regards patient-based artefacts, the most important are those related to
motion and to the presence of metallic objects, such as prosthetic devices and
surgical clips. In Figure 4.61 a patient-based artefact caused by the presence
of a hip’s prosthetic devices is shown. This last category yields streaking
artefacts that can be partially attenuated through the use of proper correction
1courtesy of http://abcradiology.blogspot.it
75
Chapter 4. A method to assess perfusion values reliability
4.1. Background
Fig. 4.5: Lung CTp image acquired at shoulder level and presenting clear photon
starvation artefacts.
Fig. 4.6: Patient-based artefacts caused by the presence of prosthetic devices.
software [261].
Scanner-based artefacts mainly derives from the miscalibration of one or
more detectors. The constant error given by the detector in each angular po-
sition results in a ring artefact centred on the isocentre of rotation [262], such
as those shown in Figure 4.7. This type of effects can be reduced with the ap-
plication of correction software and solved by recalibrating CT detectors [257].
Besides artefacts [263], also vessels [204] and bronchi [264] are usually man-
ually excluded from the perfusion analysis not to jeopardize the visual analysis
of perfusion colour maps nor the automatic computation of local or global sta-
tistical indexes regarding perfusion values.
In general, the unreliable perfusion values in colour maps are simply con-
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Fig. 4.7: Liver CTp image affected by scanner-based artefacts caused by the
miscalibration of several detectors.
sidered as those being out of range of physiological parameters, for instance,
due to vessels [152] and are detected and excluded by manually drawn an ex-
cluding ROI or adjusting an appropriate window level [83]. So far, the TCC
fitting errors and goodness of fit indexes have been mainly used to evaluate the
reliability of given simulated model fitting, from a theoretical point of view, in
lung CTp [209] or liver MRI [265] perfusion studies, rather than to assess the
voxel-based reliability of perfusion values.
In order to face the problems given by the presence of anatomical structures
(e.g. vessels and bronchi) and CTp reconstruction and acquisition artefacts
that could compromise the correct interpretation of a CTp colour map, an
automatic method to detect and exclude from perfusion analysis the regions
affected by this problem has been proposed in Sect. 4.3.
4.2 Validation of the temporal error index µϵ
The aim of this section is to study and measure the effects of motion artefacts
on TCCs and on the consequent reliability degree of perfusion colorimetric
maps through visual assessment by expert Readers. To this purpose, three
different motion compensation approaches that must show increasing effec-
tiveness were considered: no compensation, x-y only and 3D (which includes
rigid shifting along both the x-y plane and the z -axis). The temporal error
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index µϵ presented in Sect. 3.2.1 is computed on each sets of TCCs resulting
from the alignment procedure. In this way, it is easier to assess whether our
quantitative index is really able to detect this expected increasing effective-
ness, which would confirm its capability to correlate with quality of image
alignments. For the sake of completeness, a fourth registration method (here-
after, 1D), aligning on the z direction only, was considered. This method is
sometimes used in lung and liver perfusion [210], but its rank of effectiveness
with respect to the other three methods just mentioned, is unknown a priori.
In addition, the sets of perfusion maps achieved were submitted for assess-
ment by radiologists, so as to check if better alignments in any way yield more
reliable colorimetric maps. In fact, if a better image registration expectingly
brings more reliable TCCs on the available data, it cannot be taken for granted
that these yield more reliable perfusion patterns in the colorimetric maps, also
because alignments themselves might always introduce “regional artefacts”.
The set of CTp examinations used in this study are described in Sect. 4.2.1.
Each of them were acquired following the protocol described in Sect. 4.2.2.
After that, a ROI was drawn on lesion contour and aligned according to four
different strategies as reported in Sect. 4.2.3. On the whole, each patient
provided a different set of results for each of the four motion compensation
approaches, for a total amount of 44 different configurations. Voxel-based BF
values were computed on all the 44 sets of data by applying the image and
signal denoising procedures reported in Sect. 3.1.1, TCC fitting through Hill’s
equation, and computation of perfusion values according to the single-input
maximum slope (SIMS) method (Sect. 2.2.2). The temporal error index µϵ
presented in Sect. 3.2.1 was then computed on each TCC of the 44 sets of data
and validated through the procedure described in Sect. 4.2.4. Statistical tests
were carried out on the achieved data as described in Sect. 4.2.5. Experimental
results are finally presented and discussed in Sect. 4.2.6, while concluding
remarks are reported in Sect. 4.2.7.
4.2.1 CTp examinations
In order to validate our temporal error index (i.e., µϵ) as indicator of both
TCC quality and perfusion values reliability, a set of lung and liver CTp ex-
aminations pertaining to a study approved by the Institutional Review Board
of IRST was used2. The patients considered showed one primary NSCLC le-
2This study was approved by the IRB (Comitato Etico Area Vasta) of the IRCCS-IRST,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC), ITALY,
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sion or liver metastases. In particular, the examinations selected for this first
retrospective study pertained to patients who had not been able to hold their
breath for the whole duration of the acquisition. All these examinations show
residual breathing and undergo artefacts from motion. However, only exami-
nations with at least 25% of slices to be replaced with different z levels were
included in the study. Finally, 11 CTp examinations pertaining to as many
patients (age range 36 - 81 y.o.) were enrolled. Tumour type and extent of the
analysed sections are reported in Table 4.1.
Tumours’ features
Patient Tissue Type Stage Section (cm2)
ID1 Liver metastasis - 2.74
ID2 Liver metastasis - 1.95
ID3 Liver metastasis - 4.04
ID4 Liver metastasis - 2.39
ID5 Lung adenocarcinoma IV 22.11
ID6 Lung adenocarcinoma IV 15.82
ID7 Lung adenocarcinoma n.a. 20.58
ID8 Lung squamocellular carcinoma IIIB 7.29
ID9 Lung adenocarcinoma n.a. 17.33
ID10 Lung adenocarcinoma IV 8.57
ID11 Lung squamocellular carcinoma n.a. 4.33
Tab. 4.1: Table summarizing the eleven cases requiring multi-slice alignment (n.a.
stands for “not available”).
4.2.2 Acquisition protocol
The patients’ datasets were collected according to two different scanning pro-
tocols, depending on the investigated tissue (i.e., lung or liver). CT scans were
performed on a 256-slice CT system (Brilliance iCT, Philips Medical Systems,
Best, The Netherlands), with patients in the supine (feet first) position. An
initial, low dose, unenhanced full-body CT scan was performed to identify
the target lesions at baseline conditions. A 50−ml intravenous bolus of CA
with ID: IRST 162.04, on Oct 27, 2010, as a part of a wider study: Perfusion multidetector
computed tomography (256 slices) in patients with advanced NSCLC: evaluation of tumour
response after chemotherapy and radiation therapy.
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(Iomeron, Bracco, Milan, Italy) was then injected at 5ml/s for axial cine DCE-
CT, according to two different protocols for liver and lung examinations.
In liver perfusion protocol, a single acquisition of duration 55s, consisting
of 36 scans with 50mm of z -coverage (10 slices × 5mm thickness, 0.33s rota-
tion time, at 120kV , 140mA, 70mAs). Image data are reconstructed to 360
cine images (512 × 512 pixel, 350mm × 350mm, 5−mm slice spacing, 1.57s
temporal resolution).
In lung perfusion protocol, a single acquisition of duration 25s, with patient
instructed for breath-hold, giving 20 scans with 55mm of z -coverage (11 slices
× 5mm slice thickness, 0.4s rotation time, at 80kV , 250mA, 100mAs). Image
data are reconstructed to 220 cine images (512 × 512 pixel, 11 slices, 350mm
× 350mm, 5−mm slice spacing, 1.25s temporal resolution).
Accordingly, the generic protocol provides forM scans, each corresponding
to different sampling instants, of K levels each (e.g. for the lung perfusion
protocol M = 20, K = 11).
4.2.3 Image alignment
The target lesions and the arterial input (aorta) were selected in agreement
by two radiologists on a reference slice and the temporal sequence of slices
related to the corresponding (couch) z -location (level) was annotated as ref-
erence sequence. For each lesion, an ROI was then manually outlined by the
radiologists on the reference slice.
Three alignment methods were assessed in this study and compared with
the unregistered approach. Altogether, these are the four procedures used:
Standard fixed mode (SF): the reference ROI is unregistered, that is,
kept fixed along the reference sequence, as it usually occurs for standard CTp
protocols supported by most perfusion software provided by CTmanufacturers.
TCCs are built by sampling the HU (image) values at the same pixel location
for all the slices of the reference sequence. In case of motion, TCCs obtained
with this alignment method are expected to be the most subject to artefacts.
Transverse manual registration (2D): the reference ROI is manually
translated on the x-y plane of each slice of the reference sequence so that it
visually matches the borders of the lesion. In each image of the reference
sequence, each TCC is built by sampling the HU values found in the same
ROI’s pixel. According to this method, motion compensation is performed
only for x-y translations.
Multislice manual registration (3D): given the reference slice, adjacent
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slice levels (up to two levels before and after the reference level) are visually
explored by the radiologists who choose, for each of the M scans, the level
which visually presents the best matching with the reference lesion. The re-
sulting slice sequence is then referred to as the best sequence (in Figure 4.8,
the lesion ID5 from lung perfusion dataset is shown as an example), and 2D is
then performed on this sequence. According to this procedure, a 3D manual
alignment is achieved by also taking into account motions in the craniocaudal
direction.
Transverse manual registration (1D): the reference ROI is kept fixed
along the best sequence selected in 3D. According to this method, motion com-
pensation is performed only for z translation, along the craniocaudal direction.
However, although four correction approaches were considered, I would like
to draw reader’s attention mainly on SF, 2D and 3D since, by construction,
they perform with increasing quality and I expect our quantitative index to be
capable of detecting this order relationship, accordingly. To this purpose, 2D
and 1D are alternative, both expected to perform better than SF and worse
than 3D.
4.2.4 Validation procedure
So for the registration accuracy has been evaluated by assessing visual or
automatic alignment (e.g. overlap) with respect to ground-truth anatomi-
cal structures achieved by manual segmentation [255, 239], or by evaluating
the repeatability of perfusion estimations in multiple acquisitions [204]. How-
ever, no indication has been provided about the effects of image alignment on
the resulting TCCs which represent, on the other hand, the source data used
to calculate the perfusion parameters. More specifically, a recent approach
considers the quality of TCCs over the whole liver merely as a predictor for
patient motion [210]. Besides that, there is no mention of further quality check
steps by radiologists. As a matter of fact, in real studies (where no synthetic
ground-truth is available) clinical evaluation of the perfusion maps should be
performed by radiologists through visual inspection of the perfusion scan, in
order to validate the outcome of the perfusion software, confirming the pres-
ence of plausible spatial perfusion patterns. For these reasons, to validate µϵ
as a reliability index of perfusion values, two procedures have been proposed:
a quantitative one, based upon the temporal regularity of TCCs (i.e., the ten-
dency of the real signal to approach the trend of the ideal one, represented by
the fitting curve), and a qualitative one, performed by radiologists and based
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Fig. 4.8: An example of selection of the best sequence from a lung perfusion
dataset (ID5) on several (four, in this case) contiguous z levels (i.e., adjacent slices),
where Z∗ is the reference slice and ∆Z represents one z level. Accordingly, sampling
of HU levels at consecutive time instants is performed by selecting multiple levels.
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upon visual evaluation of the resulting perfusion patterns.
As a measure of the spatial fidelity of the sampled time concentration
signal and, accordingly, of its reliability in the presence of acquisition motion
artefacts, µϵ value was computed in each voxel. Accordingly, a colorimetric
map can be generated from the processed image sequence. Four colorimetric
maps of µϵ were consequently achieved for each examination, one for each
alignment method. The expected value E[µϵ] and the standard deviation σ(µϵ)
of the quantitative index values were finally calculated for each alignment
approach and for each patient.
In addition, the automatic threshold method based on the 2 − σ rule
(Sect. 3.3) has been applied to the histograms of µϵ to find out unreliable
perfusion values.
The use of this threshold as the reliability index offers a fair compara-
tive analysis for assessing the effects attributable to the alignment methods
only. In particular, I would expect that SF, 2D/1D and 3D, respectively, have
increasingly lower values for E[µϵ].
As regards qualitative index, two Readers with more than 25 years of ex-
perience in interpreting CT studies in oncology ranked the four alignment
procedures through visual exploration of the perfusion maps, using a 4-point
scale, according to the likelihood of the resulting perfusion maps with respect
to the expected enhancement patterns. The rank is an integer number ranging
from 1 to 4, where “1” corresponds to the expected perfusion pattern. The
evaluation was performed for each examination in three stages, two of which
were performed in a blinded fashion. In the first stage, each radiologist ex-
amined the full CTp sequence in order to form his own opinion regarding the
perfusion pattern. After selecting the reference sequence for the SF, through
consensus, the Readers outlined the ROIs and built the 1D, 2D and 3D se-
quences. Then, in the second stage, each Reader was provided with the four
colorimetric maps, built on the sequences just defined and corresponding to the
different alignment procedures. The colorimetric maps were proposed with no
label and in random order and each Reader assigned each map its proper rank.
In the last stage, the Readers established the final rank through agreement.
Accordingly, the rank constitutes the qualitative index.
4.2.5 Statistical analysis
The paired two-sided Wilcoxon signed rank test implemented in R software
(version 3.0.1, The R Foundation for Statistical Computing) was used to assess
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the differences in E[µϵ] between the three correction schemes (2D, 3D, 1D) and
the fixed approach (SF) and between the 3D alignment configuration and the
remaining 2D, 1D motion correction methods. p-value ≤ .01 were considered
for statistical significance.
4.2.6 Experimental results
The results of the visual ranking of perfusion patterns for the four alignment
procedures are summarized in Table 4.2, together with E[µϵ] and σ(µϵ) com-
Quantitative and qualitative indexes related to perfusion maps
IDs
SF 2D 1D 3D
E[µϵ] σ(µϵ) R E[µϵ] σ(µϵ) R E[µϵ] σ(µϵ) R E[µϵ] σ(µϵ) R
ID1 4.69 1.19 3 4.63 1.12 2 4.33 0.74 2 4.33 0.77 1
ID2 7.05 3.29 2 7.14 2.97 2 5.52 1.70 1 4.63 0.74 1
ID3 5.58 1.68 3 5.39 1.27 4 5.13 1.37 2 4.50 0.75 1
ID4 6.43 2.28 4 6.34 2.08 3 5.27 1.36 2 4.78 0.82 1
ID5 12.12 7.66 2 10.49 5.15 2 8.51 2.26 1 8.57 2.30 1
ID6 8.62 4.10 2 8.24 3.25 3 7.57 1.45 1 7.53 1.46 1
ID7 9.46 16.17 4 8.26 2.62 3 8.09 1.50 2 7.82 2.53 1
ID8 19.65 25.15 3 9.56 5.56 2 12.07 9.81 2 9.05 2.30 1
ID9 12.32 3.21 2 12.20 2.99 2 11.69 2.67 1 11.63 2.53 1
ID10 8.67 4.46 2 7.79 2.84 1 8.34 3.43 2 7.50 2.12 1
ID11 14.01 16.95 2 9.87 10.58 2 6.21 1.89 1 5.69 1.17 1
Tab. 4.2: Table summarizing both quantitative and qualitative indexes related
to perfusion maps, for the four different alignment configurations (R stands for
Rank).
puted on the ROI. The results pertaining to the quantitative index are also
reported in Figure 4.9, with bar plot of E[µϵ] and error bars representing σ(µϵ).
Firstly, it can be seen that the improvements brought by motion correction are
more evident for lung tumours (ID5-ID11), both in terms of E[µϵ] and σ(µϵ),
where the lack of breath-hold causes more marked movements and structures
with very different densities with respect to the lesion (e.g. air) can be in-
cluded, if the ROI is fixed. In fact, while the SF and 2D bars have almost
same height for liver tumours, in general, for lung tumours, E[µϵ] is far higher
for SF, and 2D, or 1D, alone may lead to a good improvement (e.g. ID11),
even in terms of σ(µϵ). In addition, while movements in the liver are often
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Fig. 4.9: Bar plot of E[µϵ], with error bars equal to σ(µϵ), for the eleven cases
with the four alignment modes.
oscillatory, in the lung the ROI may have a longer craniocaudal translation (as
shown in Figure 4.8). In fact, while liver metastases required just two z levels,
often lung tumours required three or four of them, mainly in cases where the
lesion lays in the inferior lobes, near to the diaphragm. This is why between
2D and 1D motion compensation, the latter usually yields better results.
As it can be seen, also by looking at Table 4.2, the 3D alignment procedure
determines, in all cases, the lowest value of E[µϵ], highlighting a general better
fit of the model to data, also with a more homogeneous behaviour (the lowest,
or comparable, values of σ(µϵ)). This confirms that smoother signal transitions
occur if both translational and craniocaudal compensation are applied. In
addition, as far as E[µϵ] and σ(µϵ) are concerned, Figure 4.9 shows that 3D
is always better than 2D, which, in turn, is strictly superior to SF (except
for ID2, when E[µϵ] are statistically comparable), as expected. Moreover,
this analysis still applies when considering SF, 1D, 3D (except for ID1, ID5,
ID6, ID9, where 3D and 1D have statistically comparable values for E[µϵ]).
Therefore, the quantitative index conceived confirms its capability to measure
the quality of alignments with respect to the available data. In this way, it
also becomes possible, and interesting, even to include in the comparison two
unrelated alignments, such as 2D and 1D. As a matter of fact, our quantitative
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index shows that on two occasions (ID8, ID10) only 2D performs better than
1D.
After ascertaining that E[µϵ] can measure and rank the quality of align-
ments, I now aim at assessing whether, and to what extent, better alignments
yield more reliable perfusion patterns. Shifting to the qualitative index, it is
possible to see that, although the perfusion maps achieved with 3D are consis-
tent with what the radiologists expected, the visual analysis highlights some
more uncertainties regarding the likelihood of colorimetric maps resulting from
SF and 2D with respect to the expected perfusion patterns. In fact, although
in the majority of cases perfusion maps from 2D are considered more reliable
than those from SF, four times they are considered as being equivalent and,
above all, two more times (in one liver and in one lung tumour case) they are
even perceived as being worse. Nonetheless, 1D maps are always considered
to be better than SF’s.
Usually, also due to global correlation between fitting pre-correction errors
and changes in BF values, it is taken for granted that better alignments yield
more reliable perfusion patterns [229, 266]. Therefore, I would like to draw
reader’s attention on those cases where coherence between quantitative and
qualitative ranks does not hold, that is where the quantitative and the qual-
itative indices do not agree, with respect to the expected behaviour, mainly
limiting this comparison to SF with 2D/1D, and to 2D/1D with 3D. In fact,
as already stated, nothing can be expected a priori by comparing 2D and 1D
motion compensations. Accordingly, I start analysing cases where compara-
ble errors yield different ranks (ID1, ID4), moving on to those cases where
statistically significant differences in E[µϵ] are not reflected in the perfusion
maps (ID2, ID5, ID11), concluding with the most relevant situations, where
significant differences in the quantitative index yield opposite ranks (ID3, ID6).
Starting by ID1, although the couples SF, 2D and 1D, 3D have comparable
values for E[µϵ], the perfusion maps from SF, 2D are ranked differently as
well as those from 1D, 3D. In fact, this lesion mostly oscillates along the x-y
plane, with a rather uniform “wide” hypo-perfused core, surrounded by a more
perfused thin region, in the shape of an outer circle. Failing in aligning this
region correctly, yields a perfusion map where the core actually extends up to
the border, breaking off the perfused outer circle. On the whole the errors are
similar, but the information generated changes. This is also what happens,
to a different extent, with 2D and 1D alignments, when performed alone. In
addition, although 1D and 3D have the same errors, only the pattern of the 3D
map is fully reliable. Similar considerations can be made for ID4, although a
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more relevant motion along the z direction makes 1D more effective, but with
a significantly higher error than 3D.
On the contrary, there are cases where significant differences in the quanti-
tative error have not effect on the information content of the perfusion maps.
ID2 is the smallest liver lesion (Table 4.1) also showing a “blinking” behaviour
(i.e., disappearing from the reference slices now and then) and translational
compensation is almost useless, as confirmed by the E[µϵ] values (both, quite
low) achieved when compensating along the craniocaudal direction only or
according to the 3D approach. ID5 (lung lesion of Figure 4.8) has very a
heterogeneous BF , and perfusion maps from SF and 2D yield a comparable
information content (with relevant unreliable parts), although 2D compensa-
tion yields a statistically significant improvement (P≤ 0.001), while 1D and
3D show comparable errors and reliable perfusion patterns. This is due to
the real shifting being mainly along the craniocaudal direction, but the asym-
metry of the lesion makes its changing sectioncaptured on the reference slice,
shifting along the x-y plane, simulating a translational motion that, actually,
is almost negligible. Finally, ID11 is the most stable lesion, apart from just
very few slices, where it shows a motion mainly along the craniocaudal direc-
tion. This is why ID11 has the lowest values for the quantitative index among
the lung tumours, as regards 1D and 3D. Accordingly, although 2D compen-
sates, this does not improve the overall perfusion pattern, as can be seen in
Figure 4.10 (b), also due to a high number of unreliable values. On the other
(a) (b) (c) (d)
Fig. 4.10: BF colorimetric maps of ID11 resulting from SF (a), 2D (b), 1D (c) and
3D (d) alignment approaches. The pink colour highlights pixels whose perfusion
values have been considered unreliable.
hand, 1D compensation lowers the error and yields a perfusion map (c) which
is considered as being as much reliable as that from 3D motion compensa-
tion (d), although the latter has an even a lower value. In addition, the range
of BF values for perfusion maps from SF (a) and 2D (b) is comparable, as well
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as their mean value (about 73ml/min/100g). On the other hand, the range
is narrower for 1D (c) and 3D (d) perfusion maps, although being comparable
with each other, as well as their mean value (about 56ml/min/100g).
Still remaining are the two most meaningful cases where qualitative and
quantitative assessments are reversed for SF and 2D alignments. I firstly con-
sider ID3 (Figure 4.11) for the liver, a so-called target lesion that represents
Fig. 4.11: Details of colorimetric maps of ID3 for µϵ (first row) and BF (second
row), resulting from the different alignment approaches (from left to right: SF, 2D,
1D, 3D). The white arrow points to an increase of perfusion that appeared even
more unexpected as it relates to a region where the error decreased, as shown in
the corresponding error map.
a meaningful perfusion study due to marked respiratory motions, both along
the x-y plane and craniocaudal direction. However, this lesion has quite a
high-perfusion core surrounded by a low perfused region, and it is the widest
liver lesion (Table 4.1), meaning that despite its motion the core of a fixed ROI
may sample different parts of a low-perfusion tissue. This is why E[µϵ] and
σ(µϵ) are quite limited (Figure 4.9 and Table 4.2). In addition, this is why a
much greater improvement is brought by 1D. Figure 4.11 shows the resulting
colorimetric maps related to µϵ (first row) and BF (second row). The first two
columns (from left) refer to the SF and 2D results, respectively. As it can be
seen, the manual compensation of translational motion yields improvements
on the µϵ map - the errors are attenuated in 2D, especially for boundary pixels
(red pixels in the maps roughly corresponds to unreliable pixels according to
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the two-σ rule previously described). As for corresponding BF maps, they
show both a central region with a high perfusion, surrounded by less perfused
pixels, with a more extended perfused area on the outer boundaries for 2D. It
is worth noting that according to a visual evaluation (Table 4.2), the perfusion
map from 2D (rank 4) was considered worse than SF’s (rank 3), mainly right
because of more evident signs of perfusion in the upper side (white arrow) of
2D error map. In addition, SF map is more similar to 3D even to a non-expert
eye. In fact, if just translational compensation could improve the quantitative
index (i.e., the reliability of TCCs), contemporary and non-independent mo-
tion on craniocaudal direction could even worsen the map. On the other hand,
1D compensation only (Figure 4.11, third column) yields a greater improve-
ment and, when considering the 3D alignment (fourth column), the effect of
the reduction of motion components in the craniocaudal direction can clearly
be appreciated, leading to the best results both at numerical and visual level.
The µϵ map shows the best values with a range that is halved with respect to
the previous two maps from SF and 2D and the associated perfusion map is
more realistic, presenting a very thin perfused region in the upper periphery,
with a high-perfusion area for bottom-right pixels of the ROI, with a pattern
that best resembles what the radiologists expected to see after their visual
inspection.
I have just discussed colorimetric maps of a hepatic lesion whose perfusion
patterns are somehow related to each other, at qualitative level. On the other
side, the lung lesion I am about to analyse, ID6, is paradigmatic of what the
real effect of 3D alignment on TCC and, accordingly, on perfusion patterns
could be. This is even more interesting because, among the lung lesions, ID6
is the most static one according to the x-y plane and 2D yields the minimum
improvement, as it can be seen at a glance from the plot of Figure 4.9. Fig-
ure 4.12 shows the colorimetric maps of BF values for ID6, referring to the
different alignment methods, where unreliable pixels are set to “pink”. As it
can be seen, the amount of discarded values ranges from very few pixels for 3D
(Figure 4.12 (c)), while it increases when moving towards SF (Figure 4.12 (a)).
The most important point, however, is the position of pink pixels and of the
most perfused patterns. By comparing Figure 4.12 (a) and (b), the slight im-
provement yielded by the manual translation in the upper borders of the lesion
is visible, where movements include air samples that jeopardise the reliability
of TCCs and, accordingly, of the maximum slope computation. However, the
overall map visually seems to worsen in 2D with small sparse aggregates of
unreliable pixels. This is the reason why the radiologists chose SF, although
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(a) (b) (c)
Fig. 4.12: BF colorimetric maps of ID6 resulting from SF (a), 2D (b) and 3D (c)
alignment procedures. The pink colour highlights pixels whose perfusion values
have been considered not reliable.
the quantitative indices in Table 4.2 are slightly better for 2D. It is worth
remarking that there is no way to further improve the perfusion map with-
out resorting to compensation along the craniocaudal direction (also, the map
from 1D, not shown here, is considered comparable to 3D’s for both the in-
dices). Figure 4.12 (c) has been built by choosing four different z levels and it
is clearly the best image and, yet more, this is the lung examination showing
the most uniform behaviour (E[µϵ], σ(µϵ) ranging from 7.53 to 8.62, and from
1.45 to 4.10, respectively), also being among the most stable one (see E[µϵ],
σ(µϵ) for SM in Table 4.2). However, the perfusion pattern in Figure 4.12 (c)
is quite different from Figure 4.12 (a), (b). More specifically, in Figure 4.12 (c)
it is still possible to appreciate some trace of the most perfused regions in Fig-
ure 4.12 (a), (b), although the most perfused pattern is at the bottom right,
rather than at the bottom left.
I should highlight that this could be an unavoidable side-effect of motion
compensation along the craniocaudal direction, where the definite colorimetric
map actually results from different slices, in spite of the accurate tracking. In
fact, while a section of a lesion shifting along the x-y plane only could be
tracked (only theoretically) with no errors, the tracking along the z direction
is (practically) always prone to “errors” which, for small lesions, could be of a
half a slice thickness, or even more. This means that what sampled in 3D could
represent a sort of “mixture” of different slices. Practically speaking, since
translation motion is rarely alone, 2D compensation could represent different
lesion’ sections. Nevertheless, the radiologists considered the colorimetric map
from 3D as the most reliable one, after considering both SF and 2D which, by
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coincidence, they saw previously, as being reliable. In practice, although this
behaviour is apparently unknowable, we should not forget that radiologists
form their own opinion by examining all the slices of the whole CTp scan.
Therefore, it is possible to- state that both inner parts (i.e., non-pink pixels)
of Figure 4.12 (b), (c) could contain reliable patterns, just referring to different
lesion sections.
4.2.7 Concluding remarks
First of all, results achieved in Sect. 4.2.6 shows that a better alignment could
not yield more reliable perfusion patterns, also because regionally high errors
could give a low contribution to the overall fitting error E[µϵ]. For instance,
high errors mainly due to initial motion (i.e., related to the first few slices) may
slightly affect the slope of the TCC. On the contrary, a motion in the interval
around the maximum slope time instant would significantly alter the BF value,
meanwhile being compliant with a low fitting error. Nevertheless, the auto-
matic thresholding method based upon statistical analysis of distribution of
our fitting error can highlight and exclude unreliable perfusion values in both
lung and liver lesions. The recommendation for all the foregoing is that every
perfusion maps should be critically re-evaluate by radiologists, independently
from the alignment procedure followed.
A further point is that when radiologists “play” a cine sequence to form in
their mind a perfusion map, what they expect can be found on perfusion maps
built with different registration methods, and slice sequences, accordingly. This
is because what radiologists see while observing the whole sequence of CT
images often happens at different z -depths, and not just on the reference slices.
Finally, I have proven that considering a 3D alignment, albeit being based
on rigid translations, is not an option, it is a necessity, since there are cases
where perfusion maps arising from x-y alignments are considered to have a
worse quality than those maps originating from no alignments.
In conclusion, the method presented to assess the reliability of perfusion
patterns after motion compensation contributes towards achieving a more ac-
curate and reproducible computation of perfusion values, this representing a
ground stage towards the clinical use of CTp studies.
The results presented in this Section have been published in [230].
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4.3 An automatic method to detect unreliable
perfusion values
After studying the signal pertaining to a single voxel through the use of the
index µϵ, I move my attention to the analysis of the signal coming from a
whole tumour slice. The aim of this section is to present a novel quantitative
and automatic method to detect those anatomical structures (mainly vessels
and bronchi) and those regions undergoing CTp reconstruction and acquisition
artefacts, that could compromise the correct interpretation of a CTp colour
map and, ultimately, the clinical outcome. The approach is again based on
the computation of the TCCs’ error index µϵ associated with the thresholding
methods presented in Sect. 3.3. The ability of our method to automatically re-
move the “misleading” regions is assessed and compared with the performance
of two 25-year experienced radiologists who detected, and manually bounded
for further exclusions the anatomical structures and the regions undergoing
artefacts. Moreover, changes of mean perfusion values and, above all, of their
standard deviation and CV, were analysed before and after removing the auto-
matically segmented regions. Finally, some meaningful comparisons between
colour maps achieved by using our approach and the manual thresholding on
BF values commonly used by Readers are discussed.
The set of examinations that have been selected for this study is de-
scribed in Sect. 4.3.1. Acquisition protocol and data processing are resumed in
Sect. 4.3.2. Sect. 4.3.3 presents the manual procedure carried out by the radiol-
ogists to identify vessels, bronchi, and artefacts visible on the CTp sequence of
each examination. In order to “quantify” the proficiency of the two very expert
Readers on detecting and outlining the possible signs of errors in perfusion val-
ues stemming from the CT sequence, the ROIs manually drawn were compared
with corresponding TEM, using statistical indexes. The comparison procedure
is described in Sect. 4.3.4, while the statistical tests applied are mentioned in
Sect. 4.3.5. In addition, some perfusion maps are compared where errors are
removed through our approach versus manual thresholding on perfusion val-
ues. Finally, BF mean, standard deviation, and CV values of the examination
before and after thresholding are computed and compared. Experimental re-
sults are presented and discussed in Sect. 4.3.6. Finally, Sect. 4.3.7 draws some
concluding remarks.
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4.3.1 CTp examinations
In this study, some CTp examinations of patients with primary NSCLC have
been selected among those of the study used in Sect. 4.2. In particular, lesions
having maximum transverse diameter greater than 2.5cm, and area wider than
3.14cm2 were used. Lesions whose boundaries could not be accurately identi-
fied, such as in case of highly inflamed tissues surrounding the tumour, were
excluded from the study. Finally, 22 patients (age range 36 - 81 y.o.) were
enrolled for the study, for a total amount of thirty-four examinations, with as
many lesions.
4.3.2 Acquisition protocol and data processing
The acquisition protocol followed to acquire the CTp examinations is that for
lung tumours described in Sect. 4.2.2. Two ROIs were drawn, on the aorta and
on the lesion contour, respectively. As a consequence of the results presented
in Sect. 4.2, the tissue ROIs were aligned following the 3D procedure. The
TCCs extracted from each voxel of the ROI were again fitted through the use
of Hill’s equation. Both µϵ and BF values were computed for each voxel of the
ROI and represented through the use of colorimetric maps, following the same
procedures described in Sect. 4.2.
Since µϵ histograms were all characterized by a bell-shape with a long right
tale (as described in Sect. 3.3) and higher µϵ are associated to unreliable per-
fusion values (Sect. 4.2), the two thresholding methods described in Sect. 3.3
have been applied to the µϵ distribution of each examination so as to achieve
two threshold values: T2σ and TT . TEMs as those presented in Sect. 3.3 were
created for each examination.
4.3.3 Manual annotation
For each examination, the initial sequence of 20 scans is looked through to de-
tect and manually annotate the main causes affecting the analysis of perfusion
maps, represented by artefacts, and anatomical structures such as vessels and
bronchi. The purpose of this annotation stage was twofold. On the one hand,
I wanted to achieve the best possible performance, and to this purpose the
first radiologist (hereafter, Reader A) was given no time limit for his analysis.
On the other hand, I aimed to obtain realistic results, and for this reason the
second radiologist (hereafter, Reader B) had to complete his analysis in a time
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Fig. 4.13: From left to right, lesions ID15, ID34, ID14, ID17. A small vessel (a)
and a bronchus (b) manually contoured by Readers A and B, respectively; artefact
regions induced by motion (c) and beam hardening (d), graphically annotated by
Readers A and B, respectively.
compliant with a “routine” CTp study, under the same conditions as those in
a clinical environment. The analyses were accomplished in a blind fashion.
First of all, the two Readers analysed the whole set of images in cine-mode
and detected the presence of vessels and bronchi inside the lesion. After that,
they manually outlined in the reference slice the anatomical structures also
visible in the reference sequence (Figure 4.13 (a) and (b)) using a graphic
device (Intuos R©Pro, Wacom, Krefeld, Germany). Then, the radiologists iden-
tified, and manually annotated in the reference slice, the lesion’s regions un-
dergoing the different type of artefacts, although mainly arising from partial
volume effects induced by residual motion and from beam hardening (Fig-
ure 4.13 (c), (d)). As one can see in Figure 4.13, while vessels and bronchi are
usually well identifiable, detecting artefacts is much harder and, even when
succeeding, both boundaries and extent cannot be detected with accuracy.
4.3.4 Comparison between annotated slices and thresh-
olded error masks
The way the anatomical structures and artefacts were detected and outlined,
mainly the uncertainty in delineating artefacts, drove our choice regarding the
approach to compare the regions manually outlined with the outcome of our
automatic error detection approach. For this reason, the number of numerical
structures found (or missed) and the presence of artefacts in a given region
were considered, since their extent was not visually assessable. Nevertheless,
different types of artefacts, in the same lesion are considered separately. Ac-
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cordingly, there are four different outcomes from the matching procedure: “hit”
or true positive (TP), false positive (FP), true negative (TN), “miss” or false
negative (FN), all arranged into three 2 × 2 contingency tables, for vessels,
bronchi, and artefacts, respectively [267]. Also, it is worth recalling that we
are interested in detecting only those acquisition and reconstruction artefacts,
vessels, and bronchi that can hamper the perfusion values, rather than arte-
facts or anatomical structures in themselves. Therefore, the thresholded error
masks was chosen as the reference (i.e., the “ground truth”) and the regions
manually outlined by radiologists were considered as the test condition. For
instance, when a Reader detects an item that has no correspondence on the
thresholded error mask (this representing a FP), this does not necessarily hints
a mistake, rather most probably what detected does not hamper the compu-
tation of perfusion values. On the other side, in case that a Reader does not
outline any item in correspondence of an error structure present in the thresh-
olded error map, this is considered a FN only after that a radiologist confirmed
the nature of that error structure, that is vessel, bronchus or artefact. The
simplest case is when no error structures are detected, nor visually neither
automatically, when the TN number in each contingency table is increased
by one. As far as the TP are concerned, at the beginning I hypothesized to
segment the thresholded error maps into connected ROIs and perform an au-
tomatic matching between manual and computed ROIs. Then, several known
strategies could have been considered to decree a match, ranging from inclusion
criteria to overlapping thresholds, even weighted to allow for possible different
sizes [268]. As a matter of fact, this could work for anatomical structures, but
would fail for artefacts and using different approaches would not have been
fair. Besides that, in any case determining the FNs would require the inter-
vention of radiologists. In addition, if our purpose is to quantify the Readers
errors (with the meaning defined at the beginning of this paragraph), then
it is enough to find out how many error causes, in terms of structures and
artefacts, are missed visually. For all these reasons, I decided that a visual
matching performed by the Readers would be the most appropriate for our
purposes.
4.3.5 Statistical analysis
To assess the Readers’ performance I measured how their errors, in terms of FP
and FN, impact on the the total number of negative (N=FP+TN) and positive
(P=TP+FN) cases, respectively. This is given by the frequency of their errors
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over the total number of cases, namely, the FP rate (FPR=FP/N) and the FN
rate (FNR=FN/P), computed on each of the three contingency tables. FPR
and FNR are also known as Type I and Type II statistical errors, respectively.
Also, in order to better understand the implications of these errors, it could
be useful to think of them as functions of specificity (SPEC) and sensitivity
(SENS), these being entities more used in clinics, where FPR=1-SPEC and
FNR=1-SENS.
The paired two-sided Wilcoxon signed rank test was used to compare the
mean BF values before and after thresholding, while the one-tail F test and
Z test were computed to assess the reduction of standard deviation and CV,
respectively, after thresholding. All tests are implemented in R software (ver-
sion 3.2.1, The R Foundation for Statistical Computing). p-value ≤ .01 were
considered as being statistically significant.
4.3.6 Experimental results
Table 4.3 shows the outcome of the comparison between manual annotations
Contingency tables and statistical indexes
Reader A Reader B
Type P N TP TN FP FN FPR(%) FNR(%) TP TN FP FN FPR(%) FNR(%)
Vessels 18 26 16 26 0 2 0 11 12 24 2 6 8 33
Bronchi 8 27 7 27 0 1 0 13 7 26 1 1 4 13
Artefacts 41 9 26 7 2 15 22 37 20 3 6 21 67 51
Tab. 4.3: Table summarizing contingency tables and statistical indexes relative
to the analysis conducted by the two radiologists regarding the presence of vessels,
bronchi, and artefacts.
and computed thresholded error maps, related to the 34 examinations. The
first consideration concerns the possible causes of alteration of perfusion data
(column ‘P’), that in this study were artefacts (41), vessels (18, with mean
area of about 16mm2), and bronchi (8, mean area around 23mm2). Also, FPR
and FNR columns highlight that Reader A always performed better than, or
at most as the same as, Reader B. In particular, Reader A had a specificity of
100% regarding the detection of bronchi and vessels, although Reader B also
showed quite a good performance in terms of FPR for these physiological struc-
tures. As an example, Figure 4.14 (a) shows an example of manual detection
by Reader A of bronchi and vessels, all of them detected automatically also
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Fig. 4.14: Lesions ID29 (a,b), and ID19 (c,d). Three vessels (in red) and two
bronchi (in yellow), manually highlighted by Reader A, together with two missed
artefact regions (green arrows) (a), with corresponding thresholded error masks (b);
two vessels (in red) detected by Reader A only, one bronchus (in yellow), and one
artefact from beam hardening (in green), manually contoured by Reader A (c),
with correspondent thresholded error mask (d).
by the T2σ threshold (Figure 4.14 (b), blue regions). However, both Readers’
performance decrease when it does not come down to missing structures. For
instance, Figure 4.14 (c) shows two vessels detected by Reader A only, and
highlighted by our approach (one of which, pointed out by the green arrow in
Figure 4.14 (d), detected through TT only).
Things change as Readers face artefacts. Although manifest artefacts
can be detected by both Readers (e.g. the beam-hardening artefact of Fig-
ure 4.14 (c), in green), apparently more subtle artefacts, like the two shown
in Figure 4.14 (a), originating from partial volume effects (left green arrow)
and beam hardening (right arrow), are missed by both Readers (this represent-
ing two FNs), whereas they are correctly detected by our automatic method
Figure 4.15 (b). Or else, even when artefacts are correctly detected, with a
surprisingly high precision (the three green sharpened ROIs in Figure 4.15 (a)),
their ramifications (mostly highlighted by pink pixels in Figure 4.15 (b)) are left
out of consideration – for the sake of honesty, they are almost impossible to be
assessed to the naked eye. Nonetheless, in the lesion shown in Figure 4.15 (c),
Reader B strives to argue the extent of this beam-hardening artefact induced
by the high concentration of CA into vena cava, during the initial phase of CT
acquisition. However, although the shape was not far wrong, again the extent
is heavily underestimated, as shown by the outcome of the automatic method
in Figure 4.15 (d). Moreover, this is an example where any clinical consid-
eration regarding this case could be severely misleading, due to more than
one third of the lesion (2537 out of 7299 voxels) being unreliable in a scatter
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Fig. 4.15: Lesions ID12 (a,b), and ID33 (c,d). A beam-hardening artefact manu-
ally detected with a high accuracy by Reader B (a) and the corresponding thresh-
olded error mask (b); a well-defined shape of an artefact drawn by Reader B (c),
that however fails in detecting the wide extent of its effects, highlighted in the error
mask (d).
manner, and the examination is strongly suggested to be definitely excluded.
The great benefits of using an automatic method to exclude unreliable
pixels can be also appreciated when considering the most spread alternative,
that is manual thresholding on perfusion colour maps. Figure 4.16 (a) shows an
Fig. 4.16: Lesions ID32, where no misleading regions are detected (a), with its
colour BF map manually thresholded (b); the thresholded error mask (c) and the
final BF map achieved after excluding the error regions and a subsequent visual
thresholding by using the same value as before (d).
interesting example of lesion, coming from quite a stable CT sequence, where
neither physiological structures nor artefacts where detected. Accordingly, the
few pink pixels in the corresponding perfusion colour map (Figure 4.16 (b))
only arise from the voxels with too high perfusion values, removed by Readers
through agreed manual thresholding. The resulting BF map is plausible and
shows a perfusion peak, on the top right border, whose BF values are around
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200ml/min/100g. However, the thresholded error mask in Figure 4.16 (c)
clearly highlights a high-error region, just in correspondence of the perfused
area, correctly removed as shown by the presence of the pink pixels in the BF
map in Figure 4.16 (d). This is a meaningful example where a simple manual
thresholding fails, since the error affects voxels with apparently acceptable
perfusion values. The scatter plots in Figure 4.17 resume this concept, with
Fig. 4.17: Scatter plots to explore the relationship between BF values and µϵ
errors, referring to cases ID19 (Figure 4.14 (c)) (a), ID12 (Figure 4.15 (a)) (b),
ID32 (Figure 4.16 (a)) (c), ID33 (Figure 4.15 (c)) (d). As one can see, errors also
affect physiological BF values. Blue dots are detected by the 2-σ rule, while the
red ones are detected by the triangle method only.
colour convention as the same as Figure 3.12 (a). Although, as expected, there
are cases where the errors are almost exclusively associated to non-plausible
BF values (Figure 4.17 (a), referring to lesion of Figure 4.14 (c)), most of
times errors are shared between high and low perfusion values, as shown in
Figure 4.17 (b) (referring to lesion of Figure 4.15 (a)) and Figure 4.17 (c)
(pertaining to Figure 4.16 (a)). Nonetheless, in case of wide extending artefacts
is not rare to find lesions where errors affect almost exclusively the voxels whose
BF values fall in the physiological range, as shown in Figure 4.17 (d), referring
to the lesion shown in Figure 4.15 (c).
The resulted presented above can be better acknowledged when looking at
the meaningful BF histograms of Figure 4.18, referring to lesions ID14 (a) and
ID33 (b), showing which BF values are removed by thresholding (for a better
readability, only the triangle method is shown, in the red colour). As one
can see, there are cases (Figure 4.18 (a)) where non-physiological BF values
mostly lie on tail as well as there are lesions (Figure 4.18 (b)) where removed
BF values are spread throughout the whole range, almost proportionally, and
the average of removed BF values is nearly the same as that of the original
distribution. As a consequence, as shown in Figure 4.19 mean values basically
remain unchanged for 2-σ thresholding (6 cases out of 34), almost half of them
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Fig. 4.18: BF values of the whole lesion (cyan colour) and those removed by the
triangle method (red colour), referring to lesion ID14 (a) and ID33 (b).
Fig. 4.19: Mean of BF values (µ) in the original examination (solid cyan line,
diamonds), after 2-σ (dashed blue line, squares) and triangle (dotted red line,
triangles) thresholding.
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(18 out of 34) with triangle thresholding reduce. As regards standard deviation,
they all reduce (Figure 4.20), most of them with statistical significance (20
Fig. 4.20: Standard deviation (σ) of BF values in the original examination (solid
cyan line, diamonds), after 2-σ (dashed blue line, squares) and triangle (dotted red
line, triangles) thresholding.
cases with 2-σ thresholding, and even 29 using triangle). These reductions
partly reflect in CVs, reported in Figure 4.21, which diminish in 12 cases with
Fig. 4.21: CVs related to BF values in the original examination (solid cyan line,
diamonds), after 2-σ (dashed blue line, squares) and triangle (dotted red line,
triangles) thresholding.
2-σ and 16 cases with triangle thresholding.
4.3.7 Concluding remarks
In the first place, this research work shows that the highest values of µϵ are re-
lated just to those regions corresponding to anatomical structures (i.e., vessels
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and bronchi) or affected by artefacts, altering the computation of the perfu-
sion colour map. In particular, the results presented confirm that removing
unreliable BF values could yield significant changes (commonly, reductions)
in the mean BF value of a lesion, often used as a significant statistical param-
eter in several clinical studies [170, 147], this contributing to carry out more
precise clinical assessments. Also, what this study proves is that visual-based
annotation is undoubtedly inadequate to discover the source of uncertainty in
a CTp sequence. At most, devoting more time to this task reduces the number
of FP and FN, always improving FPR and FNR (except for bronchi), but the
improvement is quite relevant limitedly to the anatomical structures. On the
other hand, this study highlights that the different types of artefacts represent
the most spread causes possibly hampering perfusion parameter values, much
more than physiological structures, perhaps this not being surprisingly and in
line with what most probably every radiologists expect. However, what seems
to be heavily underestimated is the extent of the negative effects of artefacts,
this representing the highest risk if relying only on visual assessment of CTp
perfusion sequences and maps.
In the second place, it has not to be forgotten that perfusion maps are usu-
ally provided “as is”, without any pixel-wise indication on their reliability and
what radiologists usually do through visual analysis is, at most, just detect-
ing perfusion peaks not compliant with physiological values and exclude them.
This behaviour is prone to either neglect local perfusion peaks or including all
local errors if compatible with physiological outcome. This work shows that
in most cases errors are present also in the whole range of physiological perfu-
sion values, mostly due to the presence of artefacts, highlighting at least one
examination where an apparent perfusion peak would have been kept when
clipping the colour scale manually.
The automatic error detection strategy presented, represents a method-
ological approach towards a more and more quantitative CTp imaging, this
constituting an ineluctable way towards achieving a routine clinical use of
CTp.
The results that have been presented in this Section have been published
in [236].
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In this Chapter, I extend the analysis conducted so far on the signal coming
from single voxel (Sect. 4.2) and single slice (Sect. 4.3) to the whole tumour.
While in the literature it is widely agreed that considering tumour volumes
provides more information than using a single section, usually single slices are
merged together to provide global parameters. However, the clinical represen-
tativeness of global perfusion values and their capability to deal with tumour
heterogeneity has never been investigated. This issue is faced in this Chap-
ter. In particular, a specific background is reported in Sect. 5.1 and the set
of CTp examinations selected for this study is described in Sect. 5.2. The
methodologies previously discussed to automatically detect and exclude un-
reliable perfusion values from the analysis (Sect. 4.3) are applied to all the
lesion sections, as well as the indicator of functional heterogeneity presented
in Sect. 3.5 (Sect. 5.3). A deep statistical analysis is carried out to assess
the clinical representativeness of global perfusion values and their capability
to deal with tumour heterogeneity (Sect. 5.4). Experimental results and some
concluding remarks are finally reported in Sects. 5.5 and 5.6.
5.1 Background
Tumour heterogeneity, representativeness of tumour regions, reliability of re-
sults, and reproducibility of CTp examinations represent different as well as
interconnected issues that should be addressed as a whole. In fact, as discussed
in Sect. 2.1, heterogeneity is an intrinsic characteristics of all tumours that is
also reflected in the hemodynamic behaviour, for instance, in areas of angio-
genesis or necrosis [249]. As a consequence, which part of the tumour could be
the most representative one for clinical assessments has been widely debated.
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Traditionally, the first CTp examinations were performed on one slice, due to
technology limitation of data acquisition and processing apparatuses [87]. Af-
terwards, the improvement of technology has permitted to work on the whole
tumour [269], or groups of slices, as the central ones [171]. However, authors
have still continued working on a single section only [236], chosen as the one
representing the largest tumour “diameter” [175], or better incorporating the
solid-appearing part of the target lesion [270], or else being in the middle scan
position [186, 271, 272]. Nonetheless, several researchers choose the single tu-
mour section based on visual considerations only [210], such as that having the
best quality [227], or the widest area [192], jointly to the least variability [228].
Undoubtedly, the most important issue to make CTp entering the clini-
cal practice is the possibility to achieve between-patient and among-patients
standardization. To this purpose, the reproducibility of reliable results is an
essential requirement, but it must be coupled to the clinical representative-
ness of numerical results. In the literature, it has been widely stated that by
considering the whole tumour [202], or even group of slices [205], perfusion pa-
rameters may improve reproducibility and repeatability [238], against a single
slice. That is, considering a wider “population” (i.e., more slices), averaging
values helps achieving a “global” tumour behaviour. Using global mean or
median values can also work for diagnosis purposes, where CTp has been used
to discriminate between benign and malignant in different types of lung le-
sions, including pulmonary solitary nodules. For instance, the overall mean of
pulmonary index, pulmonary and bronchial BF is computed on multiple slices
in [76] and on three tumour sections chosen according to the axial, coronal and
sagittal planes, in [273]. The overall median of all the CTp parameters for the
whole tumour is computed in [269], where the median was preferred over the
mean operator to avoid outliers.
All the studies considered refer to global perfusion parameters, whether
they are mean or median values, encompassing all the tumour characteristics.
However, in this way, besides the uncertainty intrinsic to the CTp acquisition
and processing procedure, global parameters also reduce the variability due to
tumour heterogeneity. This is acknowledged by several authors, which recog-
nize that global values only provide an overall measure of variability [203] and
that “may not be optimal for tumour evaluation prior to treatment or therapy
response evaluation” [224]. Nevertheless, very few attempts have been made
to try assessing the capability of CTp parameters to evaluate the treatment
response of patients with NSCLC, but the lack of reproducibility could not con-
firm the results. For instance, the study in [183], dealing with CTp monitoring
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of anti-angiogenic therapies in lung cancer, concludes that CTp can detect
therapy-induced changes in perfusion, but the lack of reproducibility depletes
these findings. Similar outcomes regarding the CTp capability of monitoring
anti-angiogenic therapies were reported in [187], even though in this case, no
reproducibility studies have been performed. On the other side, more recently
the authors in [192] could not find any correlation between CTp parameters
and survival of patients treated with anti-angiogenics and chemotherapy. Also,
they concluded that entropy only, computed on the HU, could be considered
as an independent prognostic factor for OS, this suggesting the importance of
tumour heterogeneity in assessing tumour aggressiveness.
5.2 CTp examinations
The same set of 22 patients with one primary NSCLC, previously enrolled in
the retrospective study described in Sect. 4.3 were considered. Here, as an
added inclusion criteria, I selected lesions having the longest axial diameter
larger than 15mm in at least three sections. Altogether, 12 patients (9 men,
3 women, mean age 64.7 y.o., range 42-81 y.o.) with a target lesion having
mean longest axial diameter of 43.5mm (range 25.3-75.2mm) and a mean area
of 1625mm2 (range 433-1995mm2) remained. Five of them underwent at least
one follow-up (FU), for a total amount of 26 CTp examinations.
5.3 Acquisition protocol and data processing
All the examinations were acquired following the acquisition protocol designed
for lung tumours, described in Sect. 4.2.2, and underwent the same treatments
used for the lesions of Sect. 4.3. In fact, tissue ROIs were drawn on each
tumour section and aligned following our 3D approach. Spatial filtering was
applied on CT images according to what described in Sect. 3.1 and the Hill’s
equation was used to fit the extracted TCCs. Voxel-based BF values were
computed according to the SIMS method. Unreliable BF values were excluded
from the analysis by using the triangle thresholding method. Mean BF values
representative of each slice (µs) and of the whole lesion (µw) were computed
for each examination. Median values were also computed for each slice (Ms)
and the whole lesion (Mw). The ranges (r) between minimum and maximum
of µs and Ms, rµ and rM respectively, were computed as a variability measure
referred to the whole volume.
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The entropy, E, presented in Sect. 3.5 was computed on the BF maps
of the whole tumour (Ew) and of each slice (Es), with the purpose to get a
measure of the hemodynamic heterogeneity. The range rE between minimum
and maximum Ew values is also considered as a measure of the heterogeneity
variability in the whole tumour. E measures are reported in arbitrary units
(a.u.).
5.4 Statistical analysis
Three groups of statistical tests were performed to assess the capability of
global values, computed on the whole tumour, to represent the clinically rele-
vant perfusion features of a tumour, assuming that the heterogeneity is among
the most important ones [36]. First, the one-way analysis of variance (ANOVA)
was performed to check whether all slices (the “groups”) of the same tumour
have the same mean value, that is, whether they can represent the same pop-
ulation, in terms of BF values. An analogous assessment was carried out for
medians, through the Chi-squared test of independence. The second group
consists in the two-tail t-test and the Wilcoxon rank sum test, which were uti-
lized for three different purposes. In fact, they were applied to test, for each
lesion, the difference of means and medians, respectively, between each slice
and the whole tumour, with the purpose to check whether a slice exists which
can represent the whole tumour (i.e., having the same global value). The same
tests were also carried out to check for µs or Ms differences between couples
of slices, whether they belonged to same tumour or different ones. Finally,
they were employed to select which tumours have the same statistical µw or
Mw values, to further compare their perfusion patterns (i.e., their Ew). In
fact, computing and using a global mean, or median, perfusion value for CTp
studies implicitly means that sets of BF values (e.g. slices or whole tumours)
with same µs (or Ms) as µw (or Mw) are clinically equivalent. The third group
of tests is composed by the one-tail t-test only, which was performed to assess
the differences between the means of Es for baseline and FU examinations.
p-value ≤ .05 were considered for statistical significance. Statistical analy-
sis was performed by using statistical software (R, version 3.2.1, The R Foun-
dation for Statistical Computing).
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5.5 Experimental results
In this section, a subset of the most interesting results achieved is presented.
Results obtained for baseline and FU examinations are kept separate and
resumed inside different sections in order to allow detecting possible differ-
ences between untreated lesions, preserving their natural vascular structure,
and lesions whose vascular network has been modified by the action of anti-
angiogenic treatments.
As the first outcome, it is worth reporting that the hypotheses that means
or medians BF values of slices were all equivalent were rejected for each exam-
ination. Actually, this finding was expected and suggests that the variability
between slices is significantly greater than the variability within slices [267].
Tables 5.1 and 5.2 report the most significant measures (entropy, mean,
median, and range) for all examinations, calculated on BF values of each slice
and the whole tumour.
5.5.1 Baseline CTp
Table 5.1 resumes the most significant measures for the baseline CTp exam-
inations. Statistical analysis shows that ten slices exist which have the same
global BF as the respective whole tumour, seven times regarding mean values,
and eight ones median values. Five times the whole tumour could be repre-
sented by the same slice detected by both µw and Mw values. µw and Mw
values never selected the slice with maximum Es and one time selected the
slice with minimum Es (ID12 and ID4, for mean and median, respectively).
Figure 5.1 reports the five slices of ID12, one of the most interesting lesion,
where the average BF value of the whole tumour (µw =125.0) corresponds to
that of the first slice (µs =124.5, Figure 5.1 (a), last row). It is worth noting
that this slice also retains the minimum Es =7.48, that is the lowest hetero-
geneity. In fact, it shows quite a uniform, low, perfusion. On the contrary,
the last slice (Figure 5.1 (e)) shows a marked heterogeneity, the highest one
(Es =8.37), having in its upper part a hyper-perfused region (with BF values
higher than 300), and a lower hypo-perfused region with BF values nearly 40.
5.5.2 Follow-ups CTp
Table 5.2 resumes the most significant measures for the FU CTp examinations.
Fifteen slices were representative of the whole tumour, thirteen of which re-
garding mean BF values, and eight pertaining to median values. Five times,
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Baseline examinations
slice whole tumour
patient measure 1 2 3 4 5 measure value r
ID1
Es 7.27 7.27 7.26 6.75 6.61 Ew 7.14 0.66
µs 67.9 62.9 62.3 45.8 40.5 µw 56.0 27.4
Ms 56.9 50.9 45.7 33.8 28.4 Mw 41.4 28.5
ID2
Es 8.17 8.15 8.22 8.05 7.91 Ew 8.20 0.31
µs 124.1 115.8 128.5 118.2 108.3 µw 120.1 20.2
Ms 107.3 96.6 110.8 99.8 93.2 Mw 102.0 17.6
ID3
Es 7.81 7.75 7.89 7.85 7.67 Ew 7.87 0.23
µs 117.6 111.3 116.4 115.1 102.3 µw 111.8 15.2
Ms 101.3 103.1 102.4 103.7 93.5 Mw 100.1 10.2
ID4
Es 7.26 7.38 7.31 7.36 7.44 Ew 7.39 0.18
µs 65.7 69.7 65.1 68.1 71.2 µw 68.0 6.1
Ms 54.9 56.9 47.9 50.0 53.6 Mw 52.8 9.0
ID5
Es 7.81 7.84 7.36 6.60 7.79 Ew 7.70 1.23
µs 115.1 106.8 80.7 43.2 107.3 µw 87.2 71.8
Ms 93.2 87.1 67.4 38.2 90.6 Mw 67.6 55.0
ID6
Es 6.10 5.96 6.38 6.62 6.59 Ew 6.54 0.66
µs 33.3 31.7 41.3 52.7 63.9 µw 42.9 32.2
Ms 27.5 28.5 34.5 47.0 58.8 Mw 36.8 31.3
ID7
Es 6.37 6.27 6.53 – – Ew 6.67 0.26
µs 46.2 38.2 60.9 – – µw 47.9 22.7
Ms 38.6 30.5 55.3 – – Mw 40.7 24.8
ID8
Es 7.43 7.07 8.10 7.92 7.62 Ew 7.95 1.03
µs 74.9 61.5 138.4 156.0 118.6 µw 105.2 94.5
Ms 57.1 53.9 119.0 141.7 104.1 Mw 85.3 87.8
ID9
Es 8.54 7.59 7.65 8.03 8.53 Ew 8.24 0.95
µs 175.7 79.6 81.4 104.6 160.1 µw 118.4 96.1
Ms 158.3 60.0 62.3 73.0 133.2 Mw 88.9 98.3
ID10
Es 6.75 6.66 6.42 6.52 6.76 Ew 6.66 0.34
µs 45.9 44.2 38.2 40.8 48.5 µw 43.4 10.3
Ms 37.8 37.3 32.5 34.6 42.6 Mw 36.4 10.1
ID11
Es 7.46 7.34 6.89 7.63 – Ew 7.50 0.74
µs 92.2 80.7 58.9 92.6 – µw 80.0 33.8
Ms 76.5 61.4 51.3 74.1 – Mw 63.3 25.2
ID12
Es 7.48 7.64 7.86 8.01 8.37 Ew 8.07 0.89
µs 124.5 110.0 113.6 116.8 157.4 µw 125.0 47.4
Ms 118.7 106.1 104.0 112.7 145.9 Mw 116.0 41.9
Tab. 5.1: Summary of measures for slices and whole tumour referred to baseline
CTp examinations: Entropy (E), Mean (µ) and Median (M) BF values, where the
subscripts s and w stand for slice or whole, respectively. For the whole tumour,
r of each slice-based measure is computed as well. Italicized and bold-italicized
values point out minimum and maximum value of a given measure, respectively.
Bold non-italicized values highlight an equivalence between µs and µw, or Ms and
Mw.
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Follow-up examinations
slice whole tumour
patient FU measure 1 2 3 4 5 measure value r
ID2 1
Es 7.85 8.06 7.99 7.88 7.72 Ew 8.08 0.34
µs 99.6 130.6 118.3 111.4 97.6 µw 112.8 33.0
Ms 85.2 110.4 99.9 85.6 75.2 Mw 92.4 35.2
1
Es 6.50 6.26 7.33 7.70 – Ew 7.50 1.44
µs 47.7 38.0 76.8 145.6 – µw 77.5 107.6
Ms 41.1 33.6 70.4 120.7 – Mw 60.1 87.1
2
Es 6.63 6.21 6.40 6.90 – Ew 6.82 0.69
µs 58.1 42.2 45.8 80.0 – µw 53.5 37.8
Ms 49.2 38.6 32.5 71.4 – Mw 43.2 38.9
ID6 3
Es 6.37 6.26 6.73 6.43 – Ew 6.67 0.47
µs 40.8 40.9 45.7 54.6 – µw 44.4 13.8
Ms 33.3 36.9 36.3 50.4 – Mw 37.8 17.1
4
Es 6.42 6.31 6.49 6.42 6.18 Ew 6.45 0.31
µs 42.7 38.1 40.3 39.3 35.3 µw 39.2 7.3
Ms 38.6 31.8 32.8 33.2 30.6 Mw 33.2 8.0
5
Es 7.47 6.14 5.94 5.64 5.75 Ew 6.50 1.84
µs 96.1 33.3 24.7 19.9 24.7 µw 35.8 76.3
Ms 91.8 29.1 19.4 16.4 21.7 Mw 24.7 75.4
ID7
1
Es 7.57 6.57 7.20 – – Ew 7.64 1.00
µs 145.5 52.2 97.7 – – µw 95.5 93.3
Ms 133.8 42.6 78.4 – – Mw 78.4 91.2
2
Es 5.82 6.33 5.90 – – Ew 6.33 0.51
µs 34.1 48.8 58.0 – – µw 45.0 23.8
Ms 32.2 42.8 56.7 – – Mw 39.8 24.4
ID9 1
Es 7.45 6.47 6.60 6.50 6.58 Ew 6.80 0.98
µs 80.8 36.9 45.1 38.7 41.6 µw 46.2 43.8
Ms 67.6 31.4 39.6 34.1 36.2 Mw 38.4 36.2
1
Es 7.04 6.83 6.63 7.46 – Ew 7.20 0.83
µs 71.4 54.7 50.4 108.4 – µw 66.9 58.0
Ms 60.7 47.3 44.6 96.5 – Mw 55.5 51.9
2
Es 6.77 6.66 7.26 7.49 7.53 Ew 7.40 0.87
µs 52.4 43.3 67.7 90.9 107.9 µw 70.2 64.6
Ms 41.7 33.6 55.6 84.0 95.9 Mw 56.5 62.3
ID11 3
Es 7.20 7.17 7.30 7.49 – Ew 7.40 0.32
µs 74.8 73.2 75.9 90.5 – µw 78.1 17.3
Ms 70.4 66.2 69.7 81.0 – Mw 71.0 14.8
4
Es 7.05 7.20 7.22 7.28 7.32 Ew 7.29 0.27
µs 69.0 72.9 70.9 71.5 79.0 µw 72.3 10.1
Ms 64.3 64.1 60.1 61.1 70.1 Mw 63.3 10.0
5
Es 7.57 7.39 7.52 7.87 8.24 Ew 7.81 0.85
µs 80.9 71.7 76.7 99.9 144.7 µw 90.1 73.0
Ms 60.7 55.2 61.3 74.2 123.2 Mw 66.8 68.0
Tab. 5.2: Summary of measures for slices and whole tumour referred to FU CTp
examinations. Notations are the same as those in Table 5.1. Here, the FU number
is also reported.
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Fig. 5.1: ID12: the whole scan (first row), HU (second row) and BF maps (third
row) ordered from left to right according to the scan position (the third section
is the central one). The BF maps are visualized using the same colour scale. By
chance, they are are also sorted according to their E value: Es =7.48 (a), Es
=7.64 (b), Es =7.86 (c), Es =8.01 (d), Es =8.37 (e).
mean and median global BF values identified the same slice. For lesion ID6-
FU3 (Figure 5.2, µw =44.4 and Mw =37.8) and ID6-FU4 (Figure 5.3, µw
Fig. 5.2: BF maps of the four consecutive slices of ID6-FU3 (1-4, from left to
right). µw =44.4, Mw =37.8.
=39.2 and Mw =33.2), the same slices (i.e., slice 3 for both) were those with
maximum E (Es =6.73 and Es =6.49, respectively), probably due to these
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Fig. 5.3: BF maps of the five consecutive slices of ID6-FU4 (1-5, from left to
right). µw =39.2, Mw =33.2.
examinations being subsequent FUs of the same lesion. In addition, this is the
only ID where mean and median select the highest E. As regards ID6-FU4, it
shows limited BF ranges (rµ =7.3 and rM =8.0, among the lowest values of all
examinations) and µs andMs are substantially equivalent for the three central
slices. This consideration regarding mean range also holds for ID6-FU3, where
rµ =13.8 is a little higher, but still among the lowest ones. As for median, in
ID6-FU3 it also selects slice 2 (Ms =36.9) that has the lowest Es =6.26. On
the other side, in ID11-FU4 (Figure 5.4), Mw =63.3 selects slice 1 (Ms =64.3)
Fig. 5.4: BF maps of the five consecutive slices of ID11-FU4 (1-5, from left to
right). µw =72.3, Mw =63.3.
which is the one with the lowest Es =7.05.
5.5.3 Baseline and FU CTp
In this section, the analysis is extended over the whole dataset, by considering
all the CTp examinations together. As regards the whole sets of slices, the
most meaningful result is that, on the whole, 93 slices were not represented
by the global BF values computed on the whole tumour. As for the sets of
111
Chapter 5. Multi-slice analysis of BF values
5.5. Experimental results
whole tumours, here the sets of slices referring to two couples of meaningful
lesions are analysed. Figure 5.5 shows the BF maps of the four consecutive
Fig. 5.5: BF maps of the four consecutive slices (1-4, from left to right) composing
lesions ID11, baseline (µw =80.0, first row), and lesion ID6-FU1 (µw =77.5, second
row). µw’s are statistically equivalent.
slices (1-4, from left to right) of ID11 (µw =80.0, first row) and ID6-FU1 (µw
=77.5, second row). Although these lesions have statistically equivalent µw, the
respective composing slices have a different heterogeneity distribution. In fact,
the heterogeneity in all slices (except for slice 3) of ID11 is quite comparable,
as it can be seen from Es values of Tables 5.1. On the contrary, slices 1 and
2 of ID6-FU1 (Figure 5.5 (a) and (b), second row) are quite homogeneous
and low-perfused, while slice 4 (Figure 5.5 (d), second row) has the highest
µs =150.8 and Es =7.75. In addition, here the heterogeneity is made of local
homogeneities, with a hyper-perfused upper region and a hypo-perfusion in
the lower one.
Similar comments can be done for ID3 and ID2-FU1, made of five slices
each, whose BF maps are shown in Figure 5.6, first and second row, respec-
tively. ID3 (µw =111.8), shows a heterogeneity that keeps quite “homoge-
neous” within all slices (rE =0.23, the second lowest value), also in terms of
mean (rµ =15.2) and median (rM =10.2) BF (among the lowest values), with
all µs around µw =111.8. On the other hand, the heterogeneity in ID2-FU1
(µw =112.8), is made of well-defined hyper- and hypo-perfused regions, mostly
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Fig. 5.6: BF maps of the five consecutive slices (1-5, from left to right) composing
lesions ID3, baseline (µw =111.8, first row), and lesion ID2-FU1 (µw =112.8, second
row). µw’s are statistically equivalent.
evident in the upper and lower part, respectively, of slices 2 and 3.
Finally, I also analysed the distribution of all slice entropies Es for baseline
and FU examinations, separately. Related histograms are reported in Fig-
ure 5.7 (a) and Figure 5.7 (b), respectively. Even at a glance, the histograms
Fig. 5.7: Histograms of entropies Es of all slices for baseline (a) and FU (b)
examinations. Mean values, highlighted by the vertical red lines, are 7.4 and 6.9,
respectively.
of baseline examinations appear shifted right with respect to the FU ones. In
fact, for baselines mean and standard deviation are 7.4 and 0.75, respectively,
while for FUs they are 6.9 and 0.64. Statistical tests confirm that the mean
entropy of all slices is greater for baseline examinations (p-value ≤ 10−4).
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5.6 Concluding remarks
In this Chapter, the representativeness of global mean and median values, as
far as the heterogeneity is concerned, has been analysed starting from the as-
sumption that computing and using a global mean, or median, perfusion value
for clinical purposes means accepting that the characteristics of the tumour
is represented by that value alone. Accordingly, this implies that sets of BF
values (e.g. slices or whole tumours), with statistically equivalent mean or me-
dian values, are equivalently representative. However, the outcome presented
in Sect. 5.5 proves that these are numerical equivalences only, not clinical ones.
In fact, some cases of lesions, with same global mean or median BF values,
which showed a very different heterogeneity were discussed. In addition, after
analysing tumour slices having the same global values as the whole tumour,
I realized that, when those slices existed, for baseline examinations they were
never those with the highest information content. Rather, it happened that
in two examinations the whole tumour had mean and median BF values cor-
responding to the slice with the lowest heterogeneity (ID12 and ID4, respec-
tively), while the remaining slices showed relevant clinical signs of different
heterogeneities. Consequently, global perfusion values computed on the whole
tumour cannot be appropriate for therapy assessment and cannot improve the
reproducibility of heterogeneity. As far as single slices are concerned, although
preserving more details, they may be not representative of the clinical status
of the whole lesion and this could severely mislead clinical considerations.
On the other hand, measuring heterogeneity is a key issue to achieve useful
information to assess the effectiveness of anti-angiogenic therapies, that cannot
be left out of consideration. This is confirmed by the comparison between the
average BF entropy of all slices before (baseline) and after (FU) treatment,
proving the effectiveness of treatments themselves, expectedly reducing the
overall BF heterogeneity of tumours. Using all the single slices of a tumour,
endowed with global BF values and a BF heterogeneity measures, would rep-
resent a step forwards, useful to help radiologists to draw more reliable clinical
considerations.
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PIXEL: a muti-centre study
A necessary step before introducing perfusion imaging techniques in clinical
practice is their validation in multi-centre studies. However, setting up this
type of studies can be very complex and, at present, only very few multi-centre
perfusion studies have been published. Probably, the project “Perfusion IndeX:
Evaluation for Liver metastases (PIXEL)” is the first CTp BF multi-centre
study on liver that has been carried out and I had the opportunity to work
on its data. In this Chapter, after a brief introduction regarding BF multi-
centre studies, the main issues related to this type of studies are discussed. An
analysis of the most important intra- and inter-centres sources of variability
that can affect the image quality and perfusion results achievable from CTp
examinations is then carried out on PIXEL data. After that, an early analysis
of image quality is performed on the examinations of each Centre in both
frequency and temporal domain. Finally, several hints and suggestions to
correctly set up a CTp BF multi-centre study are provided on the base of
PIXEL experience.
6.1 The need for multi-centre studies
The white paper [45] disseminated by the European Society of Radiology and
addressed to radiologists’ community is only one of the several attempts that
have been done to prompt a greater awareness about the enormous wealth car-
ried out by imaging biomarkers. Indeed, the role of image-based biomarkers has
become increasingly important in several medical areas, such as oncological,
cardiovascular, neurological, psychiatric, musculoskeletal, metabolic, inflam-
matory, and autoimmunity-based diseases [274]. Nonetheless, as highlighted
by the authors in [275], the introduction of a biomarker in the clinical practice
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results in a very complex procedure. Indeed, to substitute a clinical endpoint
with an imaging biomarker, such as OS or PFS, the correlation between the
biomarker and the clinical endpoint must be shown in a series of prospective
multi-centre studies culminating in a formal meta-analysis.
The need for perfusion multi-centre studies has been widely claimed in
the recent literature [64, 276, 277]. Nonetheless, the set-up of this type of
clinical studies is quite complex, this thwarting their implementation. Actually,
any guidelines specific for BF multi-centre studies have never been drawn.
However, from the work presented in [275] some general hints can be inferred,
aiming at investigating the main key-points of image-based markers validation.
In this work, the authors state that to compare results across studies, the
adoption of established standards is vital. Of course, this is also true in multi-
centre studies in which standardization should be achieved at any level, starting
from the recommendations regarding patient preparation acquisition protocols
to image reconstruction process, post-processing procedures and data analysis.
Indeed, the standardization of techniques is fundamental to limit the intra- and
inter-centre sources of variability hidden in both the acquisition and processing
steps, this enabling a correct comparison of results.
As regards all the clinical multi-centre studies, their protocol should be
defined in detail before beginning the data acquisition and by taking into con-
sideration all the limitations that may occur [275]. Indeed, as stated in [64],
to include more than one Centre meanwhile preserving the study standard-
ization as much as possible, it is necessary to adapt the study design to the
“largest common denominator among participants”. This aspect undoubtedly
represents a weak point of multi-centre studies since the achievement of the
best standardization might not agree with the best technology available and
constitute a limitation of the study, hampering the achievement of good re-
sults. Besides standardization, another aspect that should be assessed before
beginning a multi-centre study is data quality. Indeed, in the guidelines by
Miles et al. specific to CTp [83], it is suggested to measure DCE-CT image‘s
iodine sensitivity and noise (that are the two factors mostly affecting exami-
nations quality) at the beginning of each clinical trials. The iodine sensitivity
and noise measures should be carried out on phantoms that mimic the body
size of patients and by using the same image acquisition protocol that is go-
ing to be adopted in the study [83]. As proved in the phantom study carried
out on 9 different CT systems on [278], the adoption of this procedure might
allow to find allow finding out a iodine calibration factor allowing to reduce
variability introduced on quantitative measurements of contrast enhancement
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by the different CT scanners, thus allowing a direct comparison of the results
achieved.
Due to the complexity of the multi-centre studies set-up, actually there
are still very few studies that have been conducted in the oncological field
involving more than a single Centre. Among these studies there are two works
carried out with PET [279] and PET/CT [280] that introduced and applied
a series of calibration factors enabling data comparison between Centres. In
the first study [279], the effects of differences between PET calibration, image
resolution, and ROI size and positioning were investigated on phantoms and
on 23 patients with oesophageal carcinoma or lymphom. At the end of this
study, the authors proposed correction factors permitting to compare data
pertaining to the three Centres involved in the study. These correction factors
have been adopted also in the PET/CT multi-centre study on NSCLC [280]. In
this work, the examinations of 52 patients collected in 7 different Centres were
successfully analysed to assess the prognostic capability of PET/CT during
radiotherapy. Nevertheless, none of these two studies carry out a perfusion
analysis.
To the best of our knowledge, only three multi-centre perfusion studies have
been carried out so far. The first one is a French DCE-US study, involving
19 oncologic Centers for the evaluation of anti-angiogenic treatments in 539
patients with different types of solid tumours (primary HCC or metastatic
breast cancer, melanoma, colon cancer, gastrointestinal stromal tumours, or
RCC). In this case, all the DCE-US examinations were acquired with the
same type of machine and processed by using the same software [281]. The
second perfusion BF multi-centre study regards DCE-MRI. In this case, the
examinations of 9 patients with advanced squamous cell carcinoma of head
and neck acquired in two different Centres were used to determine DCE-MRI
efficacy to assess perfusion effects caused by response to lapatinib (a tyrosine
kinase inhibitor) [282]. In this work, two patients were discarded due to the low
quality of their examinations, but no analysis regarding multi-centre variability
were carried out and not any issue introduced by the use of different MRI
scanners was discussed. Finally, as regards DCE-CT two studies were carried
out using examinations acquired in different Centres. The former enrolled 356
patients with lung nodules across 7 Centres [283] to investigate the capability
of tissue contrast enhancement to predict benignity of nodules, but without
computing any perfusion parameter. Instead, the latter carried out a perfusion
analysis on examinations acquired in two Centres referring to patients with
CRC, aiming at identifying the practical and technical challenges inherent to
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the CTp technique. However, none of these works carried out any analysis
regarding multi-centre variability or discussed any peculiarity introduced by
the use of different CT scanners.
The first CTp study involving more than one Centre is a French study
named “Perfusion IndeX: Evaluation for Liver metastases (PIXEL)”. During
my period abroad, I had the opportunity to start working at this project
initially involving 19 Centres and almost 400 patients. The aim of PIXEL is to
assess the capability of HPI to predict the development of hepatic metastases
in patients with initially non-metastatic CRC before the administration of
anti-cancer therapies. As a derived goal of the study there is the identification
of a threshold value for the HPI allowing discriminating between patients
who developed liver metastases within 3 years from the CTp examination and
patients who did not. The evaluation of other indexes besides HPI and the
assessment of inter-observer variability represent further goals of the project.
The inclusion criteria of the project were:
• adult patients (age>18 y.o.)
• absence of previous cancer pathologies
• patients with CRC (with the tumour positioned more than 15cm far from
the anal margin)
• patients without liver metastases (presence of metastasis in sites other
than liver does not prevent patient inclusion)
• patients that gave their written consent
• patients followed at the hospital
Exclusion criteria are instead resumed by the following items:
• patients with liver metastases at the time of cancer diagnosis
• patients with chronic liver diseases
• patients who received chemotherapy before undergoing liver CTp
• patients who underwent cancer colorectal surgery before undergoing liver
CTp
• patients allergic to CA
• patients with renal impairment
118
Chapter 6. PIXEL: a muti-centre study
6.1. The need for multi-centre studies
• pregnant patients
Finally 15 Centres and 338 patients took part in the study. Table 6.1 resumes
PIXEL Centres and patients
Centre ID Centre CT scanner CT model
Number of Age range
patients and mean
1 Beaujon GE Lightspeed VCT 71 33 - 89 (69)
2 Hegp Broussais GE Lightspeed VCT 32 35 - 86 (66)
3 Ambroise Pare´ Philips MX8000 IDT 16 18 41 - 89 (67)
6
Henri Mondor
GE Lightspeed VCT 1 (68)
A. Chenevier
7 Pitie´ Salpeˆtrie`re Philips Brillance 64 7 49 - 78 (70)
8 Chu Nantes GE Lightspeed VCT 20 37 - 84 (68)
9 Chru Angers Philips MX8000 IDT 16 44 42 - 89 (71)
10
Haut-Le´veˆque
Siemens Definition 64 13 50 - 79 (69)
Bordeaux
12 Claude Huriez Philips Brillance 40 11 52 - 81 (65)
14
Centre Hospitalier
Philips Brillance 40 23 51 - 93 (70)
Lyon Sud
15
Institut Gustave
GE Lightspeed VCT 23 50 - 87 (64)
Roussy Villejuif
16 Chu Amiens GE Lightspeed Pro 32 49 43 - 92 (72)
17
Institut mutualiste
GE Discovery CT 750 HD 20 43 - 84 (65)
Montsouris
18
Chu Caen - Hoˆpital
Philips Brillance 40 2 60 - 81 (71)
Cte De Nacre
19
Cabinet d’he´atologie et
Philips MX8000 IDT 16 4 58 - 81 (67)
de gastro ente´rologie
Tab. 6.1: Summary of the main information regarding the Centres included in
PIXEL: ID, CT scanner, number of patients included in the study together with
their age range and mean (between brackets).
some data regarding the Centres and the patients included. Hereinafter, each
CTp examination is pointed out with an ID number where the number of the
Centre and of the patient are written after letters C and N, respectively (e.g.
ID C8N3 corresponds to the examination of the third patient of Centre 8).
The acquisition protocol was defined during a first meeting between the
responsible people of each hospital. A first unenhanced spiral CT scan was
carried out on the liver to identify the correct region that had to be analysed.
Right after, an axial CTp acquisition was performed so as to include the portal
vein trunk and the right hepatic parenchyma. The image acquisition started
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contemporaneously with the administration at 5ml/s of 40ml of iodinated
CA, with a concentration of 350mgI/ml. The CA bolus was followed by
the injection of 20ml of physiologic solution. Patients were asked to shallowly
breath over the two minutes of the CTp acquisition phase. CT tube current and
voltage were kept fixed at 100mA and 80kV , respectively, with a 1s rotation
time and exposure of 100mAs. The tissue was acquired every 1sec during the
first 30s and every 3s for the remaining 90s, yielding a total amount of 60
scans, each composed of 8 sections of 5mm thickness.
Examinations were performed since 2008 to 2011, and the patients were
monitored for 3 years after the CTp examination to assess weather they de-
veloped liver metastases. When the study started, not any indication about
the proper way to set up a multi-centre study was available and no previous
CTp multi-centre studies had ever been carried out. Therefore, no phantom
measurements or check of the correctness of the acquisition protocol param-
eters were carried out. The only check carried out on the first three to five
CTp examinations of each Centre was to verify whether the nominal sections
of the liver had been included in the CTp images. In case it had not been,
the responsible person for the Centre was reminded regarding the paramount
importance of the correct selection of the liver level to be analysed.
6.2 Technical issues in multi-centre studies
As discussed in Sect. 6.1, to carry out a successful BF multi-centre study it
is necessary to adopt common methodologies between Centres and achieve a
standardization throughout all the stages of data acquisition, processing, and
analysis. However, defining standard guidelines among Centres can be very
challenging. Indeed, despite all efforts that can be made, the use of different
scanners can hamper and sometimes prevent the achievement of comparable
data [284]. In multi-centre studies, two types of issues may cause results
variability. The former is related to the use of different devices in different
Centres, while the latter is related to the application of different acquisition
protocol. In this section, technical issues met during analysis of PIXEL data
and strictly related to the use of different vendors and models of CT scanners
in different Centres are reported and discussed.
Digital Imaging and Communications in Medicine (DICOM) is the stan-
dard adopted in medical imaging to handle, store, print, and transmit infor-
mation [285]. DICOM files are provided of a header that can contain all the
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details regarding the examination carried out, including information about pa-
tient, acquisition protocol, device used, or even the operator that accomplished
the study. Each information is described in a DICOM tag which can be public
or private, and collected in a DICOM field. Public information are those that
can be included in the standard data elements, such as the patient name or
the tube current value. On the contrary, private fields are often not visible
with common DICOM viewers and are mainly used from vendors to include
device-specific information. Despite DICOM files should contain all the infor-
mation needed for a quantitative analysis and be an effective standard, this
does not always happen. Indeed, in the review on [284] there is an important
call for manufacturers to ensure that DICOM files include embedded data in
well-defined public fields.
During the preliminary data analysis that I carried out together with the
computer engineers of the CVG1 on the CTp sequences acquired for PIXEL,
we immediately had to face two technical issues preventing perfusion data
analysis:
• the lack of some crucial information on the DICOM header
• the differences between the content of DICOM fields of different CT
vendors
The former is related to the configuration of the Picture Archiving and
Communication System (PACS) of the Centre. PACS is the system permit-
ting to store, transfer, and access all types of medical images [286]. Despite
PACS is usually configured to process and store all fields inside DICOM files,
the storage of private tags often has to be specifically enabled. Consequently,
if PACS is not configured to process also private tags, the DICOM transfer to
PACS could cause an information loss [287]. This is what happened in some
CTp examinations of PIXEL. Normally, the lost of information contained in
private fields should not compromise image data processing since, as reported
above, these fields should contain only information useful to the vendor. How-
ever, GE CT scanner store the image acquisition time instant, that should
be stored inside a standard DICOM tag, in the private tag ‘MidScanTime’
(0019,1024). While the availability of the exact image acquisition time could
not be of interest for the majority of clinical applications, the knowledge of this
parameter is of fundamental importance in perfusion analysis. Unfortunately
1a special thanks goes to Eng. Alessandro Gherardi for its help and the tools provided
in the analysis of DICOM sequences.
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there are no way to recover data missed by PACS and the only method to
recover the lost information is to retrieve the examinations directly on the CT
scanner. As regards PIXEL data, acquisition time instants were missed in 40
examinations pertaining to Centres 1 (25 examinations), 15 (2 examinations),
16 (13 examinations).
The second problem we met by analysing PIXEL data regards differences
between DICOM tags of different CT vendors. Indeed, as introduced above,
DICOM should be a standard, but vendors can modify the properties and the
content of public and private tags. The authors on [288] report how difficult
might be the analysis of the information encoded in CT DICOM metadata
due to the embedding of some required information in private tags and to
differences that can exist between fields with same tags of the same vendor
and model make by using different acquisition modalities. In our case, the
main problems we encountered regarded consistency of DICOM fields content.
In particular, three types of problems could be found:
1. data format in the same standard DICOM field were non consistent
2. private tags were used to contain data useful for data analysis and that
should be embedded in standard DICOM tags
3. the same standard DICOM tag was used by different vendors to hold
information with a different meaning
As regards the first problem, differences in encoding of standard DICOM
tags were found between different vendors. The value of the variables em-
bedded in a specific DICOM field could indeed be encoded as a string or as
sequence of bytes. To enable correct loading and usage of these parameters, an
algorithm able to automatically interpret all data of DICOM fields and trans-
late their values in a common format was implemented. A unique data format
was chosen for each parameter on the base of the suitability to data analysis.
For instance, fields containing a numeric value, such as time or tube current
and voltage, were all converted to double format so as to allow automatic
comparison between data acquired with different CT scanners. Another very
important issue is represented by the precision of the temporal data stored.
For instance, in some Centres, such as Centre 1 and 2, all the fields having
a time content are expressed in seconds and have a resolution of 1s while in
other Centres such as Centre 3 or 10, the resolution increases to less than 1ms,
thus becoming more suitable for perfusion analysis.
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The second issue regards the storage of information useful for data pro-
cessing in private field instead of standard DICOM tags. For instance, while
in Philips CT scanners the acquisition time is saved in the public field ‘Con-
tentTime’ (0008,0033), in GE scanners this information is stored in the private
tag ‘MidScanTime’ (0019,1024) that, besides being not standard, it may raise
problems, and with PACS, it is much more difficult to be retrieved. In fact, as
discussed above, private tags are not readable from all the DICOM viewers.
The third and last issue is related to the different usage that vendors do of
the same standard DICOM tag. As an example, let us consider the DICOM
sorting. To correctly carry out a perfusion study, the images acquired have to
be correctly sorted. In Centres such as Centre 9, this can simply be done by
referring to the value of the tag ‘InstanceNumber’ (0020,0013) that increases as
the order of the slices acquired (by z level and acquisition time). However, this
tag does not always assume the same meaning. For instance, in Centre 3 the
tag ‘InstanceNumber’ contains the slice ID related to a specific volume. If 60
tissue volumes are acquired, ‘InstanceNumber’ contains only integer number
between 1 and 60. To correctly sort DICOM images it is thus necessary to
consider also the tag ‘AcquisitionNumber’ (0020,0012) containing the number
of the volume acquired. However, in some other Centres, such as Centre 2,
‘AcquisitionNumber’ contains a number pointing out whether the image has
been acquired during the first or the second phase of the acquisition (i.e., the
first or the second 30− s acquisition interval). In order to fix the problem of
data sorting, an algorithm considering information from the standard DICOM
tags ‘AcquisitionNumber’, ‘InstanceNumber’, ‘ContentTime’, ‘SliceLocation’
(0020,1041) and from the private tag ‘MidScanTime’, when it exists, has been
set up.
6.3 PIXEL data: early analysis
As we have seen, several issues in multi-centre studies that can cause results
variability exist. Indeed, in addition to the difficulties related to the use of
different CT scanners, variability introduced by the use of different acquisition
parameters need to be considered. Since this is the first multi-centre study and
no information or hints about which parameters could have mainly affected
results, a complete and deep analysis of all the possible sources of intra-Centre
and inter-Centre variability was carried out. Together with the member of
CVG, all the aspects that could affect data and consequently perfusion results
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reliability and comparability were examined. The main steps of the preliminary
analysis carried out on PIXEL data together with the most significant results
achieved are resumed and discussed in the following paragraphs.
6.3.1 The DICOM files
A first check was carried out on the whole dataset to verify that the CTp
examinations were complete with all images and meta-files. When available,
the DICOMDIR file encoding the DICOM directory structures (i.e., how files
are organized) and some metadata regarding patient and acquisition protocol
were used. This file helps identifying and selecting the DICOM files proper
of the perfusion protocol, which are often mixed together with files regard-
ing other routine examinations, such as full-body non-enhanced or enhance
CT. On the contrary, the lack of the DICOMDIR file makes this first check
stage much more challenging, time-consuming and prone to errors. Indeed,
a modality that can be used is to visually check all the DICOM files of each
examination and then extrapolate only those hundreds files pertaining to per-
fusion protocol. However, this manual procedure can lead some DICOM file
to be erroneously excluded from the analysis. A semi-automatic method that
could help in such selection is that of exploiting the content of the DICOM
tags ‘SeriesDescription’ (0008,103E), which contains a description of the series
acquired. However, this tag is optional (i.e., its corresponding field could also
be empty, as happens for the examinations of Centre 16) and it may also have
different contents, depending on the operator selecting its value. For instance,
in Centre 1 this DICOM tag is described as “Perfusion Foie” (i.e., “liver per-
fusion” in French), in Centre 9 it assumes the value “PERFUSION”, while
in Centre 10 it can be equal to “Dyn2min 4.8 B30s” or “DynMulti 2min 5.0
B30s”. In particular, in this last Centre, the several acronyms composing the
tag refer to features of the acquisition parameters adopted. Indeed, “Dyn” and
“Multi” refer to the type of acquisition, which is dynamic and multi-slice (al-
though the term “multi” is not always specified), and are followed by the total
duration of the acquisition (2 min), the slice thickness (4.8 mm or 5 mm) and
the CT software’s convolution kernel used for data reconstruction (“B30s”).
Due to the variability of the content of this tag, in some cases the use of the
manual method for DICOM selection is inevitable.
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6.3.2 The dataset
Once the DICOM files pertaining to perfusion analysis have been correctly
identified, it is necessary to verify that the dataset is complete. For each
examination, the number of DICOM files must equals the result of the product
between the number of sections composing each tissue volume acquired (that,
however, has not been defined in the nominal acquisition protocol (NAP)) and
the number of acquisition time instants (according to the NAP, they should
be 60). For instance, with 8 sections for each tissue volume, 480 DICOM
files are expectedly collected for each examination, while with 16 sections per
volume the number of DICOM files reach 960. The a priori knowledge of these
numbers permits to easily find out whether some data have been missed. For
instance, the examination of the third patient of Centre 8 has 479 DICOM,
this suggesting that one DICOM file has been missed. Examinations where
the missed DICOM files could not be found neither recovered from the source
were excluded from the study.
6.3.3 Volume slices: number and thickness
The number of the acquired slices per volume depends on the sections’ thick-
ness: since the CT z -coverage is limited by a physical constraint, it is possible
to achieve more sections by reducing their thickness. For instance, in some
CT scanners with a maximum z -coverage of 4cm, it is possible to acquire 8
sections of 5mm each or 16 sections of 2.5mm. The nominal slice thickness in
the acquisition protocol of PIXEL was equal to 5mm. However, 8 Centres only
adopted this slice thickness value in all the examinations (Centres 1, 6, 8, 12,
14, 15, 16, and 18). On the contrary, in Centres 3 and 17 some examinations
were acquired with a slice thickness of 5mm and some others of 6mm. In Cen-
tre 7, the slice thickness used was of 5mm or of 0.625mm. The remaining 4
Centres, used a slice thickness other than 5mm in all the examinations: 2.5mm
were adopted in Centre 2, 4.8mm in Centre 10, 6mm in Centres 9 and 19. A
different slice thickness affects quality of the data acquired and consequently,
of the perfusion results. Indeed, by reducing slice thickness it is possible to
achieve more details about the tissue, to reduce partial volume effects, and to
increase quality of motion correction, but at the expense of an higher noise
level inside images. The comparison of results achieved with a different slice
thickness should therefore be considered carefully.
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6.3.4 Pixel size
Another aspect related to partial volume effect is pixel size. Voxel dimension
was not established in the NAP, but it can have relevant effects on the preci-
sion of the perfusion values computed. Indeed, using bigger voxel sizes mean
averaging more information that has to be represented in one voxel. Very dif-
ferent voxel sizes have been found in the same Centre and between different
Centres, ranging from 0.29mm to 0.98mm. The voxel size is also related to
the FOV selected for the acquisition. Figure 6.1, reports an example of three
(a) (b) (c)
Fig. 6.1: In (a), a wide FOV has been used (examination C9N4), in (b), the
FOV is correctly placed (examination C1N1) while, in (c), the FOV is very narrow
(examination C1N62).
examinations acquired with a different FOV. In Figure 6.1 (a), the FOV is
too wide, this resulting in the acquisition of CT images with big pixel size
(0.98mm) and lot of background that is useless. In Figure 6.1 (b), the FOV
is correctly centred on the patient and the acquisition covers all the abdomen
section (voxel size of 0.54mm). Finally, in Figure 6.1 (c) the FOV is narrow
and focused on the liver only. In this case, the voxel size is smaller (0.49mm)
than in the other two examinations, thus permitting to achieve more precise
perfusion values. However, often the use of too a narrow FOV does not permit
to visualize the spleen (that is fundamental for the application of the DIMS),
besides causing sometimes a data loss, since respiratory movements can move
liver outside the FOV. Accordingly, the examinations with a very narrow FOV
have to be included with a great care.
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6.3.5 Acquisition protocol and time information
The sampling time in the acquisition protocol is really a tricky issue to cope
with. The knowledge of the correct time instants in which each image was
acquired is fundamental to achieve reliable perfusion values. For instance,
overestimating the time interval between two acquisition, yields to underes-
timate the BF , meanwhile overestimating BV and MTT . The example in
Figure 6.2 reports a tissue curve of the examination C8N2. The data points
(a) (b)
Fig. 6.2: The same TCC is represented by using two different timelines. In (a) the
real acquisition time of each sample is used (BF of 37.9ml/min/100g), while in (b)
data samples are distributed according to the NAP (BF of 23.3ml/min/100g).
of the same TCC have been placed using different time samples: in (a) the
real reported acquisition time was used (i.e., one image, and hence one data
point, each second), while in (b) data points have been distributed according
to the NAP (the first 30 samples are placed at 1s distance and the last 30 at
3s). BF values computed on the two curves differ of 14.6ml/min/100g, this
highlighting the importance of knowing and using the correct acquisition time
instants.
As regards the acquisition time instants, the acquisition protocol was cor-
rectly followed in all the examinations of Centres 1, 6, and 16. However, even if
the acquisition protocol has been correctly followed, some examinations present
a time glitch (i.e., one or more tissue volumes have been acquired with a lag,
that might be of the order of milliseconds or even of seconds). A couple of
examples of time glitch are presented in Figure 6.3, showing the time intervals
between consecutive volumes acquired in three different examinations. In Fig-
ure 6.3 (a), the NAP has been followed and no time glitches are present. In
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(a) (b) (c)
Fig. 6.3: Time intervals between consecutive volumes referred to three different
examinations. Time intervals of C16N1 are presented in (a). In this case no glitches
are present. In (b), the time intervals of C1N1 show a small glitch in the second part
of the acquisition. Finally, (c) shows time intervals of C17N1 where a significant
glitch is present in the middle of the sequence.
fact, between consecutive volumes there are exactly 1s in the first part and 3s
in the second part of the acquisition. In Figure 6.3 (b), a short time glitch is
visible in the second portion of the acquisition, where the interval between two
consecutive sampling instants is longer than 3s. Finally, in Figure 6.3 (c) a big
glitch (of more than 4s) is visible in the examination whose volumes have all
been acquired with 1s of sampling time. These time glitches are completely
operator independent and can be randomly present in different examinations
of the same Centre, without any apparent reason. Consequently, the only way
to achieve correct perfusion results is to use the acquisition time specified in-
side DICOM tags. The use of the acquisition time instant declared in the NAP
is thus not recommended to compute perfusion and has to be accurately eval-
uated in those cases where time information are not available from DICOM
files.
Particular difficulties to follow the NAP were met by those Centres with
a Philips CT scanner, which does not allow switching the time sampling fre-
quency as GE does. Therefore, some Centres such as 3, 9, 12, 18, and 19
adopted the solution of acquiring all the sequence of images with 1s sampling
time. In some cases, images were acquired for 60 times (60s), this resulting
in very short acquisitions. In other cases, the duration of the acquisition was
kept fixed to 120s (e.g. Centre 12), this resulting in a huge number of data and
an heavy radiation dose delivered to patients. In some other Centres the two
phases have been separated by a pause of 2s (e.g. Centre 15) or 4s (e.g. Centre
10). In Centres 7, 8 and 17 instead, different temporal acquisition protocols
have been adopted in different examinations. Indeed, while some examinations
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of Centre 8 have been correctly acquired following the NAP, some others have
been acquired by using two phases (the former having a time interval of 1s
and the latter of 4s, separated by a pause of 2s), and another one using a one
phase only. In Centre 17 instead, some examinations have been acquired by
keeping the time interval fixed at 1s (with the exception of the glitch of 4s
between the first and the last slot of 30 volumes) and some others by using
a protocol similar to that followed in Centre 15. As regards Centre 7, each
examination has been acquired using different time intervals. In particular,
one examination only was acquired using a one phase protocol (with a time
sampling fixed at 1s). The remaining examinations were carried out using a
two phase protocol, adopting either a uniform time sampling for both phases,
fixed at 1.5s or 1s time sampling for the first phase and 3s for the second one.
In addition, the time interval between phases varies from 8s to 26s. The case
of Centre 2 is different since the examinations have been all acquired using
a multi-phase protocol composed by four different parts having different time
intervals between volumes (3s, 2s, 3s, and 5s were sequentially used as time
intervals). Finally, a yet different acquisition protocol was followed by Cen-
tre 14. Through the analysis of the acquisition time instant, it was possible
to realise that all the examinations of that Centre had been acquired with a
lag between the two phases of the protocol of nearly 14s. The lack of the
acquisition portion during which CA diffuses inside tissue prevents the use of
the data acquired by this Centre that had to be definitively excluded from all
perfusion studies. The same conclusion can be drawn also for those examina-
tions of Centre 7 acquired by using two phases and a very high time interval.
Unfortunately, for 57 examinations of Centres 1, 3, 7, 10, 12, 15, and 16 it
was not possible to retrieve the acquisition time instants neither to check out
the acquisition protocol followed for these examinations. At the moment, not
any test has been carried out yet to assess whether and to what extent, these
glitches may affect the reliability of the obtained TCCs and of the computed
perfusion values, accordingly.
Finally, it is worth noting that two examinations pertaining to Centre 12
(C12N10 and C12N11) could not be analysed, since their DICOM fields were
all empty. The acquisition protocol applied and the sample timing used could
thus not be verified and the two examinations were consequently not considered
any longer.
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6.3.6 Tube current and voltage
Other two parameters that deeply affect the quality of CT data acquired are
the tube current and voltage. The nominal values are 100mA and 80kV re-
spectively. However, several differences have been found between the values of
these two basic parameters in several Centres. In three Centres only (Centres
1, 6, 10) indeed, the examinations were acquired by using the nominal tube
current and voltage parameters. In Centres 8, 16 and 17, the same param-
eters were used for almost all the patients. In four patients indeed, one of
the two parameters has been modified. In four Centres, the tube voltage was
correctly kept at 80kV , but different values of tube current were applied. For
instance, Centre 2 applied a tube current of 80mA, while Centres 12 and 18
used tube current values definitely higher (equals to 200mA and 260mA, re-
spectively). In Centre 15, the examinations are performed by using a variable
and very high tube current, ranging from 204mA to 672mA. The use of high
tube current values does not jeopardize the quality of CT images, but mainly
contribute to deliver patients a very high radiation dose. In Centres 9 and
19, tube current and voltage were kept at 90kV and 133mA, respectively, for
all patients. In Centre 7, the greatest part of examinations have been carried
out at 80kV and 303mA, respectively. However in this Centre, several ex-
ceptions have been made. Indeed, two examinations (C7N6 and C7N1) have
been acquired at 30mA and 100mA (the former at 120kV ). In addition, a
third examination (C7N3) has been acquired in two different phases having
different acquisition parameters. In particular, part of the examination has
been acquired with a tube current of 50mA and voltage of 120kV , while in
the latter part, 303mA and 80kV , have been used, respectively. Therefore,
the quality of these three examinations has to be assessed with a particular
care, since too a low tube current could compromise image quality insomuch
to prevent the achievement of reliable results. Accurate quality controls are
finally needed also for the patients of Centres 3, where both tube and voltage
current consistently vary between patients, assuming several different values
without apparent motivations.
6.3.7 Radiation dose
Related to the tube current and voltage values, there is the radiation dose
delivered to patients. This aspect does not directly influence quality results,
but constitute a very important aspect of perfusion studies. The maximum
nominal dose level in the acquisition protocol had to be lower than 100mAs. To
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verify whether the radiation dose has been kept low, I checked several DICOM
tags. While the field ‘ExposureTimeInms’ (i.e., the duration of exposure for
the frame in milliseconds) is empty in all the examinations and ‘CTDIvol’ (i.e.,
CT Dose Index describing the average dose for this frame, in mGy) is often
incomplete, the only field available to evaluate the radiation dose delivered to
patients is ‘Exposure’ (i.e., the exposure expressed in milliampere per second,
calculated as the product of exposure time and tube current). By analysing
this DICOM tag in the various examinations, I noticed that the exposure was
kept low in almost all the examinations. An exception is represented by those
few examinations of Centres 3, 7, 8, 16 and 18 where high values of tube current
had been selected, making exposure vary between 130mAs and 200mAs, and
for all the patients of Centre 15 where the exposure reached a peak of 672mAs.
6.3.8 Administration of the contrast agent
Another aspect of the acquisition protocol that could introduce variability in
perfusion results regards CA. As reported in [289], the use of different quanti-
ties, concentration, and injection rate of CA can have deep effects on the shape
of arterial and tissue TCCs. The nominal CA administration in PIXEL was of
40ml at 5ml/s. However, the features of the injected CA should be specified
in optional DICOM tags such as ’ContrastBolusVolume’ and ’ContrastBolus-
IngredientConcentration’ (pointing out the volume injected in ml of diluted
CA and the mg of active ingredient per ml of diluted agent, respectively) that
are often empty. Partial information about CA injection have been retrieved
from DICOM tags in 6 Centres only. What emerged is that also in this case,
many variations have been made in the different Centres, and even through
the examinations of the same Centre. In Centres 2, 6, 8, different quantities of
CA have been administered to patients. Indeed, while in Centre 6 the quan-
tity of CA was proportional to patient weight (1.5ml/kg), in Centres 2 and 8
variable quantities of CA (40ml, 50ml, 60ml, and 80ml) were administered in
different examinations, apparently without any selecting criterion. In Centres
8 and 15 instead, different injection rate (4ml/s and 5ml/s) were applied for
CA administration. On the contrary, in Centre 16, what varied is CA concen-
tration (350 and 370mgI/ml). Besides different CA quantities, injection rate,
and concentration, even different CA were administered in different Centres
and in the same Centre as well. For instance, in Centre 2 three different io-
dinated intra-vascular CA (Xenetin, Iomeron, Omnipaque) were administered
to patients. To the best of our knowledge, there are still no studies comparing
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the effects of using different CA on perfusion results. In this case, CA are all
of the same type: iodinated and intra-vascular. However, it is important to
pay attention on the possible variability introduced by these CA.
Finally, it is important to note that in examinations C9N43 and C10N16
no CA was administered to patients. Therefore, these two examinations were
excluded from the analysis.
6.3.9 CT scanners
Further sources of variability that can affect quality of results achieved di-
rectly derive from the different CT scanners used. The use of different image
reconstruction algorithms and filters in different CT scanner models or vendors
may indeed affect the quality of CT images on which perfusion parameters are
computed and induce variability, accordingly. As a matter of fact, different
filter types and convolution kernels to reconstruct images in examinations were
used in Centres 2, 3, 7, 15, 16, and 17, and even within the same Centre. In
the absence of proper calibration studies using phantoms, it is not possible
to evaluate how much these factors introduce variability in perfusion results.
However, results achieved by analysing images of the same Centre, obtained
by using different reconstruction algorithms, and used together, should be first
analysed separately to assess the degree of variability introduced, before being
compared.
6.3.10 Resuming of the acquisition parameters used in
the different Centres
Table 6.2 resumes the main acquisition parameters used in the different Cen-
tres. We recall that Centre 14 was excluded from the analysis due to its tempo-
ral acquisition protocol being unsuitable for perfusion analysis (see Sect. 6.3.5).
In addition, 5 examinations pertaining to different Centres have been excluded
from this resuming Table. In fact, CA was not administered to two patients
of Centres 9 and 10, this leading to a total amount of 43 and 12 patients in
the two Centres, respectively. Two more examinations from Centre 12 have
been excluded, because of the lack of any information inside DICOM tags.
Finally, one patient from Centre 7 has been excluded since the examination
was acquired using different acquisition parameters during the two phases of
the examination (see Sect. 6.3.6).
Acquisition time protocol used in Centre 2 is not specified in Table 6.1 since
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Acquisition parameters summary
Centre ID
Tube Tube Exposure Slice CA Time sampling
current (mA) voltage (kV ) (mAs) thickness (mm) D (ml) S (ml/s) C (mgI/ml) n1 t1 (s) delay (s) n2 t2 (s)
NAP 100 80 100 5 40 5 350 30 1 0 30 3
1 100 80 100 5 NA NA NA 30 1 0 30 3
2 80 80 80 2.5
40(2)
NA NA Multi-phase60(19)
80(7)
NA(4)
3
149(7)
NA NA NA 60 1 - - -
152(2) 80(4) 50(2) 5(5)
200(4) 90(11) 100(15)
300(1) 120(3) 150(1) 6(13)
303(4)
6 100 80 100 5 * 5 NA 30 1 0 30 3
7
30(1) 80(5) 100(5) 5(5)
NA NA NA ** ** ** ** **100(1) 120(1) 150(1) NA(1)
303(4)
8
100(19) 80(18) 100(19)
5
40(13) 4(1)
NA
30 1 0 30 3
200(1) 100(1) 200(1) 50(1) 5(13) 30 1 2 30 4
120(1) NA(7) NA(7) 60 1 - - -
9 133 90 100 6 NA NA NA 60 1 - - -
10 100 80 100 4.8 NA NA NA 30 1 4 30 3
12 200 80 100 5 NA NA NA 120 1 - - -
15
204(1)
80
204(1)
5 40 NA 30 1 2 30 3
239(1) 239 (1)
261(1) 261(1) 4(3)
392(1) 392(1)
405(1) 405(1)
427(1) 427(1) 5(19)
438(15) 438(15)
672(1) 672(1)
16
100(48)
80
100(48)
5 NA NA
350(11)
30 1 0 30 3150(1) 150(1) 370(12)
NA(26)
17
100(19) 80(19)
100
5(19)
NA NA
350(15) 30 1 4 30 3
133(1) 90(1) 6(1) NA(5) 30 1 4 30 1
18 260 80 130 5 NA NA NA 60 1 - - -
19 133 90 100 6 NA NA NA 60 1 - - -
Tab. 6.2: Summary of the acquisition parameters of the NAP and of those used
in the different Centres. If different value of the same parameters have been used
in a Centre, the number of examinations acquired with each parameter value is
pointed out between brackets. D, S, and C have been used to indicate quantity,
injection speed, and concentration of CA administered. * the quantity of CA was
patient-based (see Sect. 6.3.8). ** a different time sampling was used for each
examination of the Centre.
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it is composed by several acquisition phases using different sampling frequency
(see Sect. 6.3.5).
Finally, information regarding CA administration are often not available
(NA) inside DICOM tags since included in optional public fields (see Sect. 6.3.8).
Undoubtedly, tube current and voltage and slice thickness are three of the
acquisition parameters that mostly affect perfusion results. As one can see,
only 6 Centres (1, 6, 7, 8, 16, and 17) acquired at least one examination using
for these parameters the values agreed in the NAP. Therefore, a total amount
of 158 examinations have been acquired using at least the agreed tube current
and voltage and slice thickness (71 in Centre 1, 48 in Centre 16, 19 in Centre
17, 18 in Centre 8, 1 in Centres 6 and 7).
6.4 Assessment of image quality
In the CTp guidelines by Miles et al. [83], it is clearly stated that quality as-
surance is of fundamental importance. In its simplest definition, image noise
is measured as the standard deviation of voxel values in a homogeneous area.
Measures of image quality such as standard deviation or SNR are indeed sug-
gested and necessary in multi-centre studies, where differences in CT scanners
and related software may bias data analysis. In Sect. 6.3, the main sources
of variability in the acquisition protocol of each Centre that can affect quality
of results have been discussed. For instance, the use of a lower tube current
can lead to a higher photon starvation effect, while a lower spatial resolution
(i.e., arising from using wider voxel area or thicker slice sections) results in
heavier partial volume effects. Nowadays, all CT scanners are endowed with a
reconstruction software that can somehow attenuate or correct artefacts and
noise. However, each vendor has its own software and the computing pipeline
applied to data are protected. The efficacy of the reconstruction and correc-
tion algorithms may vary between CT scanners of different vendors or even
between different models of the same vendor.
In the following paragraphs, the main results achieved through image qual-
ity analysis in both frequency (Sect. 6.4.1) and temporal (Sect. 6.4.2) domains
are reported and discussed. Three examinations were randomly chosen from
each Centre. Centres 6 and 18 having less than three examinations were ex-
cluded, as well as Centre 14 whose examinations were not suitable for perfusion
analysis (Sect. 6.3.5). The analysis carried out on these examinations is com-
posed by four main steps, resumed in Table 6.3. First of all, I verified whether
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Summary of image quality tests
Domain Test Aims Analysis
Frequency 1 Verify presence of noise peaks Frequency analysis of CT images’ spectrum
Time
1 Evaluate background noise Background density values analysis
2
Evaluate background noise Study of background density
temporal variability values variations over time
3 Evaluate liver noise
Comparison of liver and background
noise and analysis of SNR values
Tab. 6.3: Summary of image quality tests carried out.
noise affecting CT images could be identified in the frequency domain and
removed through the use of frequency filtering techniques. To this purpose I
visually analysed the frequency spectrum of CT images of each examination,
searching for frequency peaks or patterns. After that, I carried out an analysis
in the temporal domain made of three different tests. First, I evaluated the
influence of beam hardening, scatter noise, and CT reconstruction algorithms
on CT images through the analysis of the background noise. In particular,
the histograms and the standard deviation of the background density values
collected in the whole temporal sequence were analysed. In the second test,
I verified whether noise caused by beam hardening, scatter noise, and CT
scanner reconstruction algorithm keep constant over time. To this purpose,
I analysed the variations of mean background density values between slices
acquired in different time instants. Finally, I evaluated the presence of noise
inside liver. Since in this portion of the image, noise depends both on fac-
tors affecting background and on features of the tissue analysed, I selected a
uniform region of the liver (i.e., without big vessels) and compared liver and
background noise through the use of statistical indexes and the computation
of SNR.
6.4.1 Frequency domain
First of all, an analysis of the frequency spectrum of the single slices was per-
formed to find out possible peaks related to noise patterns. In Figure 6.4,
three representative frequency spectrum related to as many different CT ven-
dors, together with the images on which they were computed, are reported.
All the examinations acquired with CT scanners of the same vendor are char-
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(a) (b) (c)
(d) (e) (f )
Fig. 6.4: Frequency spectrum and relative CT images acquired with GE (a,d),
Philips (b,e), and Siemens (c,f) scanners, pertaining to examinations C1N1, C7N7,
and C10N1, respectively, are represented.
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acterized by similar frequency spectra, independently from the model of the
scanner used. Probably, this is due to the different reconstruction algorithms
used by vendors. In particular, by analysing several frequency spectrum, I
realised that all those computed on CT images acquired with GE scanners
(Figure 6.4 (a)) are characterized by features creating a sort of Moire pattern
resembling the traits of a pepper-wort. On the contrary, the spectrum of CT
images acquired with Philips (Figure 6.4 (b)) or Siemens (Figure 6.4 (c)) scan-
ners are characterised by completely different features. In fact, their spectrum
shows that data are mainly distributed on the four principal directions of the
space (horizontal, vertical, and diagonal ones). Despite in some examinations
the traits of the spectrum can be less or more pronounced, features of CT im-
ages acquired with Philips and Siemens scanners results to be very similar. All
the frequency spectra analysed, do not show any frequency peak. This can be
ascribed to the use of reconstruction algorithms (which are probably based on
Fourier sampling) and to the presence of artefacts (e.g. beam hardening and
scatter) and Poisson noise, that are unstructured. Therefore, typical frequency
filtering methods cannot improve image quality in terms of noise and artefacts
removal.
6.4.2 Temporal domain
The image analysis presented in this section considers CT images of the refer-
ence sequence (see Chapter 4) of each examination. Examinations of Centres
3 and 7 were excluded from the analysis since the lack of time information
inside DICOM fields to correctly sorting the images prevented their usage.
The analysis carried out in the temporal domain is subdivided into three main
steps. The first one regards the analysis of the noise characteristic of the image
generation process (i.e., hardware and software reconstruction noise), mostly
independent from the image content. Thereafter, the analysis moves towards
liver tissue noise, also depending on the features of the tissue analysed. Finally,
a comparison between outcomes of these two steps is carried out by means of
apposite indexes.
First of all, I analysed the content of images in a void region of the scan-
ner. A ROI was placed on the background visible in the reference slice of each
examination. A great care was used to exclude blankets and patient clothes
from the ROIs of all the slices of the reference sequence. Examinations with
a FOV so narrow as not to allow drawing a ROI on the background (e.g. Fig-
ure 6.1 (c)) could not be used in this part of the analysis and were replaced by
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examinations of the same Centre having a wider FOV. Therefore, histograms of
the density values of the ROI collected in all the time instants of the sequence
were created and standard deviation values were computed. Some examples
of the ROIs drawn on the reference slice, together with the histogram of den-
sity values, is reported in Figure 6.5. All histograms represent a Gaussian
(a) (b) (c) (d)
Fig. 6.5: CT images with the ROI placed on background region and histograms
of background density values of examinations C19N12 (a,b) and C1N65 (c,d).
distribution centred on around −1000HU , which is the density value of the
air in the ideal case (i.e., without noise). Some of them (as the one shown in
Figure 6.5 (b)) also present a peak in correspondence of −1000HU . Instead,
the peak in all histograms on the lowest attenuation values (i.e., −1024HU)
is the density values set up a-priori for the voxels falling out of the FOV. The
mean and standard deviation values computed on the whole sequence of each
examination by excluding the peak on −1024HU are resumed in Table 6.5.
The noise found in these regions can be attributed to the reconstruction al-
gorithms used in CT scanner, beam hardening effect and scatter noise. The
standard deviation of background value distributions varies from negligible
(4.6HU , Centre 8, second examination) to significant levels (29.6HU , Centre
16, first examination). The examinations more affected by acquisition noise
are those of Centres 2, 10, 16, while those showing the lowest noise levels are
those of Centres 8, 9, 15, 19.
After that, we investigated whether the noise in these background regions
kept constant over time. To this purpose, we computed mean and standard de-
viation of background values in each slice of the sequence. Both the histograms
of means and standard deviations are characterized by a Gaussian distribution
(two examples are provided in Figure 6.6). However, while the histograms of
means (Figure 6.6 (a), (b)) usually present similar range, those of standard
deviation’s can be more varying. For instance, while in C8N2 (Figure 6.6 (c))
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Mean and standard deviation of background density values
Centre
Examination 1 Examination 2 Examination 3
Mean (HU ) Std (HU ) Mean (HU ) Std (HU ) Mean (HU ) Std (HU )
1 −998.2 10.8 −986.5 23.1 −997.4 8.9
2 −980.9 27.8 −987.7 22.1 −995.9 13.3
8 −1005.4 9.5 −996.5 4.6 −988.6 10.5
9 −991.7 13.1 −1003.2 8.3 −996.4 9.6
10 −993.5 17.6 −992.1 19.6 −989.3 21.0
12 −990.9 16.4 −994.4 16.0 −993.3 15.9
15 −991.5 6.8 −993.0 7.0 −997.7 14.7
16 −973.9 29.6 −995.3 11.7 −976.6 29.4
17 −994.0 16.6 −994.3 16.3 −995.8 15.3
19 −999.4 9.8 −1007.0 6.5 −994.2 13.5
Tab. 6.4: Mean and standard deviation of background density values computed
on the whole sequence of the three examinations considered for each Centre.
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Fig. 6.6: Histograms of means (a,b) and standard deviations (c,d) of background
density values collected in the slices of examinations C8N2 (a,c) and C1N27 (b,d).
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the distribution of standard deviations is very narrow (range of about 1HU),
meaning that the noise keeps constant in all slices of the examination, in C1N27
(Figure 6.6 (d)) the range is wider (about 6HU), this pointing out that noise
changed over time. In addition, in order to have a measure of the variations
of the density values in the background regions over time, the standard devi-
ation of the mean density values computed on each slice were calculated for
each examination. These results are represented in Figure 6.7, where standard
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Fig. 6.7: Standard deviation of the mean of the background density values referred
to all slices of the sequence (a) and related histogram (b).
deviation of mean background density values found in the 30 examinations
analysed vary from 0.7HU to 5.0HU . The examinations showing the highest
variation are those characterized by the most variable noise. As one can see
from both the graphics of Figure 6.7, there are only three examinations (i.e.,
C2N46, C2N49 and C8N1) presenting values of mean background standard
deviation greater than 3HU . Instead, in the most part of the examinations
(i.e., those with standard deviation of mean values lower than 3HU), the vari-
ations of system noise are limited. This is most probably due to periodical
manteinance by manufacturers, which must ensure a stable performance of
CT scanner over time.
As the second step of the analysis, we focused our attention on the noise
present in the liver that is just partly related to the acquisition process, but
also due to image content (for instance, patient motion can cause artefacts
affecting tissue image, but not image background). To this purpose, a ROI
has been drawn on a region of the liver excluding big vessels, that remained
quite uniform over time. Since the presence of CA inside tissue affects liver
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density values, only slices belonging to baseline portion of the sequence were
considered in this part of the analysis. In order to select slices pertaining to
the baseline portion only, the time instant of CA arrival in aorta was used as
discriminant. Indeed, until CA does not arrive inside input vessels of the liver,
it cannot reach the tissue. To this purpose, a ROI was placed on the aorta and
the last local minima before the aortic peak was selected. Figure 6.8 reports an
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Fig. 6.8: The aortic curve (in the red colour) and one TCC of the examination
C1N2 (in the blue colour) are shown. The green vertical line highlights the last
local minimum of the aortic TCC before it starts enhancing.
example of the point selected on the aortic TCC of examination C1N2. This
same point is also used also in the algorithm developed to compute correct
baseline values and described in Sect. 7.3.2.
Liver density values found in the baseline portion of each examination are
all characterized by a normal distribution, such as those shown in Figure 6.9.
Table 6.5 resumes mean and standard deviation values of these distribution
together with other fundamental data related to image quality, such as tube
current and voltage, or background standard deviation. Despite distributions
of baseline density values of liver show average values µD that are consistent
with those found in the literature [290], some unexpected very low (less than
µD−2·std) or even negative density values, mainly attributable to the presence
of both noise and artefacts inside images, are present in all the examinations,
as well as extremely high density values (above µD + 2 · std) also due to the
presence of microvessels, artefacts and noise.
As the last step of this analysis, I evaluated noise related to tissue only. To
this purpose, I compared the noise measured in the liver (i.e., depending from
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Main parameters regarding image quality
Centre Examination σB (HU ) σL (HU ) σL/σB µl(HU) SNR (dB)
Tube Tube
current (mA) voltage (kV )
C1
N1 10.4 31.1 3.0 68.2 16.4
100 80N27 24.4 37.3 1.5 66.3 8.7
N65 8.4 19.9 2.4 64.7 17.8
C2
N46 27.4 67.4 2.5 51.7 5.5
80 80N47 27.2 54.0 2.0 57.7 6.5
N49 12.0 30.3 2.5 60.6 14.1
C8
N1 8.8 25.5 2.9 41.0 13.4 100 100
N2 4.6 11.1 2.4 52.0 21.1 200 120
N13 9.8 24.6 2.5 68.5 16.9 100 80
C9
N4 12.8 26.2 2.0 54.9 12.6
133 90N5 8.4 16.7 2.0 66.9 18.1
N6 9.4 22.7 2.4 66.5 17.0
C10
N1 18.55 47.79 2.6 59.3 10.1
100 80N5 21.1 58.6 2.8 63.4 9.6
N6 22.0 58.5 2.7 56.3 8.1
C12
N1 16.9 56.4 3.3 54.5 10.2
200 80N2 15.8 34.1 2.2 59.5 11.5
N5 16.0 50.2 3.1 52.4 10.3
C15
N6 14.9 22.3 1.5 42.4 9.1 438
80N7 6.5 14.8 2.3 64.7 20.0 405
N12 7.0 18.9 2.9 53.5 18.2 239
C16
N4 31.6 45.8 1.4 63.1 6.0
100 80N13 11.1 34.3 3.1 52.0 13.4
N14 31.5 57.0 1.8 67.8 6.7
C17
N1 17.5 33.5 1.9 57.6 10.3
100 80N2 17.1 27.1 1.6 64.6 11.5
N3 15.9 27.5 1.7 65.1 12.2
C19
N7 9.5 16.7 1.8 62.1 16.3
133 90N12 5.9 11.1 1.9 73.4 21.9
N13 13.7 40.6 3.0 46.2 10.6
Tab. 6.5: σB , σL, ratio between σL and σB , µL, SNR, tube current and voltage
referred to the 30 examinations considered.
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Fig. 6.9: CT slice of examination C1N1 with the ROI placed on a liver uniform
region (a) and a histogram of liver density values (b). Density values exceeding
mean ±2 · std are highlighted in the red colour and probably are those mainly
affected by noise, artefacts or presence of microvessels.
tissue, beam hardening effect, scatter noise, and CT scanner reconstruction
algorithm) with that of the background (i.e., attributable to the same causes,
except for tissue). The ratio between liver standard deviation σL and back-
ground standard deviation σB was computed. SNR (expressed in dB), was
calculated according to Eq. 6.1:
SNR = 20log10(µL/σB) (6.1)
where µl is the mean liver density value. σB and σL found in the examinations
considered are represented in Figure 6.10. As expected, the noise on the liver,
depending on both acquisition scanner and patient is higher than that on
the background. In particular, the two histograms of Figure 6.10 highlight
that the range of background standard deviation is about a half that of liver
standard deviation. However, the CV of the two examinations are almost
equal (50% in the liver and 47% in the background), this pointing out a high
consistency between data acquired in the liver and in the background. Indeed,
if by increasing the signal, also the noise increases proportionally, the SNR
(i.e., the inverse of CV) keeps constant, independently if measured in the
tissue or in the background. The highest liver noise level has been found in two
examinations of Centre 2 and in all those of Centres 10, 12, 16. Most of these
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Fig. 6.10: Liver (in the blue colour) and background standard deviation (in the
green colour) of each examination are represented (a), together with the related
histograms (b,c).
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examinations also show high background noise levels. It is important noting
that Centres 2, 10, 12, and 16, showing the highest noise levels, are equipped
with different CT scanner model (a GE Lightspeed VCT, a GE Lightspeed Pro
32, a Philips Brilliance 40, and a Siemens Definition 64). Consequently, the
lower quality of examinations cannot be attributed to the CT scanner model
used in the acquisition.
As regards the ratio between liver and background standard deviation value
is greater than 1 in all the examinations (i.e., the noise on the liver is always
higher than that on the background). The highest values of the ratio can be
found in some examinations of Centres 1, 8, 20, 12, 19. This probably means
that the quality of CT scanner does not permitted to set proper acquisition
parameters.
Finally, according to Eq. 6.1, I computed SNR whose values are resumed in
Table 6.5 and represented in Figure 6.11. As one can see from the histogram
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Fig. 6.11: SNR of each examination (a) and the related histogram (b)
.
(Figure 6.11 (b)), SNR varies from 5.5 to 21.9dB almost uniformly. Indeed,
except for the peak around 10dB, there is almost an equal number of exam-
inations showing each different value of SNR. Tube current used to acquire
each examination represent one of the main causes making SNR varying in
the same Centre. In fact, two of the examinations of Centre 2 (C2N46 and
C2N47), that are those acquired with the lowest tube current, present very
low SNR values (5.5 and 6.5dB), pointing out a low image quality. The agree-
ment between acquisition parameters and image quality is even more evident
in Centre 8, where examination C8N2 that has been acquired using a very
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high tube current (200mA) has the highest SNR value (21.1dB), if compared
with the other two examinations (SNR of 13.4 and 16.9dB, tube current of
100mA). However, an exception to this “rule” is represented by the exami-
nations of Centre 15 where C15N6 the examination acquired with the highest
tube current, is also the one showing the lowest SNR. The causes of this in-
consistency can be found in the different pixel size and filters used during the
phase of image reconstruction of these three examinations of the same Centre.
Finally, it is interesting to note that examinations of Centres 10, 12, and 17
are those presenting the most similar SNR values, pointing out that in these
Centres, the image quality is kept constant over patients.
6.5 Some hints to set up of a CTp multi-centre
study
The set-up of a multi-centre study is something of very challenging. The
selection of a standardized acquisition protocol and method of data processing
to be used between Centres may not be enough to assure the success of the
study. In fact, several issues and pitfalls can be hidden behind apparently
simple choices, such as the adoption of a unique shared protocol, indeed very
difficult to implement. Every information has to be collected with a high
detail before beginning the acquisition campaign, so as to prevent as much as
possible all the eventual sources of variability. Based on PIXEL experience,
this section resumes some hints that besides the guidelines by Miles et al. [83]
for the CTp studies should be taken into account to improve the set up of a
CTp multi-centre study. The information described in the next paragraphs
can be resumed in the following five groups:
• planning phase
• calibration phase
• medical staff training
• early check of the CTp examinations
• data analysis
The planning phase starts from the enrolment of candidate Centres that will
take part to the study, till the selection of the acquisition protocol and the
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details regarding data processing. The second phase is of fundamental impor-
tance to reduce between-Centres variability and performing a first skim of the
Centres enrolled. Later on, a training period of the technicians and the medical
staff of each Centre that will be involved in the execution of the CTp examina-
tions is strongly advised so as to guarantee the foster homogeneity of the data
acquired. A check of the first (3-5) CTp examinations acquired in each Cen-
tre is then necessary to detect and correct possible discrepancies between the
expected and the achieved results. Finally, the last group of recommendations
regards the way data are processed.
6.5.1 Planning phase
This phase is particularly delicate for all the clinical studies and in case of
multi-centre studies is of vital importance. First of all, a board of experts in-
cluding at least radiologists, physicists, computer engineers responsible of data
processing should be set up. The information regarding technical characteris-
tics of the medical devices that will be used in each Centre to carry out CTp
examinations must be collected and analysed by this board. All the limitations
and the problems related to the devices used in each Centre should be known,
starting from those directly related to the CT scanner, such as the maximum
spatial and temporal resolution achievable by the device, to those related to
the connected devices, such as the injection pump used to administer CA or
the storage system of the Centre.
Later on, a meeting between responsible people of each Centre and the
board of experts features of devices used in the several Centres must be carried
out to defined the protocol to be followed. During this meeting, all the aspects
of the study should be faced. The appropriate patient population that can be
included in the study should be defined as well as all the inclusion and exclusion
criteria. The acquisition protocol to be used should be established considering
radiation dose, quality issues, and devices limitations. Centres using devices
with inappropriate requirements (e.g. CT scanners that are not able to allow a
good temporal resolution [83]) should be excluded from the study. Moreover,
as discussed in Sect 6.1 the acquisition protocol should be set so as it could be
fullfilled by each Centre, in order to guarantee the lowest data variability, this
improving further reproducibility studies. The inclusion of each Centre should
also be evaluated based on how much the examination quality should decrease
due to the inclusion. Of course, excluding some Centres may compromise study
timelines and the global validity of the results achieved. A proper trade-off
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has to be found before beginning the multi-centre study.
As regards longitudinal studies, it is important to note that they should
be carried out by using the same equipment and acquisition methods adopted
during the first examinations, in order not to add late sources of result vari-
ability.
6.5.2 Calibration phase
Before carrying out CTp examinations on patients, it is highly suggested to
make static and dynamic analyses of quality on phantoms. Specific calibra-
tions such as those carried out in [278], should be applied across Centres to
ensure that consistent perfusion parameters can be obtained. Large differences
between image quality of different Centres (that, for instance, can be assessed
by using SNR) should be evaluated with particular care. To avoid any bias on
data analysis, the adjustment of the acquisition protocol or the exclusion of
those Centres giving a too low image quality should be also considered in the
early stage of the study.
6.5.3 Training of medical and technical staff
Before beginning the acquisitions, the medical staff of each Centre that is
going to perform the CTp examinations should undergo a specific training.
This is fundamental to reduce as much as possible the sources of inter-Centre
variability related to the acquisition phase. Information regarding patient
preparation ([83]), acquisition protocol, information to be inserted in DICOM
field, and data storage should be clearly communicate to the technical staff
and acknowledged. Finally, a special recommendation should be given about
the preparation of the data to be send to experts that will carry out the
perfusion analysis. To avoid loss of data information, examinations should be
downloaded and stored directly from CT scanner rather than from PACS. A
check to assess the completeness of the stored data should be carried out for
each examination. Moreover, events possibly affecting data quality such as
detectors recalibration or change of the x-ray tube should be reported to the
experts responsible of data analysis.
6.5.4 Check of CTp examinations
The first 3 to 5 CTp examinations acquired by each Centre should be examined
from an expert before acquiring more data. The acquisition of the correct tissue
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portion and the presence of all the parameters needed to carry out a perfusion
analysis should be checked. The agreement between the acquisition parameters
of the examinations and those declared in the standardize protocol should be
verified. All the problems found out during this first analysis must be reported
to the Centre involved, so that it can agree a possible solution. A second
check should be carried out on these Centres to verify whether the problem
encountered has been solved. In case of persisting problems, it is necessary
to evaluate whether the effects caused on results by these inconsistencies can
be negligible or if it is necessary to exclude the Centre from the study, thus
avoiding administration of radiation dose to patients whose examinations will
not be analysed in the study.
6.5.5 Data analysis
After receiving the first CTp examinations from the Centres, the experts should
carry out a preliminary data analysis. An early check of the data received is
important to prevent further exclusion of examinations from the study due to
missing data. In this case, it is indeed important to request data to the Centre
as soon as possible so it can be recovered before being missed. It is necessary
to verify that all the acquisition parameters are stored in the DICOM header.
Subsequently, it must be checked whether the acquisition parameters used for
each examination have been kept constant throughout the whole duration of
the study and if they correspond to those of the NAP. Finally, an image quality
study has to be carried out for each examination in order to verify whether
the quality has been changing over time. The results achieved during this
preliminary data analysis should be evaluated in order to decide whether each
examination can be included in the study.
After these checks, the same post-processing methods should be applied to
each examination (exception made for calibration factors that could change
between each Centre or examination). The same filtering techniques, align-
ment methods, fitting algorithm and model to compute perfusion parameters
should be used as well as the same methodology to place the ROIs on tissue and
vascular inputs. Finally, a standardised protocol to qualitatively and quanti-
tatively interpret images must be used. Adoption of voxel-based techniques to
evaluate perfusion values reliability and to discard misleading data (such those
presented in Chapter 4) are suggested. Moreover, a statistical data analysis
to test between-Centres variability should be carried out before using all data
coming from different Centres. Clinical outcomes could indeed be affected by
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between-Centres variability sources and separate data evaluations might be
required.
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In order to extend our study on normal liver and on examinations acquired
in several Centres, the algorithm previously developed to process CTp images
and compute perfusion parameters in tumours has been deeply revised and
improved (Sect. 7.1). In particular, in this Chapter, several algorithms have
been implemented and tested, such as that to register liver ROIs on CTp
image sequences (Sect. 7.2), or that to compute more correct baseline values1.
Finally, early analyses have been first carried out on patients of Centre 1, and
subsequently extended to some more Centres to achieve landmark values of
baseline (Sect. 7.3) and BF in normal liver (Sect. 7.4) and to verify whether
the use of different CT scanners could affect the results achieved (Sect. 7.3
and 7.4).
7.1 Summary
During the first analysis of PIXEL examinations (Sect. 6.3 and 6.4), a lot of
parameters were highlighted that introduce intra- and inter-centre variability
and prevent the acquisition of data under the same standardized protocol.
Since this is one of the first CTp multi-centre study that has ever been carried
out, the effects of deviation of each parameters from the nominal ones are
unknown. To reduce as much as possible the number of variability sources
and carry out an analysis in which differences between results depend only
on inter-patients and inter-scanner variability, I started by including in the
analysis only the examinations acquired according to NAP. Both the studies
on baseline and BF values (detailed in Sects. 7.3 and 7.4, respectively), have
1The “baseline” is meant as the portion of the TCC before the arrival of CA inside tissue
(Sect. 7.3)
151
Chapter 7. PIXEL: a muti-centre study
7.1. Summary
been first carried out on a randomly selected set of patients belonging to a
single Centre and subsequently extended to more Centres. The reason is that
Centre 1 had the greatest number of examinations and, moreover, correctly
applied NAP to all examinations. As regards multi-centre studies, Centres
with at least 10 patients whose examinations have been acquired by using
the same tube current and voltage, exposure, and slice thickness agreed in
NAP were identified. In particular, Centres 8, 16, and 17 were selected and
the highest number as possible of usable examinations were identified in each
Centre. Multi-centre analysis was carried out by using the same number of
examinations in each Institute.
Working on normal liver required that, besides the algorithms, the Graph-
ical User Interface (GUI) ought to be upgraded as well. In particular, the
GUI has been optimized in order to improve its performance on data process-
ing, for both time processing and memory usage. Also, it had to be partly
redesigned to allow for missing information due to inhomogeneities of acquisi-
tion protocol. For instance, the possibility for the user to insert a time vector
corresponding to the acquisition protocol adopted by the Centre where DI-
COM acquisition time was lost, has been introduced. The DIMS method was
finally implemented and inserted into the GUI.
Also the algorithm to compute perfusion values from data acquired with
the liver protocol has been reviewed step by step. The algorithm pipeline is
shown in Figure 7.1. In this section, all the steps of the algorithm pipeline are
CT image 
sequence
ROI 
definition
Filtering
Motion
correction
Baseline
computation
Perfusion 
computation
Perfusion
values
Pre-processing Computation
Fig. 7.1: The whole algorithm pipeline allowing to compute perfusion results from
data acquired with liver protocol.
outlined, while some steps (i.e., motion correction, baseline computation, and
perfusion computation) are detailed in the next sections of the Chapter.
The first step of the pipeline regards ROI definition. In CTp (Chapters 3
and 4), a large ROI is drawn on the reference slice, outlining tumour borders.
However, when dealing with normal tissues, no mass is present to be contoured.
Tissue ROIs have then been manually drawn on a central section of the volume
acquired and placed within the outer border of the liver. Whole ROI has to lay
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within the liver borders in all the images of the CTp sequence and, possibly,
should be placed quite far from liver margins so as to avoid partial volume
effects. The ROI placement procedure must be carried out with a great care
so as to exclude big vessels, such as portal vein or hepatic artery. An example
of a typical ROI drawn on a liver section is represented in Figure 7.2.
Fig. 7.2: ROI of examination C8N7 drawn on normal liver, far from liver margins
and excluding big vessels.
After ROI definition, a two-stage pre-processing is performed: CT image
filtering and motion correction. As regards the first step, several spatial filters
applied to the raw data was considered. Mean and median filter of different
size (3 × 3, 5 × 5, and 7 × 7) were tested on PIXEL data. Figure 7.3 reports
the effects of these filters applied on the same liver image as Figure 7.2. As
one can see, the application of filters characterized by increasing kernel size
produces deeper effects on CT images. In fact, the 3×3 mean (Figure 7.3 (a))
and median (Figure 7.3 (d)) filters cause a very light effect on CT images
that is almost imperceptible. Instead, a filter with kernel size 5 produce a
little more evident effect. In fact, in Figure 7.3 (b) and (e), it is possible to
detect the exact area on which the filter has been applied. Instead, 7×7 mean
(Figure 7.3 (c)) and median (Figure 7.3 (f)) filters are even more aggressive
and cause a strong blur on images. At the end of this preliminary analysis, I
decided to keep the same 5 × 5 median filter previously used to process CT
images of liver and lung tumours. The reason for this choice was that using
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(a) (b) (c)
(d) (e) (f )
Fig. 7.3: Mean (first row) and median (second row) filter of different size are
applied to DICOM image of examination C8N7. In particular, results of filtering
obtained using kernel dimension 3×3, 5×5, and 7×7, are represented in (a,d), (b,e),
and (c,f), respectively.
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median filters allows exploiting original HU density values, thus avoiding the
introduction of new values resulting from mathematical operations, such as
averaging. As regards filter kernel size, I selected the 5× 5 since I considered
it as a good trade-off between information preserving and noise removal.
Motion correction is another problem that had to be faced. Due to the long
duration of the acquisition protocol (i.e., 2 min), all the examinations have
been acquired in condition of shallow breathing. Consequently, the effects of
motion were evident in all directions and the application of motion correction
methods was necessary. The ROIs pertaining to liver and lung tumour exam-
inations analysed in Chapters 3 and 4 were manually aligned. However, this
was possible thanks to the relatively low number of examinations and frames
available for each acquisition (only 20 time instants for lung and 36 for liver,
respectively). The high number of examinations of this project (almost 400)
and acquisition time instants of each examination (60) roused the needs for
an automatic motion correction algorithm. Unfortunately, to the best of our
knowledge, there are no general purpose methods available for liver motion
correction CTp applications. Consequently, I developed my own early proto-
typic algorithm that permitted to achieve good preliminary results and it is
going to be improved with the collaboration of the computer science engineers
of the CVG. The algorithm is presented in Sect. 7.2.
After defining the ROI and pre-processing the sequences, the first compu-
tation we decided to address was the baseline (i.e., the density values assumed
by tissue before CA arrival). In ideal conditions (i.e., without noise), tissue
density values before CA arrival (i.e., the baseline attenuation value) should
be constant in time. By subtracting from each TCC its baseline value, it is
therefore possible to achieve the time attenuation curves (TACs) [86]. Practi-
cally, TACs are TCCs without offset that in ideal conditions assume value of
zero before the arrive of CA in the tissue. In Figure 7.4 (a), a tissue TCC is
reported together with the baseline value selected and the corresponding TAC
achieved by subtracting the baseline value from the TCC.
Due to the influence of the baseline value, I decided to directly address
baseline computation in my Thesis work. As discussed in Sect. 7.3, in the
literature several methods to compute baseline values and TACs have been
used. However, these methods often lead to different results that deeply affect
the computed perfusion values finally achieved. For instance, an underestima-
tion of baseline value (as the one represented in Figure 7.4 (b)) would lead
to a TAC with a greater AUC, this resulting in overestimated BV values. Of
course, since MSM is based on the computation of tissue TCC slope that re-
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Fig. 7.4: An aortic (in the red colour) and a tissue TCC (in the blue colour) are
shown together with the horizontal dot line representing baseline value selected
and the TAC (in the green colour) that can be achieved by subtracting baseline
value to TCC. In (a), the baseline is correctly selected while in (b) its value is
underestimated, this resulting in a different TAC, having a greater AUC.
mains unchanged after the subtraction (or addition) of an offset, BF values
computed with this method remains unchanged after the selection of one or
another baseline values. However, as discussed in Chapter 3, the goal of this
Thesis is not to develop algorithms specific for the application of the MSM,
but to set-up methodologies that can be applied to all the methods and mod-
els. Since in PIXEL protocol, image acquisition started contemporaneously
with the injection of CA, several images without presence of CA inside tissue
were available. This allowed me to carry out a study on baseline values and
to set-up an algorithm (see Sect. 7.3) to compute for each tissue voxel the
best baseline value that should be used in perfusion studies. Results achieved
with this algorithm were compared with those obtained by using the methods
presented in the literature. Finally, two studies have been carried out. The
former employed data of a single Centre to test the goodness of the algorithm
developed by comparing baseline values obtained with those reported in the
literature achieved with unenhanced CT scan. The latter study was based
on multi-centre data analysis and have been carried out to analyse whether
the use of different CT scanners could introduce variability on baseline values
computed.
The last step of the algorithm pipeline of Figure 7.1 is the computation of
perfusion parameters. This has been done by using the MSM by considering
both single and dual vascular input, the latter being implemented from scratch.
Finally, two studies have been carried out and described in Sect. 7.4. In the
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former, examinations of a single Centre were considered while, in the latter, a
multi-centre data analysis has been carried out to evaluate whether the use of
different CT scanners could introduce variability on perfusion results.
7.2 Early prototype of rigid registration algo-
rithm
As discussed in Sect. 7.1, PIXEL data were acquired by asking patients to
breath shallowly. This kind of breathing causes motion throughout the se-
quence in all the three main directions. However, if the acquisition is long and
without pauses so as to permit patients to breath, shallow breathing repre-
sents the best method to acquire images. Indeed, by asking patients to hold
their breath as much as they can, it might happen that some deep breaths
in the second part of the examination jeopardize the outcome and that the
examination has to be discarded since affected by too a high motion moving
the investigated tissues out of the FOV. For instance, the work in [155], using
breath-hold protocol, finally excludes 14 out of 43 patients with CRC due to
respiratory motion.
Since it was the first time I coped with examinations acquired in shallow
breathing, first of all I tried understanding how deep the motion caused by
breathing was. To this purpose, I randomly chose some examinations from
Centre 1 and for each of them I drew a ROI on a central slice (the refer-
ence slice) of the sequence, following the liver contour. After that, I manually
carried out a ROI alignment by using the 3D modality (see Sect. 4.2). Conse-
quently, for each acquisition time instant, the slice showing the best matching
with the reference slice was selected. Figure 7.5 reports an example of the
slices that have been selected in five consecutive time instant. The ROI was
then over imposed on the selected slice for each time instant and translated on
the x-y plane to achieve the best matching with liver contour as possible. In
Figure 7.6 (a)-(e), ROIs of examinations C1N7 aligned on the same five con-
secutive acquisition time instant are shown. In Figure 7.6 (f), the same ROIs
are all superimposed to emphasize the displacement in x-y. Displacement of
the ROI along the z direction and on the x-y plane could then be measured.
For instance, the maximum ROI displacement between two consecutive time
instants measured in examination C1N59 is equal to 4.4mm in x direction,
to 14.2mm in y direction, and to 3 slices (15mm) in z direction. As for the
maximum displacement of the ROI on the whole acquisition, it was equal to
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z=2 z=3 z=4 z=5
t=15
t=14
t=13
t=12
t=11
Fig. 7.5: Example of z level selection in consecutive time instant of examination
C1N7. Each row represents a time instant while each column a different z level.
The selected z level of each time instant is contoured by the red square.
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(a) (b) (c)
(d) (e) (f )
Fig. 7.6: Example of a ROI aligned on the x-y plane of different slices of exam-
ination C1N7, pertaining to different time instants. In (f), the ROIs in (a-e) are
been superimposed.
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119.1mm, 148.6mm, and 4 slices (20mm) in x, y, and z direction, respectively.
As one can see, even the motion between two consecutive time instants can be
relevant, especially in the y and z directions.
One of the main difficulties, and probably the reason why no algorithms for
liver motion correction specific for CTp examinations have been developed so
far, is represented by the very narrow section of liver that can be analysed with
CTp, this causing the loss of many anatomical reference points that could be
used to make tissue alignment easiest. Moreover, the presence of a very narrow
FOV (especially in case when only a portion of liver is acquired) makes motion
correction even more challenging.
To face this issue, I developed a preliminary algorithm for automatic rigid
motion correction. As the first step, I simplified the problem by decomposing
motion in two parts: in the cranio-caudal direction and in the transversal
plane. Accordingly, the alignment procedure of the tissue ROI drawn by the
clinicians on a reference slice can be split in two main steps:
1. selecting the correct z level (i.e., the slice on which placing the ROI)
2. aligning the ROI in the x-y plane
Thereafter, for both these steps, I looked for the most suitable anatomical
reference points fulfilling the following criteria:
• being capable of providing clear information regarding liver motion
• being of general-purpose (i.e., not specific for a single patient or acqui-
sition protocol or CT scanner)
• being easily detectable by an automatic procedure
As regards the alignment in the craniocaudal direction, as a reference point I
identified the space between liver and thorax. Indeed, as shown in Figure 7.72,
liver is characterized by a wedge shape, with the base at the top and the vertex
at the bottom. The space occupied by the liver on the transversal plane (that is
the one on which images are acquired) allows evaluating with a great accuracy
the liver z level. In particular, Figure 7.8 shows an example of 4 adjacent
slices with a ROI encompassing this region. As one can see, the space between
thorax and liver undergo relevant size changes by selecting different z levels.
Instead, as regards motion on the x-y plane, I realized how liver follows
the motion of the rib cage caused by breathing. Indeed, during the inspira-
tion phase, the rib cage expands and liver follow the ribs (Figure 7.9) that
2courtesy of http://pie.med.utoronto.ca
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Fig. 7.7: Representation of liver, its vasculature (in the red and blue colours) and
biliary ducts (in the green colour).
(a) (b) (c) (d)
Fig. 7.8: Four adjacent slice of examination C1N7 with a ROI contouring the
space between liver and thorax.
(a) (b)
Fig. 7.9: An example of two CT images of examination C1N7 acquired at the end
of the inspiration (a) and expiration (b) phases.
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consequently, can be chosen as anatomical reference points. In the following
paragraphs, the steps taken in order to achieve a correct 3D rigid alignment
are reported and discussed. The procedure has to be applied to all the images
acquired in each time instant.
The first part of the algorithm aims at selecting the correct z level on
which translating the ROI by measuring the distance between liver border’s
and thorax. In order to automatically select the correct slice in each time
instant, it is necessary to follow these three main steps:
1. bounding patient’s body
2. selecting the image area on which algorithm has to work
3. bounding the region between liver and thorax
For the sake of clarity, the pipeline of this first part of the algorithm is repre-
sented in Figure 7.10.
Bounding 
patient’s 
body
Bounding 
region 
between liver 
and thorax
Selecting
the correct
z level
Working area
selection
HU image
Selection of the correct z level
Fig. 7.10: Pipeline of the first part of the motion correction algorithm allowing
selecting the correct z level at each time instant.
The first step needed to find the correct z level on which translate the
ROI is the separation of patient’s body from the background (i.e., air, clothes,
blankets, and patient’s table). To this purpose, a mean spatial filter has been
applied to the original CT image (Figure 7.11 (a)) in order to smooth details
and differences between similar structures (Figure 7.11 (b)). After that, a
threshold to exclude low density structures (mainly pertaining to the back-
ground) has been applied to the filtered CT images. The mask achieved has
been first inverted (Figure 7.11 (c)), then modified through the application of
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(a) (b) (c) (d)
Fig. 7.11: Original CT image of examination C1N7 (a) and its filtered version (b).
Mask achieved by thresholding low density values (c) and after closure opera-
tion (d), giving the mask of patient body.
a closing operation, allowing obtaining a second mask perfectly discriminating
between patient’s body and background (Figure 7.11 (d)).
To second step aims at speeding up the algorithm and excluding misleading
anatomical structures from the analysis, to this purpose, the area of the image
where the algorithm focuses its analysis has been restricted to the dorsal right
side of the rib cage (that inside images corresponds to the bottom left of the
patient). Since in some examinations patients were not centred in CT images
(e.g. due to a restricted FOV centred on the liver) the centre of CT images
(CCTI) could not be used to identify the posterior right portion of patient’s
rib cage. To this purpose, a method exploiting vertebrae position has been
used. Since the vertebral column is one of the few anatomical structures that
does not move during acquisition, its vertebrae position has been identified
on a non-enhanced image, once and for all. In order to automatically detect
vertebrae, a threshold on CT images has been performed (Figure 7.12 (a)),
this permitting to select highest density values only (corresponding to bones,
calcifications, or high concentration of density values inside vessels). Then, a
morphological closing has been applied (Figure 7.12 (b)) to exclude the smallest
objects and fill the “holes” due to the presence of bone marrow (that having
a lower density with respect to bones has been excluded from the mask).
Thereafter, the vertebra in the slice has been selected as the bigger object
inside the obtained mask and the coordinates of its central point have been
calculated (Figure 7.12 (c)). Finally, the area of interest where the algorithm
have to focus on has been selected. In particular, the centre of the vertebra
has been used as the point discriminating between the right and the left side of
the patient. As regards the identification of the bottom and the top portion of
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Fig. 7.12: Thresholded mask including only high density values of an unenhanced
CT image of examination C1N7 (a) and its closure version (b). Original CT image
with the centre of vertebra (red marker) and the border of the region selected (in
the green colour) highligted (c).
the rib cage, the CCTI has been used if the centre of the vertebra was placed
under the CCTI (i.e., the FOV is large and the posterior part of the patient is
included in the bottom half of CT image). On the contrary, if the centre of the
vertebra was found above the CCTI (i.e., the FOV is narrow or the images are
not centred on the patient), the whole left portion of the image was considered
(Figure 7.12 (c)).
The third and last step of the algorithm used to select the correct slices
is that detecting and outlining the region between liver and thorax. To this
purpose, the original CT image (Figure 7.11 (a)) was thresholded to obtain a
mask excluding background and anatomical regions having very low density
values (e.g. those areas not pertaining to a specific anatomical structure such
as an organ). In this case, the original CT image has been used, in place of the
filtered image, to achieve the most precise profile of this region. Then, the ob-
tained mask (Figure 7.13 (a)) underwent a closing operation to remove a great
part of noisy voxels (Figure 7.13 (b)). In order to remove background elements,
the mask of Figure 7.13 (b) was ANDed voxel-by-voxel with the patient’s body
mask obtained at the previous step of the algorithm (Figure 7.11 (c)), to ob-
tain Figure 7.13 (c). After that, all the elements of the mask out of the region
defined at the first step of the algorithm (Figure 7.12 (c)) were excluded from
the analysis (Figure 7.13 (d)). At this point, the region between liver and
thorax has been isolated. Therefore, the maximum thickness of this region
(intended as the maximum orthogonal distance between liver and the thorax)
can be measured as shown in Figure 7.13 (d).
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(a) (b) (c) (d)
Fig. 7.13: Thresholded mask (a) obtained from the original CT image of ex-
amination C1N7 by excluding structures with very low density values, after the
application of a closing operation (b), the AND operation with the body patient
mask (c) and the selection of the region identified in the first step (d). The red line
in (d) points out the maximum thickness of the region between liver ad thorax.
Distance between liver and the thorax found on the reference slice is com-
pared with that found in the other images of the sequence. In each time instant,
the slice showing the most similar distance to that found on the reference slice
was selected.
In order to evaluate the efficacy of this algorithm to select the correct slice,
a 3D alignment have been manually performed on several examinations. The
outcomes of these tests showed that the algorithm always selected the same
slice manually chosen by clinicians.
After selecting the correct z level where copying the ROI in each time
instant, it is necessary to translate the ROI on the x-y plane. As discussed
above, ribs are great reference points for this phase of the algorithm. Therefore,
it is necessary to automatically identify ribs in each image of the sequence
and use their relative distance to the ROI to correctly align it on the image
sequence. To this purpose, it is necessary to follow these three steps:
1. identifying the ribs
2. detecting the set of proper points of the ribs (i.e., their inner part with
respect to patient’s body)
3. fitting the ribs’ points found at the previous step
These steps are also represented in the pipeline of Figure 7.14.
To identify ribs inside each CT image of the reference sequence, I applied
a threshold to isolate high density structures. However, this would cause the
inclusion of undesired structures (e.g. vessels filled with CA). To reduce the
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Ribs 
identification
Ribs’ points 
detection
Ribs’ points
fitting
Alignment
on the 
x-y plane
HU image
ROI alignment on the x-y plane
Fig. 7.14: Pipeline of the second part of the algorithm of motion correction
allowing to obtain the ROI’s alignment on the x-y plane.
possibilities of achieving misleading results, I excluded the majority of the areas
found inside the rib cage. To this purpose, I first applied an erosion operation
to the mask of patient’s body (Figure 7.11 (d)) using a structuring element of a
high dimension so as to preserve all ribs, including the dorsal ones that usually
are far from body contour due to the presence of dorsal muscles in patient
back. The eroded mask ANDed with the original CT image is represented
in Figure 7.15 (a). The eroded portion of patient’s body mask corresponding
(a) (b) (c)
Fig. 7.15: Eroded CT image of examination C1N7 (a), portion of the image
eroded (b), and results of thresholding in (c), performed to include in the analysis
high density elements only.
to the region where ribs can be found has been used. The image obtained
by applying the eroded mask to the original CT image (Figure 7.15 (b)) has
therefore been thresholded in order to include in the analysis the high density
elements only (Figure 7.15 (c)).
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After having identified ribs, it has been necessary to identify the side of
their border closest to the internal part of the patient. To this purpose, the
point found in the middle of the mask of patient’s body has been taken as
reference point (RP). The closest points of each rib to RP are those we are
looking for. In order to select them, a closing operation (Figure 7.16 (a)), has
(a) (b)
Fig. 7.16: Mask of high density structures obtained from Figure. 7.15 (c) after
closing operation (a). Selected points of the ribs (in the blue colour) and RP (in
the red colour) (b).
been applied to the thresholded mask of Figure 7.15 (c), to close the holes
caused by the presence of bone marrow. Thanks to this passage, it has been
possible to obtain a unique continuous element for each rib. After that, the
distance between RP and the points of each rib has been computed. The 5%
of the closest points of each rib (Figure 7.16 (b)) have been considered as the
internal side of the rib. A percentage number has been chosen to weight the
number of points to be considered for each rib, depending on their dimension.
However, in some cases, some points found do not belong to ribs. Indeed, if a
vessel is close to liver borders (and hence to rib cage) and filled with CA, it
could be erroneously included (Figure 7.17 (a)). In order to avoid the inclusion
of misleading points not pertaining to the ribs, I exploited the characteristic
convex shape of the rib cage. First of all, I created a mask having the points
identified as the vertices (Figure 7.17 (b)). Thereafter, I created its convex
hull (Figure 7.17 (c)). All those points placed inside rib cage and hence not
belonging to ribs, responsible for concavities in the first mask, were excluded
from the analysis (Figure 7.17 (d)). After isolating the points of each ribs, I
fitted these points by means of smoothing splines (Figure 7.18). The fitting
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(a) (b) (c) (d)
Fig. 7.17: Example of examination (C1N7) (a) in which small vessels filled of CA
could mislead the analysis. Mask of the points identified (b), convex mask (c), and
points excluded from the analysis (d) (in the red colour).
(a) (b)
Fig. 7.18: Example of fitting applied to the points of the rib cage on an un-
enhanced (a) and enhanced (b) CT images of examination C1N7.
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curve draw the interior contour of rib cage that will be used as a guide for the
translation of tissue ROI on the x-y plane.
In order to align tissue ROI on each slice, the horizontal and vertical dis-
tances between ROI and ribs’ fitting curve have been measured. In particular,
starting from the reference slice on which the clinician has drawn the tissue
ROI, the horizontal distance is measured as the distance between the left-most
points of the fitting curve and of the ROI. Instead, the vertical distance is mea-
sured as the distance between the bottom-most points of the fitting curve and
the ROI. These distances can be better visualized in Figure 7.19 (a) where the
(a) (b) (c) (d)
Fig. 7.19: ROI manually drawn on the reference slice of examination C1N7 and
horizontal and vertical lines passing through the left-most and bottom-most points
of the ROI (in the blue colour) and the ribs fitting curve (in the red colour) (a).
Examples of a ROI automatically aligned on CT images acquired during baseline
phase (b), in correspondence of CA arrival in aorta (c), and during the enhanced
phase (d).
left and bottom-most points of the ROI and the fitting curve of the ribs are
highlighted by vertical and horizontal lines. The distance between the red and
the blue lines have been used in the other slices of the sequence to reposition
the ROI. In particular, by finding in each CT image the left-most and the
bottom-most points of the fitting curve, it is possible to replace the ROI by
keeping the horizontal and vertical distances fixed. Figure 7.19 (b)-(d) depicts
an example of ROIs aligned with the automatic algorithm and placed on slices
acquired in different time instants. As one can see, the algorithm developed
is capable to follow liver motion. Its flexibility allows obtaining good results
on both un-enhanced and enhanced CT images, independently from size and
position of tissue ROI. Comparison with manual alignment showed that po-
sitions of the ROIs manually aligned were comparable with those achieved
automatically.
However, this automatic motion correction algorithm has some limitations.
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First of all, it cannot be applied on examinations showing a too narrow FOV.
Vertebrae and at least three ribs on the right flank and the dorsal side of the
patient should be present inside images to permit the correct translation of the
ROI on the x-y plane. Moreover, the algorithm could meet difficulties in the
identification of the correct z level in those cases where the acquisition has col-
lected data from the upper part of the liver. In these cases, the space between
liver and thorax could not be so different between adjacent slices. Even though
this is not the case of PIXEL examinations, because the acquisitions had to
be focused on the central part of the liver. In order to apply this method to
any type of liver CTp examinations, this algorithm should be refined.
Despite these limitations, this preliminary implementation of the algorithm
has shown to work well on the most part of PIXEL examinations. The algo-
rithm presented in this section constitutes the starting point for more advanced
and complete methods of motion correction, allowing to include also those ex-
aminations previously excluded (i.e., those with a very narrow FOV) and to
carry out an elastic registration. Expert computer science engineers of the
CVG are actually working on this topic.
7.3 Baseline
As discussed in Sect. 7.1, the selection of a correct baseline value is of fun-
damental importance to achieve reliable perfusion results [81, 86]. However,
actually several methods to compute baseline and obtaining TACs have been
adopted in the literature, but to the best of our knowledge, no studies have
been carried out to determine which method could be the best one to achieve
baseline values and which are the main advantages and disadvantages of the
methods commonly used. In the following paragraphs, the methods that have
been used in the literature to achieve baseline values and to obtain TACs are
discussed (Sect. 7.3.1). An algorithm for the computation of the correct base-
line values is then described (Sect. 7.3.2), compared with methods used in the
literature (Sect. 7.3.3), and applied to some examinations of PIXEL. Results
achieved considering examinations of Centre 1 only and of four different Cen-
tres are presented and discussed (Sects. 7.3.4 and 7.3.5, respectively). Finally,
some concluding remarks are reported in Sect. 7.3.6.
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7.3.1 TACs computing methods
The achievement of a correct TAC on which computing perfusion values de-
pends on the baseline values selected that can differ according to the choices
regarding the following three aspects:
• use of local or global baseline values
• number of slices considered to compute baseline
• method used to subtract baseline to TCCs
Both local and global baseline values have been used in the literature. Global
baseline values are usually computed as the average of liver density values
inside the tissue ROI on the first image acquired [63]. Global values have
been used both in those studies where perfusion parameters are computed on
a single TCC (obtained by averaging density values in the ROI at every time
instant) [291, 292, 112], and in those studies where a voxel based analysis
is carried out [135]. Despite liver is considered an organ characterized by
a homogeneous texture [293], local density variations due to micro-vascular
structures composing this tissue can be present. As discussed in Sects. 7.3.4
and 7.3.5, local baseline values in the same patients can cover a range of values
even higher than 30HU . The use of local baseline values, following local density
variations of liver tissue are thus crucial to achieve reliable perfusion values
and avoid incurring in under-or over-estimation.
Most of times, baseline is extracted from the first slice acquired in the
sequence [294, 86] so as to be sure that CA has not arrived yet. If local baseline
values are used, this means for each TCC considering its corresponding density
value in the first CT image acquired as the baseline value. In this case, the
presence of noise and artefacts affecting the first CT image can alter baseline
values and lead to incorrect perfusion values. Of course, if the acquisition
protocol used allows to have only one scan in which tissue is non-enhanced,
the baseline value can be extracted from that image only. On the contrary,
if further non-enhanced scan are available, it would be important to use all
of them so to achieve as more reliable baseline values as possible. To this
purpose, the authors in [193] used two volumes acquired before the arrival of
CA in the heart to compute baseline, even if they do not explain how the
baseline was computed on the two images. Probably, the work computing
perfusion on rats [295] is the first one declaring to compute baseline as the
average of the density values of more than one scan (the first 4-5 acquisitions
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are indeed used). Therefore, the needs of baseline values less affected by the
presence of noise and artefacts starts being a recognized necessity [81, 86].
A further source of variability can be found in the methods used to extract
the TACs. To this purpose, several methods exist leading to as many differ-
ent perfusion results. The first method consists in the subtraction of the first
image from the images acquired after the arrival of CA inside tissue. TACs
are therefore directly extracted from the resulting CT images [86, 254]. The
main drawback of this method arises from motion issues being neglected. In-
deed, if patient move (and this is our case since acquisitions are carried out
in shallow breathing conditions), there will be a mismatch between the tis-
sues to which baseline values pertain and the tissue from which these baseline
values are subtracted. This problem does not hold when TACs are obtained
by subtracting local baseline values directly from the data-point of the tissue
TCCs considered [81, 193]. Indeed, since TCCs are usually extracted from
already registered images, density values composing one TCC belong to the
same tissue portion. Consequently, baseline values subtracted from the TCC
correctly pertain to the same tissue portion to which all the TCC data points
pertain.
To achieve the best baseline density values as possible, it is thus important
to adopt local baseline values and to use as the highest number of data points
as possible. Finally, to achieve TAC these baseline values are subtracted voxel-
based directly from TCCs.
7.3.2 Baseline value computation
In this section, the method to compute baseline values is presented. This
algorithm allows computing the best baseline values as possible for each tissue
voxel through exploiting the maximum possible number of data-points.
The main problems related to baseline computation are:
1. deciding the baseline portion (BP), that is how many time instants to
include, that is which are the time instants before CA arrival
2. setting up a proper processing method
As regards the second item, we simply perform an average operation on the
data point selected in the first item. While the first point of BP is naturally
chosen as the first time instant, the real problem is to find out what the ending
point (EP) is.
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The algorithm to find out voxel-based baseline EP values is an adaptive
iterative algorithm subdivided into five steps:
1. tissue TCCs denoising
2. selecting the TCC portion on which looking for BP termination
3. iterative TCC fitting
4. computing TCCs fitting error index
5. selecting the time instant corresponding to EP
The first step needed to better distinguish between the two TCC portions
(i.e., BP and the portion after CA arrival) is the application of a 5-point
moving average filter to each TCC. This procedure allows to better detect the
global trend of the TCCs and to reduce quantity of noise inside the signal that
could lead to the achievement of misleading results. Figure 7.20, reports an
Fig. 7.20: Example of TCC (in the blue colour) randomly chosen among those of
patient C1N1, and its corresponding filtered version (in the black colour) achievable
by applying a 5-point moving average filter.
example of a liver TCC (in the blue colour) that has been randomly selected
from the examination C1N1. As one can see, the signal resulting from the
application of a temporal filter to the TCC (in the black colour) permits to
achieve a denoised curve whose trend better follows the ideal one (see Sect. 2.2).
Thereafter, I started looking for the possible time instants of EP. While
the first data points of each TCC certainly belong to BP, in order to speed up
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the algorithm I selected the proper TCC portion on which looking for baseline
EP. Both the extremities of this interval of possible EPs were selected in a
conservative way so as to preserve all the possible solutions. In particular, the
starting point of the interval (SI) is selected as the time instant of CA arrival in
aorta, following the same principle used in Sect. 6.4.2. While SI is the same for
all the TCCs (since it is extracted from the aortic signal that is one for all tissue
voxels), the ending point of the interval (EI) is kept variable. In particular,
EI is selected for each voxel as the minimum time instant between the peak
time instant of the tissue TCC peak and of the averaged TCC (computed as
the averaged tissue TCC on the whole ROI). The purpose of selecting the
minimum between these two time instants is to reduce computation time in
those cases where a high noise level causes a delay in the absolute peak of
the tissue TCC. This step allows the algorithm to adapt the research of EP
to the most appropriate signal portion, dependently on the time taken by CA
to join that specific tissue voxel. In this way, EI always represents one of
the points surely localised after the arrival of CA in the corresponding tissue
voxel. This permits to include in the interval all the data points that could
correspond to EP and to exclude those data that have been acquired after the
arrival of CA inside tissue. Figure 7.21 reports an example of the EI selected:
(a) (b)
Fig. 7.21: The mean TCC (in the black colour) and one TCC of the examination
C1N2 (in the blue colour) are shown together with SI (the green vertical line) and
EI (the blue (a) or the black (b) vertical line). In (a) EI has been selected from
the tissue TCC while in (b) from the mean curve.
in Figure 7.21 (a) the EI corresponds to the peak of the tissue TCC while in
Figure 7.21 (b) it corresponds to the peak of the mean tissue TCC.
After defining the set of possible solutions, the part of the algorithm aiming
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at computing the correct EP has been implemented. Based on the ideal case
(i.e., absence of noise) where the TCC data points belonging to BP have con-
stant values, TCCs BP has been modelled with a horizontal line. In particular,
an iterative algorithm considering at each iteration different possible EP has
been implemented. Indeed, in the first iteration, the first TCC portion up to
SI is fitted with a horizontal line. The ordinate of the fitting line is given by
the average values of the TCC data points considered. Then, at each iteration,
one more subsequent TCC point is included in the TCC portion that is fitted.
This iterative fitting process goes on until EI is found. An example of the
partial results of this process is reported in Figure 7.22 (a).
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Fig. 7.22: A TCC of the examination C1N2 (in the black colour), its SI (the
red vertical line) and the linear (horizontal) fit obtained during the first five iter-
ations (a); the correspondent µϵ values calculated at each iteration, reported by
using the same colour (b).
Now that all the possible BPs of the TCC have been modelled, an index able
to evaluate the coherence between the TCCs data points considered at each
iteration and their ideal version represented by their fitting curve is needed.
To this purpose, the goodness-of-fit error index µϵ has been used. In this
case, the residuals ϵ in each data point are calculated as usual as the distance
between the original data and their fitted (expected) version. Every time that
a data point is included in the analysis, the µϵ value computed increases if it
is far from the last mean TCC value computed, and decreases if it is closer.
Figure 7.22 (b) shows µϵ values computed at each iteration on the TCC data
points considered. However, it is worth noting that an increase of the µϵ value
can be caused by both presence of noise and CA arrival inside tissue. In order
175
Chapter 7. PIXEL: a muti-centre study
7.3. Baseline
to reduce the influence of noise and the probability for the algorithm to fall
in local minima solutions, a 5-point moving average filter has been applied on
the time series of the µϵ values (Figure 7.22 (b)).
Now that all the possible TCCs BP and an index evaluating BP data
points coherence with their expected version are available, the correct baseline
EP value has to be selected. To this purpose, I decided to take advantage
from the features of the first and second derivative of the signal. To achieve
precise derivative values of signal, I exploited the analytic derivatives proper-
ties. Therefore, µϵ values achieved after the application of the moving average
filter have been fitted through the use of smoothing spline, by using a very low
smoothness degree. Figure 7.23 shows an example of TCC (a), with related
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Fig. 7.23: A TCC of examination C1N2 and its EI (the red vertical line) (a); the
µϵ values achieved after the application of moving average filter (the blue stars)
and of spline (the black solid line) (b); the first derivative of the fitted µϵ values,
its local minima (the green markers) and EI (the red vertical line) (c).
µϵ values achieved after the application of the moving average filter and its
continuous version (b). Thereafter, the first analytic derivative of the fitted µϵ
has been computed (c) and its local minima values identified. The local min-
ima values of the first derivative correspond to points after which the original
signal (in this case µϵ) increases. As discusses above, the increase of µϵ can
correspond both to the inclusion of an outlier or to the arrival of CA inside
the tissue voxel. In this last case, the increase of µϵ will be constant for several
time instant (i.e, for all the enhancement portion of the TCC). Consequently,
the last local minima value of the first derivative of fitted µϵ could be assumed
as the time instant when enhancement starts. An exception arises in those
cases where the first derivative of µϵ is constant and does not present a local
minima, in correspondence of CA arrival (Figure 7.24). To also detect these
points, I computed the local minima of the second derivative of µϵ and se-
lected those data points with an absolute value lower than a specific threshold
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(a) (b) (c) (d)
Fig. 7.24: A TCC of examination C1N2 and its EI (the red vertical line) (a); the
µϵ values achieved after the application of moving average filter (the blue stars)
and of spline (the black solid line) (b); the first derivative of the fitted µϵ values
and its local minima (the green markers) (c); the second derivative of the fitted µϵ
values and the points where the first derivative is constant (red markers) (d).
(experimentally found and fixed equals to 0.01). The time instant of end BP
has been then selected for each TCC as the last of the local minima on the
first and the second derivative. Accordingly, the baseline value of the TCC is
finally computed as the mean value of the TCC data points of the BP.
7.3.3 Baseline algorithm: preliminary test
In this paragraph, a comparison of results achieved with the algorithm devel-
oped and the state-of-the-art algorithms is carried out. To this purpose, the
algorithm to compute baseline values was first tested on some CTp exami-
nations randomly chosen between those of Centre 1. In this paragraph, data
regarding three representative examinations (C1N23, C1N37, C1N38) are pre-
sented and discussed. Colorimetric maps and histograms of baseline values
achieved for these examinations are reported in Figure 7.25 while Table 7.1
collects the main statical parameters, such as mean, median, standard devia-
tion, and range values, respectively. As one can see, baseline histograms, can
be of several shapes. For instance, histogram of Figure 7.25 (a) presents a sort
of Gaussian-like distribution with a short tale on the right that is heavy till
65HU and very light for higher density values. The histogram in the middle
(Figure 7.25 (b)) is bimodal, presents a heavy left tail, and is the one with
the wider range of baseline values (26.7HU). The histogram of the last ex-
amination (Figure 7.25 (c)) instead, is multimodal, but the range of baseline
values represented (16.4HU) is similar to that of the first histogram (15.2HU).
None of these histograms present groups or sparse baseline values far from the
principal distribution. This is reflected also in the three colorimetric maps
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Fig. 7.25: Baseline histograms and colorimetric maps achieved with our adaptive
algorithm and pertaining to examinations C1N23 (a,d), C1N37 (b,e), C1N38 (c,f).
The red vertical line on histograms points out the mean baseline value of that
examination.
Baseline values
Examination Mean (HU ) Median (HU ) std (HU ) Range (HU )
C1N23 58.7 58.4 2.1 15.2
C1N37 60.3 60.4 4.2 26.7
C1N38 64.7 64.3 3.0 16.4
Tab. 7.1: Mean, median, standard deviation, and range of baseline values achieved
in three examinations (C1N23, C1N37, and C1N38) by using the algorithm pro-
posed in Sect. 7.3.2.
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(Figure 7.25 (d), (e), (f)) that does not show groups of voxels with homo-
geneous colours quite close to the hot ones. All neighbouring voxels assume
colours in a continuous range, this hinting at similar tissue features inside the
ROI. By observing the colorimetric maps it is also possible to achieve informa-
tion about the spatial distribution of baseline values. As one can see, all the
colorimetric maps are locally highly homogeneous. The presence of a local spa-
tial correlation is demonstrated by the gradual passage of baseline values from
lower to higher baseline values that in colorimetric maps results in progres-
sive colour gradients. This spatial correlation of baseline values reflects local
spatial coherence of tissue features. Moreover, since baseline values obtained
through the use of our algorithm are computed in each voxel by using only
data pertaining to one TCC, independently from the signal of the neighbour
voxels, baseline local spatial homogeneity can be considered as a qualitative
indicator of algorithm goodness.
Below, results obtained with the algorithm described in Sect. 7.3.2 are
compared with those of the methods proposed in the literature and discussed
in Sect. 7.3.1. For the sake of a better readability, the adaptive algorithm of
Sect. 7.3.2 is referred to as “BFA” (i.e., Baseline finding algorithm), while the
methods proposed in the literature are referred in a different way, according
to the approach utilized. Thereafter, with the label “G1”, we refer to the one
global baseline value obtained as the average of the density values of the ROI
of the first CT image [135]. “V1” points out the method where the voxel-based
baseline values are assumed as being the corresponding density values of the
ROI of the first CT image [294]. Finally, “V5” refers to the method where the
voxel-based baseline values are computed as the mean density values assumed
by each voxel in the first five CT images [295]. The main features of these four
methods to compute baseline are resumed in Table 7.2.
Since before CA arrival the tissue density should be constant, this portion
of TCC could be fitted by a horizontal line whose ordinate is equal to the
baseline value. Therefore, to have a measure of the goodness of the baseline
value chosen, µϵ has been computed on the BP of each TCC automatically
selected by our algorithm as the absolute mean value of residuals between the
original TCC value and the computed baseline value. Table 7.3 resumes mean
and standard deviation of baseline and µϵ computed with the four different
methods.
Figures 7.26 and 7.27 present baseline histograms and colorimetric maps
achieved for the three examinations by computing baseline values accordng to
V1 and V5, respectively, where histograms of Figure 7.26 are composed by
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Baseline methods
Method
Number of Type of
volumes considered value
G1 1 Global
V1 1 Voxel-based
V5 5 Voxel-based
BFA
As many
Voxel-based
as possible
Tab. 7.2: Summary of the main features of the methods used to compute baseline.
Baseline values computed with four different methods
Baseline µϵ
Examination Algorithm Mean (HU ) std (HU ) Range (HU ) Mean (HU ) std (HU ) Range (HU )
C1N23
BFA 58.7 2.1 15.2 3.86 0.66 5.5
V1 59.3 5.3 37.0 5.23 1.98 15.3
G1 59.3 − − 4.23 0.81 5.7
V5 58.6 2.8 19.2 4.08 0.75 5.8
C1N37
BFA 60.3 4.2 26.7 5.58 0.86 6.8
V1 58.5 8.5 58.0 7.81 2.91 22.3
G1 58.5 − − 6.67 1.47 10.6
V5 59.1 5.4 37.4 6.12 1.21 11.4
C1N38
BFA 64.7 3.0 16.4 3.74 0.94 6.7
V1 66.4 5.1 34.0 4.92 2.03 14.1
G1 66.4 − − 4.73 1.20 8.2
V5 64.4 3.4 20.8 3.94 0.97 6.7
Tab. 7.3: Baseline’s and µϵ’s mean, standard deviation, and range values obtained
on the three examinations of Table 7.1 by using four different algorithms for the
computation of baseline values.
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(a) (b) (c)
(d) (e) (f )
Fig. 7.26: Baseline histograms and colorimetric maps achieved with V1 and per-
taining to examinations C1N23 (a,d), C1N37 (b,e), C1N38 (c,f). The red vertical
line on histograms points out the mean baseline value of that examination.
(a) (b) (c)
(d) (e) (f )
Fig. 7.27: Baseline histograms and colorimetric maps achieved with V5 for pa-
tients C1N23 (a,d), C1N37 (b,e), and C1N38 (c,f). The red vertical line on the
histograms point out the mean baseline value.
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integer-valued bins (as the density values inside CT images).
As one can see from Table 7.3, mean and standard deviation values of
µϵ are ever lower in BFA that is the algorithm computing baseline on the
highest number of time instants of each TCC as possible. The second method
in terms of goodness of baseline chosen is V5. Indeed, this algorithm that is
voxel-based exactly as BFA, compute baseline values by averaging the first five
density values assumed by the TCC, this resulting in a more robustness with
respect to methods based on a single image only. Indeed, the highest values
of µϵ mean and standard deviation are assumed by V1 and G1 that compute
baseline considering a single image only. In particular, V1 is the one showing
the highest error index, since any averaging operations that could attenuate
the influence of local noise and artefacts are not used.
Colorimetric maps of Figure 7.26 obtained with V1 are much less homoge-
neous than those obtained by using BFA in all the three examinations. More-
over, V1 baseline histograms of the three patients show a wider range with
respect to the other methods (see Table 7.3). On the contrary, baseline values
achieved with V5 are more similar to those obtained with BFA. Indeed, colori-
metric maps are much more homogeneous than those achieved with V1, even
though a lower local variability can be noted, with respect to those obtained
with BFA, mainly due to the lower number of points considered. Greatest
differences between neighbouring baseline values are most of all visible in ex-
amination C1N37. As expected, also the range of baseline values achieved with
V5 is intermediate between those obtained with V1 and BFA. The histograms’
range values is related to colour content found in perfusion maps. Indeed, the
greatest difference of baseline range values computed with V5 and BFA is vis-
ible in the examination C1N37 (i.e., the one showing the highest local colour
differences for the baseline values computed with V5).
Since BFA has shown to be the best method to compute baseline values, dif-
ferences between results achieved using the proposed algorithm and the other
three methods have been computed in each voxel for the three examinations.
Histograms of absolute differences between baseline values achieved with BFA
and the methods used in the literature are reported in Figure 7.28. As one can
see, average differences increase according to the value of µϵ computed.
The use of different methods to compute baseline value leads to different
results that affect reliability of perfusion values computed. The two methods
mainly used in the literature (V1 and G1) are those yielding the least correct
baseline values. As regards V5, despite it allows achieving good results, dif-
ferences with BFA can differ of even more than 5HU . The use of voxel-based
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Fig. 7.28: Histograms of absolute differences between baseline values computed
according to BFA and to V1 (first row), G1 (second row), and V5 (third row),
referring to different examinations; from left to right: C1N23, C1N37, C1N38,
respectively. Vertical red lines point out histograms mean value.
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baseline values computed on the largest number of time instants is therefore
highly suggested, in order to achieve the best perfusion results as possible.
7.3.4 Baseline values in a single Centre
In this section, the BFA algorithm has been applied referring to 40 exam-
inations randomly chosen from Centre 1. One central section of each CTp
sequence has been selected and a ROI has been drawn free-hand on the liver,
following the modalities described in Sect. 7.1. ROIs area mean and standard
deviation was of 23.18± 10.3cm2. Voxel-based baseline values have been com-
puted for each ROI and represented through the use of a colorimetric map.
Mean, median, standard deviation, and range values have been computed for
each patient.
Baseline values obtained in each examination together with their mean
values are represented in Figure 7.29. Each data column represents one ex-
Examination
Fig. 7.29: Baseline bins of each examination, represented with blue dots, appear-
ing like continuous blue lines. Red markers represent mean baseline values for each
examination.
amination. The blue points composing each column represent the bin having
non-zero values in the related histogram of baseline values. As one can see,
range of baseline values of each examination are quite similar in almost all the
examinations. Averaged baseline values under 40HU have been found in two
examinations only and could point out presence of steatosis [296].
Averaged baseline values over all the examinations are resumed in Table 7.4
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Baseline values in Centre 1
Mean (HU ) Median (HU ) std (HU ) Range (HU )
61.7 63.6 10.1 32− 79
Tab. 7.4: Mean, median, standard deviation, and range of baseline values achieved
in 40 examinations of Centre 1 using BFA algorithm.
In the literature, normal mean density values for the liver have been mea-
sured through the use of unenhanced CT scans and are around 50− 65HU [297].
Other works, extend their range value to 30HU − 70HU [290, 298, 299]. In a
recent retrospective study involving 48 patients with normal liver who under-
went two CT examinations carried out with two different CT scanners in less
than one year [300], the mean liver density values measured ranged respec-
tively from 9.6 to 63.2HU and from 20 to 77.2HU . Therefore the mean values
achieved for baseline in our study are compliant with values of normal liver
reported in the literature. Consequently we can conclude that baseline values
of normal liver of patients with CRC are compliant with values of normal liver
in healthy subjects reported in the literature.
In Figure 7.30, the histogram of the absolute differences between mean and
Fig. 7.30: Histogram of the absolute differences between mean and median base-
line values of the various examinations.
median baseline values of the 40 examinations is shown. As one can see, mean
and median baseline values are very similar in all the examinations (difference
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values lay under 1HU), this suggesting quite symmetric distributions (as those
achieved in Sect. 7.3.3, Figure 7.25 (a), (b), (c)).
Finally, all the baseline colorimetric maps computed showed a high spatial
correlation, this confirming preliminary results achieved in Sect. 7.3.3 (Fig-
ure 7.25 (d), (e), (f)). Indeed, presence of spatial coherence hints at local
similarities of tissue features and at the goodness of the algorithms developed.
7.3.5 Multi-centre study of baseline values
In this section, a multi-centre study has been carried out on baseline values
of examinations pertaining to 4 different Centres. Centre 8 was the one with
the smallest number of patients that could be enrolled in the study since 10
of them had to be discarded. Indeed, in 6 examinations some DICOM files
were missed, in 2 examinations a different acquisition protocol from the one
agreed in PIXEL (Sect. 6.1) was followed, and two more patients developed
liver metastases within three years from the CTp examination. Finally, 10
examinations remained available in Centre 8 and, in order to have a fair com-
parison between Centres, the same number of patients was selected in the other
three Centres as well. 40 examinations (10 from each Centre) were chosen on
the whole that met the criteria discussed in Sect. 7.1.
Tissue ROIs were drawn on each examination following the method dis-
cussed in Sect. 7.1. Baseline values of each examination were computed by
using the BFA algorithm described in Sect. 7.3.2 and represented through
the use of a colorimetric map. Baseline mean, median, standard deviation,
and range values were computed for each examination. One-way ANOVA
(p-value ≤ 0.05) was applied to check for differences of mean baseline values
among Centres.
ROIs area mean and standard deviation values in Centres 1, 8, 16, and 17,
were of 20.1± 6.0cm2, 25.9± 7.6cm2, 22.3± 7.0cm2, 21.7± 8.7cm2, respec-
tively. Baseline mean, median, standard deviation, and range values computed
for each Centre are resumed in Table 7.5. Again, as occurred in the single-
centre study discussed in Sect. 7.3.4, baseline values of patients with CRC
found in these 4 Centres are compliant with values of normal liver reported in
the literature [297, 290, 298, 299, 300].
Histograms of the baseline values collected in each Centre are represented
in Figure 7.31. As the first consideration, all the histograms are multimodal
meaning that the baseline values can be arranged into groups. As one can see,
Centre 8 is the one presenting the largest range of baseline values. By com-
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Baseline values of 40 examinations acquired in 4 different Centres
Centre Mean (HU ) Median (HU ) std (HU ) Range (HU )
1 56.0 58.3 13.1 67.6
8 60.6 64.4 15.0 87.0
16 59.0 58.8 11.1 66.2
17 62.3 62.0 4.7 29.6
Tab. 7.5: Baseline mean, median, standard deviation, and range values in 40
examinations acquired in 4 different Centres.
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Fig. 7.31: Histogram baseline values referring to all the examinations of Centres
1 (a), 8 (b), 16 (c), 17 (d).
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paring baseline ranges of the various Centres on the histograms, it is possible
to note that in Centre 8 there are some baseline values that are very low with
respect of those achieved in the other Centres. By deepening the analysis, I
realized that these baseline values mostly pertained to one patient affected by
liver steatosis (being his mean liver value 8.9HU lower than mean spleen value
21.6HU of more than 10HU [296]). Patients with this kind of disease were
not excluded from PIXEL cohort and liver values of this examination were
compliant with this type of pathology [301]. While histograms of Centres 1
and 16 show distributions with similar range, Centre 17 is characterized by a
very narrow distribution (this is also confirmed by standard deviation value,
that in Centre 17 is almost one third with respect to the other Centres).
As an example, in Figure 7.32 four baseline colorimetric maps pertaining
(a) (b) (c) (d)
Fig. 7.32: Baseline colorimetric maps of Centres 1 (a), 8 (b), 16 (c), and 17 (d).
to examinations randomly chosen from Centres 1, 8, 16, 17, respectively, are
shown. As one can see from Table 7.5, all the four Centres present statistically
equivalent mean baseline values, as confirmed by one-way ANOVA. In addition,
also in this multi-centre study, all the baseline colorimetric maps pertaining to
the different Centres show a spatial local correlation, with quite gradual colour
changes between different regions of the ROI. This spatial correlation reflects
the local spatial coherence of tissue features. Moreover, since the baseline
values obtained with our algorithm are computed in each voxel by using only
data pertaining to one TCC, independently from the signal of the neighbouring
voxels, the baseline local spatial homogeneity can be considered as a qualitative
indicator of the algorithm goodness.
188
Chapter 7. PIXEL: a muti-centre study
7.4. Computation of perfusion values
7.3.6 Concluding remarks
One of the first operation to perform a CTp study is the subtraction of baseline
values from TCCs (Sect. 2.2). Therefore, the selection of a correct baseline
value is of fundamental importance in order to achieve accurate perfusion
results. In the literature, several methods to compute baseline values are
presented, although no comparative studies decreeing the best method exist.
However, no studies to evaluate which could be the best one have been carried
out so far.
A novel algorithm to compute baseline values has been conceived to improve
the methods used in the literature by considering as the highest number of data
points as possible. The data analysis highlighted the effectiveness of this new
method and its capability of providing better results if compared to the other
methods. The use of our adaptive voxel-based approach method to compute
baseline values is therefore highly suggested for all the liver CTp studies.
Moreover, the analysis carried out on patients of Centre 1 pointed out that
the baseline values of normal liver in patients with CRC are compliant with
values of normal liver reported in the literature for healthy subjects. This
result was also confirmed in the examinations acquired in Centres 8, 16, 17.
In addition, the outcome of statistical analysis carried out on baseline values
obtained in the multi-centre study pointed out that the use of different CT
scanners does not affect baseline values.
7.4 Computation of perfusion values
In several hepatic CTp studies, perfusion values obtained in cancer tissue have
been compared with those computed on normal liver. However, in case of
liver diseases, perfusion values are obtained on normal liver in often small tis-
sue regions, just apparently free from pathology, without considering that the
obtained results could somehow be influenced by the presence of occult metas-
tases or by the pathology itself. In the next paragraphs, I refer to perfusion
values computed on patients with CRC, but free from any hepatic disease.
Patients who developed liver metastases within three years from CTp exam-
ination, or that might be affected by liver steatosis, were excluded from the
study. Perfusion values obtained in patients of the same Centre (Sects. 7.4.1
and 7.4.2) and of four different Centres (Sects. 7.4.3 and 7.4.4), respectively,
are compared with each other to assess whether the use of different CT scan-
ners might affect perfusion parameters. Although in the literature the use of
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dual vascular input is highly suggested, many works are still carried out by
using a single vascular input. Here, all the measures presented are obtained by
considering both single (Sects. 7.4.1 and 7.4.3) and dual (Sects. 7.4.2 and 7.4.4)
vascular input. Some concluding remarks are finally reported in Sect. 7.4.5.
7.4.1 Single input BF values in normal liver
In this first study, perfusion values have been computed in all the examinations
of Centre 1, on patients with healthy liver that did not developed metastases.
In addition, in order to ensure nominally more homogeneous values, I excluded
two patients with proved liver steatosis and one not-well defined circular for-
mation. In three more cases, CTp acquisition was not centred on liver and
perfusion analyses were not possible. Three more examinations were finally
discarded since artefacts were too heavy. Altogether, 14 examinations were
excluded from the study and 57 patients were finally considered.
ROIs were drawn in each examination following the same criteria used in
Sect. 7.1. A single central section was selected and a ROI was drawn on the
liver, avoiding big vessels. BF was computed in each voxel of the ROI through
the use of the SIMS. BF values were shown through the use of colorimetric
maps and their mean and standard deviation values were computed for each
patient. Mean, median, standard deviation, and interquartile range (IQR) of
all mean BF values were finally computed.
Mean of ROIs’ area was of 22.3± 12.1cm2. BF values of each examination
together with their mean values are shown in Figure 7.33. Each column of data
is representative of one examination. The blue data of each column represent
the bin having non-zero values in the related histogram of BF values. The
other statistical parameters are resumed in Table 7.6.
Single input perfusion parameters in normal liver
Perfusion Unit of
Mean Median std IQR
parameter measure
BF ml/min/100g 34.3 32.5 13.1 14.6
Tab. 7.6: Mean, median, standard deviation, and interquartile range values of
mean BF values of the examinations of Centre 1.
Let us define the mean and the standard deviation of the BF mean values
of each examination as mmBF and smBF , respectively, and the mean and the
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Examination
Fig. 7.33: Representation of BF values of each examination considered in Centre
1. Red markers represent mean BF values for each examination. Green horizontal
line represents the mean BF values computed over all the examinations of Centre 1.
Blue horizontal lines delimit the range between mean and one standard deviation
of the BF values computed over all the examinations of Centre 1.
standard deviation of the BF standard deviation values of each examination
as msBF and ssBF , numered from bottom to top, left to right, respectively. By
calculating the two thresholds T1 and T2 as follows:
T1 = mmBF + smBF (7.1)
T2 = msBF + ssBF (7.2)
it is possible to classify the distributions of BF values in four different groups
(Figure 7.34). The former represents most of the examinations (76%) while
the other three only a minority of cases. The first group includes all the exam-
inations having a BF mean value lower than T1 and a BF standard deviation
value lower than T2 (these examinations are represented in the green colour
in Figure 7.34). C1N1 and C1N32 are two examples of examinations pertain-
ing to this group and having different distributions of BF values. Indeed, as
one can see from Figure 7.35, both the examinations are characterized by a
Gaussian-like distribution of BF values, but while the histogram of C1N1 (Fig-
ure 7.35 (a)) is symmetric, that of C1N32 (Figure 7.35 (c)) has a long-right
tail. The high perfusion values of this tail pertain to the highly perfused region
in the middle-upper portion of the ROI (Figure 7.35 (d)), possibly due to the
presence of a vessel. However, by excluding this highly perfused region (Fig-
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Fig. 7.34: Scatter of mean and standard deviation BF values. Red vertical and
horizontal lines represent the threshold values T1 and T2 used to subdivide the four
groups of examinations, respectively.
(a) (b)
10 20 30 40 50
0
100
200
300
400
500
600
700
BF (ml/min/100g)
N
u
m
b
e
r 
o
f 
v
o
x
e
ls
0
5
10
15
20
25
30
35
40
(c)
10 20 30 40 50 60
0
200
400
600
800
BF (ml/min/100g)
N
u
m
b
e
r 
o
f 
v
o
x
e
ls
(d)
0
10
20
30
40
50
(e)
0
5
10
15
20
25
30
Fig. 7.35: Histograms and BF colorimetric maps of examinations C1N1 (a,b) and
C1N32 (c,d). In (e) the colorimetric map of C1N32 after the exclusion of BF values
higher than 35HU .
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ure 7.35 (e)), one can see that tissue is heterogeneously perfused with BF values
varying from 10 to 35ml/min/100g. The colorimetric maps of Figure 7.35 (b)
and (e) are representative of normal liver functional features, showing gradual
spatial variations from low to high perfusion values, this hinting at the coex-
istence of alternating adjacent high and low vascularized regions. The same
heterogeneous coarse texture is visible in all the examinations of Centre 1.
The second group (represented in Figure 7.34 by the markers in the ma-
genta colour) collects the examinations having a low BF mean (less than T1)
value, but a high BF standard deviation (above T2). In Figure 7.36, two rep-
(a) (b) (c) (d)
Fig. 7.36: Histograms and BF colorimetric maps of examinations C1N37 (a,b)
and C1N71 (c,d).
resentative examples of examinations pertaining to this category are reported.
As one can see, both the histograms of Figure 7.36 (a), (c) are bi-modal. Also
in this group of examinations, the tissue is still composed by both high and low
vascularized regions. However, despite the presence of local perfusion correla-
tion between neighbouring voxels (Figure 7.36 (b), (d)), the spatial transitions
between low and high BF values are sharper with respect to those found in the
first group of examinations, this causing a lack of voxels with medium perfusion
values and the bi-modality of the relative histograms, accordingly. Of course,
the symmetry of the BF histograms strictly depends on the percentage of the
area of the two regions composing the tissue. Indeed, while in C1N37 the area
of the tissue showing the highest perfusion equals that of the regions with the
lowest perfusion, this causing a sort of histogram symmetry (Figure 7.36 (a)),
in C1N71 the regions lowly perfused are predominant and this is reflected in
the histogram shape that is heavily right skewed (Figure 7.36 (c)). For the sake
of completeness, the right tale (perfusion values higher than 65 ml/min/100g)
is constituted by the voxels of the vessel present in the middle-upper portion
of the ROI.
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The third group (represented in the blue colour in Figure 7.34) is that
collecting examinations having a high mean BF (higher than T1) and a low
BF standard deviation (lower than T2). In Figure 7.37, two representative
(a) (b) (c) (d)
Fig. 7.37: Histograms and BF colorimetric maps of examinations C1N7 (a,b) and
C1N30 (c,d).
examinations (C1N7 and C1N30) pertaining to this category are reported. As
one can see, the tissue of these examinations results to be more perfused than
those found in the previous groups. The histograms (Figure 7.37 (a), (c)) are
both Gaussian-like and present just light right tails, this meaning that a great
portion of the tissue analysed is characterized by high perfusion values. Indeed,
differently from examinations C1N32 and C1N71, where the voxels presenting
the highest perfusion values are grouped in one small connected region, in
the colorimetric maps of C1N7 and C1N30 (Figure 7.37 (b), (d)), the high
perfusion values are distributed on extended connected areas. Therefore, in
this case, the very high perfusion values are not ascribable to the presence of
a vessel, but rather to the intrinsic features of the tissue analysed which is
highly vascularized.
Finally, the last category (represented in the black colour in Figure 7.34)
include examinations having high BF mean and standard deviation values
(higher than T1 and T2, respectively). In this group, two examinations only
have been included. Both C1N21 and C1N26 present a wide range of perfusion
values, also including very high BF values (higher than 100ml/min/100g).
Their corresponding histograms (Figure 7.38 (a), (c)) have a Gaussian-like
shape with a long right tale. The highest perfusion values (i.e., those in the
right tail of the histograms) are all collected in small connected regions of the
colorimetric maps (Figure 7.38 (b), (d)), corresponding to quite big vessels.
In order to remove unreliable perfusion values caused by the presence of
vessels, artefacts, and noise, the triangle method has been applied to threshold
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(a) (b) (c) (d)
Fig. 7.38: Histograms and BF colorimetric maps of examinations C1N21 (a,b)
and C1N26 (c,d).
the colorimetric perfusion maps of each examination. The distributions of
perfusion values obtained for each examination after applying thresholding
are represented in Figure 7.39. As one can see, comparing it with Figure 7.33,
Examination
Fig. 7.39: Representation of BF values of each examination considered in Centre
1 after thresholding. Red markers represent mean BF values for each examination.
Green horizontal line represents the mean BF values computed over all the exami-
nations of Centre 1. Blue horizontal lines delimit the range between mean and one
standard deviation of the BF values computed over all the examinations.
BF values distributions of most of the examinations are practically unchanged
after thresholding, since characterized by very low fitting errors. Nonetheless,
in other examinations, such as C1N21 and C1N26, the highest perfusion values
are mainly attributable to the presence of vessels and the effects of thresholding
become clearer and well visible in Figure 7.39. Figure 7.40 reports histograms
and colorimetric maps of examinations C1N21 and C1N26 obtained after the
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Fig. 7.40: Histograms and BF colorimetric maps of examinations C1N21 (a,b)
and C1N26 (c,d) after thresholding.
application of thresholding method. As one can see, by comparing Figures 7.38
and 7.40 the right tale of the two histograms (Figure 7.38 (a) and (c)) heavily
shrank and the typical liver heterogeneous texture found in the examinations
of the other groups is now well visible (Figure 7.40 (b) and (d)).
Mean, median, standard deviation, and interquartile range values of all
mean BF values of each examination are resumed in Table 7.7. As one can
Single input perfusion parameters in normal liver after thresholding
Perfusion Unit of
Mean Median std IQR
parameter measure
BF ml/min/100g 34.1 32.5 12.9 14.0
Tab. 7.7: Mean, median, standard deviation, and interquartile range values of
mean BF values achieved after the application of the triangle method in the ex-
aminations of Centre 1.
see, the exclusion of unreliable perfusion values has yielded a moderate de-
crease of the statistical parameters resumed in Tables 7.6 and 7.7. Indeed,
the exclusion from the analysis of the highest BF values (e.g. those related to
the presence of vessels) causes the reduction of mean perfusion values, while
the removal of the most unreliable BF values (both high or low) leads to
a decrease of both standard deviation and interquartile range values. This
can be noted also by looking at the histograms of mean and standard devia-
tion of BF values of each examination before (Figure 7.41 (a), (c)) and after
(Figure 7.41 (b), (d)) thresholding. In particular, after thresholding, both
the histograms (Figure 7.41 (b), (d)) are narrower and with a higher con-
centration of data on the left side than those achieved without thresholding
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Fig. 7.41: Histograms of mean (a,b) and standard deviation (c,d) of BF values
before (a,c) and after thresholding (b,d).
(Figure 7.41 (a), (c)), this causing a reduction of the distributions’ mean, stan-
dard deviation, and interquartile range values. However, since examinations
of Centre 1 were not particularly affected by high noise levels or the presence
of artefacts and vessels, the application of thresholding causes only slight vari-
ations on the distributions of BF mean and standard deviation values and,
consequently, the reduction of the overall statistical indexes (i.e., those re-
ported in Tables 7.6 and 7.7) can be considered negligible, although for single
examinations they could be relevant.
7.4.2 Dual input BF values in normal liver
The same examinations and ROIs of Sect. 7.4.1 were also used to compute
perfusion values considering a dual vascular input. In addition, a ROI was
placed on the portal vein and on the spleen of each examination of Centre
1 (Figure 7.42). 22 examinations were excluded from the study since it was
not possible to detect either the spleen or the portal vein. Indeed, spleen was
not visible inside CT images of 17 examinations due to the too narrow FOV
or to splenectomy (Figure 7.43 (a)), while in 5 more examinations the portal
vein either the spleen were not visible because of the z level selected that
was different from different from the one agreed (Figure 7.43 (b)). A total
amount of 35 examinations were finally analysed. Voxel-based aBF , pBF ,
and HPI values were computed using the MSM and shown through the use of
colorimetric maps.
aBF , pBF , and HPI were computed on each voxel of the tissue ROI. Mean
and standard deviation values of these perfusion parameters were calculated
for each patient. Distribution of aBF , pBF , and HPI values are represented
in Figure 7.44. Mean, median, standard deviation, and interquartile range of
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Fig. 7.42: ROIs placed on portal vein (in the red colour) and spleen (in the green
colour), referring to examination C1N24.
(a) (b)
Fig. 7.43: CT images of examinations C1N21 (a) and C1N79 (b), excluded from
dual input analysis due to the too narrow FOV and a wrong z level acquired,
respectively.
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(a)
(b)
(c)
Examination
Examination
Examination
Fig. 7.44: aBF (a), pBF (b), and HPI (c) found in the examinations of Centre
1. Red markers represent mean BF values for each examination. Green horizontal
line represents the mean BF values computed over all the examinations of Centre 1.
Blue horizontal lines delimit the range between mean and one standard deviation
of the BF values computed over all the examinations of Centre 1.
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mean aBF , pBF , and HPI values were finally computed and are resumed in
Table 7.8.
Dual input perfusion parameters in normal liver
Perfusion Unit of
Mean Median std IQR
parameters measure
aBF ml/min/100g 19.4 17.3 8.8 8.0
pBF ml/min/100g 94.4 93.6 26.6 37.3
HPI % 18.0 15.7 9.1 12.1
Tab. 7.8: Mean, median, standard deviation, and interquartile range values of
mean aBF , pBF , and HPI values found in the examinations of Centre 1.
In healthy subjects, the major part of blood is supplied to liver by the portal
vein [302, 303]. The data shown in Table 7.8 and in Figure 7.44 highlight that
this condition holds even in case of patients with CRC. Indeed, mean aBF
is lower than mean pBF in all the examinations and consequently, the mean
HPI assumes values always lower than 50%. However, as one can see by
analysing the distributions of HPI (Figure 7.44 (c)), the local HPI values can
also reach very high peaks, revealing the presence in some examinations of
voxels characterized by a prevalence of arterial vascularization. Nonetheless,
these examinations are all characterized by very wide range of HPI values.
In fact, no examinations showing a narrow range (lower than the 70%) and
containing very high HPI values (higher than 80%) exist. Therefore, generally,
liver tissue is prevalently characterised by portal vascularization and in those
cases where there are some tissue voxels mostly receiving blood from arterial
circulation, they represent only a minority of cases. In Figure 7.45, is reported
an examples of an examination having some voxels characterized by prevalent
arterial vascularization. High local HPI values (Figure 7.45 (c)) are all grouped
in continuous regions, mainly corresponding to those hypo-vascularized areas of
pBF represented in the blue colour inside the corresponding colorimetric map
(Figure 7.45 (b)). Therefore, despite the global prevalence of blood supply is
portal, inside liver there can be adjacent regions receiving blood in different
percentage from the aorta and the portal vein. This result is also supported by
data found in the literature, which report HPI values in normal liver that are
higher than 50% [229, 240, 304] and in some cases reach peaks of even more
than 80% [240].
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(a) (b) (c)
Fig. 7.45: Examples of aBF (a), pBF (b), and HPI (c) colorimetric maps, refer-
ring to patient C1N83 having very high HPI values.
The scatter plots of aBF and HPI mean and standard deviation values
(Figure 7.46) point out that there is a relationship of direct proportionality be-
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Fig. 7.46: Scatter of aBF (a), pBF (b), and HPI (c) mean and standard deviation
values.
tween mean and standard deviation of these parameters, that is, aBF and HPI
standard deviation are data dependent. In Figure 7.47, colorimetric maps of
different examinations having low (Figure 7.47 (a)) and high (Figure 7.47 (b))
aBF mean and standard deviation values are reported. As one can see, the
couple of colorimetric maps apparently show comparable distributions of per-
fusion values. However, by analysing the two maps from a quantitative point
of view, it is possible to see that colours are split on completely different ranges
and that consequently, resulting mean and standard deviation values are to-
tally different. The same considerations can be drawn for the couple of HPI
colorimetric maps of Figure 7.47 (c) and (d). Perfusion mean and standard de-
viation values for the colorimetric maps represented in Figure 7.47 are reported
201
Chapter 7. PIXEL: a muti-centre study
7.4. Computation of perfusion values
(a) (b) (c) (d)
Fig. 7.47: aBF (a,b) and HPI (c,d) colorimetric maps pertaining to examinations
having low (a,c) and high (b,d) mean and standard deviation values.
in Table 7.9.
Perfusion mean and standard deviation values
Figure Examination
Perfusion Unit of
Mean std
parameter measure
7.47 (a) C1N9 aBF ml/min/100g 12.6 6.0
7.47 (b) C1N26 aBF ml/min/100g 44.6 18.3
7.47 (c) C1N85 HPI % 14.1 4.7
7.47 (d) C1N22 HPI % 37.8 6.2
Tab. 7.9: Perfusion mean and standard deviation values of maps represented in
Figure 7.47.
As regards pBF , no relationships are present between its mean and its
standard deviation values (Figure 7.46 (b)).
Now, let us apply the triangle method (Sect. 4.3) to aBF and pBF dis-
tributions of each examination to exclude unreliable perfusion values. The
results obtained are reported in Figure 7.48 where the distributions of aBF ,
pBF , and HPI values of each examination are represented. Here, HPI values
of each examination are taken into consideration only in those voxels where
both aBF and pBF are considered as being reliable. As for BF values in the
single input analysis, the most clear effects of triangle thresholding method are
visible on the highest aBF and pBF values caused by the presence of noise,
artefacts, and misleading anatomical structures (i.e., vessels) that have been
removed from the analysis. Meaningful examples are C1N1, C1N36 as regards
aBF and C1N5, C1N24 for pBF . On the contrary, effects of thresholding are
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(a)
(b)
(c)
Examination
Examination
Examination
Fig. 7.48: aBF (a), pBF (b), and HPI (c) found in the examinations of Centre
1 after excluding the most unreliable perfusion values. Green horizontal line rep-
resents the mean BF values computed over all the examinations of Centre 1. Blue
horizontal lines delimit the range between mean and one standard deviation of the
BF values computed over all the examinations of Centre 1.
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less evident on distribution of HPI values, although they can be better high-
lighted through the comparison of Figures 7.44 and 7.48 (e.g. see C1N13 and
C1N70).
Mean, median, standard deviation, and interquartile range of mean aBF ,
pBF , and HPI obtained after the application of the triangle method are re-
sumed in Table 7.10. Once again, global results collected after thresholding are
Dual input perfusion parameters in normal liver after triangle thresholding
Perfusion Unit of
Mean Median std IQR
parameters measure
aBF ml/min/100g 19.2 17.3 8.9 8.1
pBF ml/min/100g 93.6 92.7 26.3 37.6
HPI % 17.9 15.7 9.1 12.0
Tab. 7.10: Mean, median, standard deviation, and interquartile range values of
mean aBF , pBF , and HPI values found in the examinations of Centre 1 after the
exclusion of the most unreliable perfusion values.
very similar to those of Table 7.8 obtained from the original data. Of course,
this is not surprising, since these values come from global operators (e.g. mean
or median) that flatten the differences.
7.4.3 Multi-centre study on single-input BF values
In this section, single-input BF values are computed on 40 examinations ac-
quired in four different Centres. The aim of this multi-centre study is to
evaluate whether and to what extent the use of different CT scanners may
affect BF values in normal liver. To this purpose, patients free from liver dis-
eases and who did not develop liver metastases within three years from CTp
examination, were randomly selected from Centres 1, 8, 16, and 17. In order
to carry out both a single-input (in this section) and a dual-input perfusion
analysis (in Sect. 7.4.4), the 10 examinations selected from each Centre have
both portal vein and spleen visible inside CT images.
A circular ROI has been drawn inside aorta and another one has been
outlined on one section of the liver, following the same criteria adopted in
Sect. 7.4.1. Voxel-based BF values have been computed for each examination
by applying the SIMS method and shown through the use of colorimetric
maps. Mean, median, standard deviation, and interquartile range have been
204
Chapter 7. PIXEL: a muti-centre study
7.4. Computation of perfusion values
calculated for each Centre on the mean BF values of each examination. One-
way ANOVA and Kruskal-Wallis tests (p-value ≤ 0.05) have been applied to
BF values of the four Centres to verify whether the use of different CT scanners
could introduce variability on computation of the averaged perfusion values.
BF values distributions of each examination, together with their mean
values, are represented in Figure 7.49. The black line highlighting BF mean
Examination
Fig. 7.49: BF values of each examination of Centres 1 (in blue), 8 (in green), 16
(in purple), and 17 (in cyan) are represented. BF mean value of each examination
is highlighted with the red marker while the BF mean value obtained in each Centre
is represented by the black line.
value over the 10 examinations of each Centre has nearly the same height in
all the groups. Their values are reported in Table 7.11, together with median,
BF values of normal liver acquired in 4 different Centres
Centre
Mean Median std IQR
(mg/ml/100g) (mg/ml/100g) (mg/ml/100g) (mg/ml/100g)
1 35.2 33.1 11.3 10.9
8 32.8 28.5 13.9 17.4
16 33.8 28.5 17.3 6.9
17 34.0 32.4 13.7 22.2
Tab. 7.11: BF mean, median, standard deviation, and interquartile range of BF
mean values achieved from the 40 examinations acquired in Centres 1, 8, 16, 17.
standard deviation, and interquartile range of each Centre. Median BF values
of the four Centres are all lower than their means and less homogeneous. In
fact, BF values histograms of each Centre are all right skewed, this pointing out
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that in each group there is a greater number of examinations having BF value
lower than the global mean value of the Centre. The highest standard deviation
of BF values can be found in Centre 16, where examination C16N13 stands out
from the others due to its particular high perfusion values. However, Centre
16 also shows the lowest BF interquartile range. Since standard deviation
considers all data while the interquartile range ignores the outliers, such a low
value of interquartile range points out that despite the presence of C16N13,
perfusion results of Centre 16 are those with the lowest variability. For the
sake of completeness, let us show the colorimetric map of examination C16N13.
BF values of this examination are particularly high both with respect to the
examination of Centre 16 and to those of the other Centres. However, as one
can see from Figure 7.50 (a), functional tissue features of this examination
(a) (b)
Fig. 7.50: BF colorimetric map (a) and µϵ histogram of examination C16N13 (b).
does not differ from those described in Sect. 7.4.1 (i.e., alternated adjacent
regions characterized by low and high levels of vascularization). In addition,
by analysing colour gradients inside BF colorimetric map (Figure 7.50 (a))
and the shape of the µϵ values histogram (Figure 7.50 (b)), it emerges that
the computed perfusion values are correct. Indeed, the local spatial coherence
and the gradual variation from low to high adjacent perfusion values gives hint
of a good quality of the map (Figure 7.50 (a)). As regards the histogram of
µϵ values (Figure 7.50 (b)), the very low range of the error values and their
nearly normal distribution without right tales (that as described in Chapter 3
is typical of normal liver tissue not particularly affected by noise or by the
presence of artefacts and vessels), prove that the achieved perfusion values
have to be considered as being reliable since computed on reliable TCCs. The
visual analysis of the CT image sequence also confirmed that no big vessels
or artefacts were visible on tissue ROI. Therefore, the high perfusion values
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found in C16N13 can be exclusively attributed to features of tissue, that in
this patient results to be exceptionally vascularized.
In addition, I would like to bring reader’s attention on the trend of BF
values and distributions among sets of subsequent patient’s IDs, that is possible
to identify in Figure 7.49, especially for the examinations of Centre 17. As
a matter of facts, patients ID have been assigned in this Centre according
to increasing acquisition time, except for the first two examinations (since
C17N3 has been acquired after C17N4, in the same day as C17N6). A possible
motivation could be looked for a gradual change of acquisition parameters (also
including CA administration), however there are not enough information to
check it. Finally results of one-way ANOVA and Kruskal-Wallis tests confirm
that differences between mean and median BF values in the four Centres are
not statistically significant (p-value = 0.99 and p-value = 0.84, respectively).
This analysis has been repeated by applying thresholding triangle method
to error data, but results remain the same and no appreciable changes can be
detected.
7.4.4 Multi-centre study on dual-input BF values
Perfusion parameters of the same examinations used in Sect. 7.4.3 are com-
puted by considering a dual vascular blood supply. ROIs have been drawn on
the portal vein and on the spleen of each examination (see Sect. 7.4.2). aBF ,
pBF , and HPI have been computed for each patient as reported in Sect. 7.4.2.
One-way ANOVA and Kruskal-Wallis tests (p-value ≤ 0.05) have been com-
puted for data of the four Centres to verify whether the use of different CT
scanners could introduce variability on dual input perfusion mean and median
values respectively computed on healthy liver.
Figure 7.51 shows the distributions of aBF , pBF , and HPI values found
in the various examinations. Examination C16N14 presents some aBF values
higher than 130ml/min/100g (the highest one has value 493.9ml/min/100g).
These outlier values are caused by the presence of artefacts and noise that can
be removed through the application of the triangle method (see Figure 7.52).
In order to correctly visualize aBF distributions of all the examinations, the
highest limit of the y axis has been fixed to 130ml/min/100g.
In Table 7.12 mean, median, standard deviation, and interquartile range of
aBF , pBF , and HPI found in each Centre are reported.
As one can see from both Figure 7.51 and Table 7.12, Centre 17 is the
one showing the lowest inter-patient perfusion values dispersion (i.e., in this
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(a)
(b)
(c)
Examination
Examination
Examination
Fig. 7.51: aBF (a), pBF (b), and HPI (c) values of each examination of Centres
1 (in blue), 8 (in green), 16 (in magenta), and 17 (in cyan) are represented. BF
mean value of each examination is highlighted with the red marker while the BF
mean value obtained in each Centre is represented by the black line.
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Dual input perfusion parameters in normal liver
Centre
Perfusion Unit of
Mean Median std IQR
parameters measure
1
aBF ml/min/100g 18.0 17.3 8.7 9.6
pBF ml/min/100g 107.4 107.2 28.4 41.8
HPI % 15.6 12.6 9.9 12.5
8
aBF ml/min/100g 17.6 9.8 20.0 4.7
pBF ml/min/100g 94.9 100.1 40.8 55.0
HPI % 17.9 9.4 20.3 6.7
16
aBF ml/min/100g 24.3 17.5 19.3 15.1
pBF ml/min/100g 105.2 91.4 31.9 52.9
HPI % 18.2 14.5 10.4 14.9
17
aBF ml/min/100g 14.3 12.7 5.9 2.3
pBF ml/min/100g 103.3 104.4 27.0 25.8
HPI % 12.6 11.5 4.6 5.3
Tab. 7.12: Mean, median, standard deviation, and interquartile range values of
mean aBF , pBF , and HPI values found in the examinations of Centres 1, 8, 16,
17.
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Centre distributions of aBF , pBF , and HPI in the various patients are more
similar than in the other Centres), as shown by its lowest standard deviation
and interquartile range values. On the contrary, when considering Centres
1, 8, and 16 only, Centre 8 is the one showing the highest standard deviation
values. However, as regards aBF and HPI , Centre 8 is also the one showing the
lowest interquartile range, this meaning that by removing the “most outlier”
examinations (e.g. C8N19 and C8N20), the remaining ones show very similar
perfusion mean values.
Also in this dual-input study, aBF results much lower than pBF in all the
examinations, except for C8N20 showing HPI mean, median, and standard
deviation of 65.3%, 66.6%, 13.9%, respectively. Despite these values could seem
exceptionally high, such HPI values (of even about 77.9%) have been already
found in the literature for patients with CRC, free from liver metastases and
steatosis [304]. However, the presence of this exception does not affect global
HPI values of the Centre whose median value is the lowest one and whose
mean value is very low (17.9%), compliant with those values found in the
literature [305].
Results of both one-way ANOVA and Kruskal-Wallis tests point out that
differences between perfusion parameters obtained in different Centres are not
statistically significant for all the perfusion parameters analysed. p-value ob-
tained for aBF , pBF , and HPI using the two statistical tests are resumed in
Table 7.13.
Summary of p-value
Perfusion parameter One-way ANOVA Kruskal-Wallis
aBF 0.50 0.29
pBF 0.84 0.92
HPI 0.74 0.49
Tab. 7.13: Summary of p-value obtained for One-way ANOVA and Kruskal-Wallis
tests applied on dual-input perfusion values.
In order to remove the most unreliable perfusion values possibly affecting
the accuracy of perfusion results, the triangle thresholding method have been
applied to data. Distributions of aBF , pBF , and HPI values are shown in
Figure 7.52. Mean, median, standard deviation, and interquartile range values
obtained after removing unreliable results are resumed in Table 7.14. As seen
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(a)
(b)
(c)
Examination
Examination
Examination
Fig. 7.52: aBF (a), pBF (b), and HPI (c) values obtained after the application
of the triangle thresholding method for each examination of Centres 1 (in blue),
8 (in green), 16 (in magenta), and 17 (in cyan) are represented. Mean values of
each examination are highlighted with the red marker while the mean value of each
Centre is represented by the black line.
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Dual input perfusion parameters in normal liver
Centre Perfusion Unit of
Mean Median std IQR
parameters measure
1
aBF ml/min/100g 17.8 17.3 8.6 9.7
pBF ml/min/100g 106.3 107.1 27.7 39.3
HPI % 15.6 12.6 10.0 12.4
8
aBF ml/min/100g 17.5 9.6 20.1 4.7
pBF ml/min/100g 94.6 100.3 41.3 55.0
HPI % 17.7 9.4 20.4 6.8
16
aBF ml/min/100g 24.0 17.3 19.0 15.1
pBF ml/min/100g 103.8 89.8 30.5 51.2
HPI % 18.1 14.3 10.3 15.0
17
aBF ml/min/100g 13.9 12.2 6.2 3.5
pBF ml/min/100g 102.8 104.0 26.9 23.5
HPI % 12.3 11.0 4.8 5.4
Tab. 7.14: Mean, median, standard deviation, and interquartile range values of
mean aBF , pBF , and HPI values found in the examinations of Centres 1, 8, 16,
17 after thresholding most unreliable perfusion values.
in the previous sections, removing unreliable values just bring a little variation
of global perfusion values, in this case within absolute values lower than 1.5%.
However, more evident improvements can be appreciated in the distribution of
perfusion values achieved for each examination. For instance, the examination
C16N14 first characterized by aBF values higher than 200ml/min/100g, after
thresholding shows aBF values lower than 100ml/min/100g.
By analysing the global results collected in Table 7.14, it is possible to
note that, once again, Centre 17 is that characterized by the lowest standard
deviation and interquartile range values, while Centre 8 is that showing the
highest standard deviation value and the lowest aBF and HPI interquartile
ranges (if considering Centres 1, 8, and 16 only).
Despite the removal of unreliable perfusion values, examination C8N20 still
presents a prevalently arterial vascularization (HPI value higher than 50%),
this confirming that this feature is attributable to tissue features only, and not
to computing errors introduced by the high presence of noise or artefacts.
p-value of aBF , pBF , and HPI obtained by applying one-way ANOVA
and Kruskal-Wallis tests to respectively verify whether mean and median of
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perfusion values could show any inter-Centre variations are resumed in Ta-
ble 7.15. The statistical analysis carried out on thresholded data confirms the
Summary of p-value
Perfusion parameter One-way ANOVA Kruskal-Wallis
aBF 0.61 0.25
pBF 0.86 0.91
HPI 0.75 0.48
Tab. 7.15: Summary of p-value obtained for One-way ANOVA and Kruskal-Wallis
tests applied on dual-input perfusion values after thresholding the most unreliable
perfusion values.
results obtained by the same tests applied to the original data. Indeed, as one
can see, no statistically significant differences have been highlighted between
Centres. p-value are very similar to those obtained on non-thresholded data.
The highest variation between p-value can be noted for the tests applied on
aBF that consequently, can be considered as the perfusion parameter mostly
affected by presence of noise, artefacts and vessels inside the tissue analysed.
7.4.5 Concluding remarks
Several CTp studies compute perfusion values on healthy tissue in order to
have a reference point. However, frequently these studies get these reference
values on few patients, often from a small tissue region of liver considered as
being normal. In addition, the liver of these patients are often affected by
pathologies, even tumours, that are not excluded to possibly affect normal
tissue. Accordingly, these BF values could not be appropriate as a reference.
On the contrary, results reported in Sects. 7.4.1 and 7.4.2 have been computed
on a wide set of patients free from any liver pathologies and by considering
in each examination as the widest tissue regions as possible. Therefore, these
results represent an important landmark for all the future hepatic single- and
dual-input perfusion studies using healthy tissue as a reference point.
Finally, as regards the two CTp studies that have been carried out in
Sects. 7.4.3 and 7.4.4, the outcomes are definitely encouraging. Indeed, results
obtained in four Centres of PIXEL on examinations acquired by using different
CT scanners, but same acquisition protocol and parameters are directly com-
parable. Therefore, these results create a fast track for the set up of further
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multi-centre studies that represent the first step to permit CTp to be adopted
in clinical routine. The development of further studies, comparing a higher
number of examinations, acquired with other different CT scanner models,
but with the same acquisition protocol, would indeed confirm the capability of
CTp to provide reproducible results. After that, further multi-centre studies
investigating CTp capability of providing diagnostic and prognostic informa-
tion would allow moving forward a definitive decision regarding the usefulness
of this technique.
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Lung and liver cancers are the most common causes of tumour death. Sev-
eral steps forward have been done in cancer care through the introduction of
anti-angiogenic therapies, but the lack of techniques to be used in the stan-
dard clinical practice to early assess their efficacy is an obstacle to make the
most of their usage. This Thesis addresses CTp, one of the most promising
techniques for the earlier assessment of the efficacy of the anti-angiogenic ther-
apies. Despite CTp can provide fundamental functional information regarding
both tumour diagnosis and prognosis, some open issues still exist that prevent
its use in the standard clinical practice. This Thesis aims at filling in some
gaps so as to advance CTp technique towards ordinary use in oncology. The
most relevant achievements can be summarized as follows:
• methods and indexes to detect unreliable CTp perfusion values
• assessment of the clinical representativeness of the global averaged per-
fusion values
• tentative guidelines to set up a multi-centre CTp study
• signal processing algorithms to improve accuracy of perfusion values
• comparison of perfusion results of examinations carried out in different
Centres
First, a method conceived and realized to automatically detect and ex-
clude from perfusion analysis those unreliable perfusion values associated to
the presence of noise, artefacts, vessels, and bronchi has been validated. The
advantage brought by using this method over the classical manual approach
is twice. The first is the huge amount of time saved by radiologists, due to
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the automation of the post-processing stage. Besides that, this method allows
detecting those structures affecting perfusion results which are missed by ra-
diologists, or at least allows determining their correct extent. It is also worth
noting that our results confirm that removing unreliable perfusion values yield
a significant improvement on the accuracy of perfusion results, and of clinical
assessment, accordingly.
As regards the representativeness of the global perfusion values, often used
in CTp studies to achieve a higher reproducibility, a deep analysis has been
carried out. The results of statistical tests combined with the evaluation of a
specific statistical index used to assess the degree of perfusion heterogeneity,
highlighted that global perfusion values cannot be appropriate for therapy
assessment, since they disregard the heterogeneities and “flatten” the range
of perfusion values. Moreover, the inconsistencies found between numerical
and clinical equivalences highlight that the use of global values may even lead
to misleading clinical considerations. Therefore, in order to make reliable
clinical diagnosis, radiologists should use all the tumour slices, endowed with
a perfusion heterogeneity measure.
During my PhD period, I have also had the opportunity to work at the
widest European multi-centre CTp study (PIXEL) on liver and to analyse all
the examinations collected in the 15 different Centres, providing my contribu-
tion at both methodological and technical level. First of all, the detection and
the analysis of all the intra- and inter-centre sources of variability allowed me
to draw some hints on how to correctly set-up a multi-centre study. Hopefully,
these hints will give a deep contribute to build up more accurate guidelines,
prompting the spread of multi-centre studies that represent a crucial step to
translate CTp in the standard clinic. Moreover, the signal processing algo-
rithms I developed, such as those to compute the baseline values of the unen-
hanced stage of CTp or to automatically register ROIs on liver CTp images,
provide a real contribution to the achievement of more accurate perfusion pa-
rameters. In addition, the results of perfusion analysis carried out on normal
liver show that they can be used as a benchmark for hepatic single- and dual-
input perfusion studies, thus becoming very useful for the assessment of effects
of liver pathologies on normal tissue. Finally, the two perfusion studies carried
out on examinations acquired in different Centres, following the same NAP,
highlighted that perfusion results could be directly compared, for both single-
and dual-input models. These encouraging outcomes could favour proliferation
of multi-centre studies needed to assess the reproducibility of CTp technique,
by analysing a huge number of examinations, performed with CT scanners of
216
Chapter 8. Conclusions
different models and vendors.
For the sake of completeness, it is worth remarking that all the methods
and the algorithms presented in this Thesis (except for the algorithm to align
liver CTp images) can be applied on both liver and lung tissues, also being
independent from either the methods used to compute perfusion parameters
or the perfusion parameters themselves. Actually, in this work I have dis-
cussed results achieved through the maximum slope method that permits BF
computation only. However, all the considerations drawn regarding the meth-
ods to automatically detect unreliable perfusion values, the representativeness
of global perfusion values, or the correct computation of baseline values, also
hold if considering other perfusion models or computing methods and perfusion
parameters, such as BV , MTT or PS .
In conclusion, the work presented in this Thesis provides a clear upgrade
of the state of the art. Researchers and clinicians have now at their disposal
methods and techniques helping them to achieve more accurate and reliable
results and making more aware clinical considerations. However, more accu-
rate models and methods have to be explored in multi-centre studies set up
using updated guidelines stemming from previous experiments. As a matter of
fact, assessing reproducibility of results through multi-centre studies or meta-
analysis is a crucial step to make CTp-based image biomarkers entering the
clinical practice. Despite the solution is not at hand, I strongly believe that the
integration between medical, bioengineering and computer science techniques,
will play a key role in the next future to help translation of CTp into clinics.
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Appendix
In this section, the steps needed to obtain Eq. (2.9) presented in Chapter (2)
are reported. It is worth noting that this part is almost never included in
the papers discussing models and methods to compute perfusion parameters,
probably because it is dense of mathematical concepts that could jeopardize
reader’s attention. For this reason, I chose to create a dedicated appendix so
as to keep a better fluency of the reading inside Chapters.
First of all, I recall some properties of convolution and therefore I illustrate
the procedure used to obtain Eq. (2.9).
Given two functions f(t) and g(t), their convolution is defined as:
f(t)⊗ g(t) =
∫ ∞
0
f(τ) · g(t− τ)dτ (A.1)
The convolution of a continuous function f(t) with the discontinuous unit step
function σ(t) (whose values are equals to 0 for t < 0 and to 1 for t ≥ 0) is
represented in Eq. A.2:
f(t)⊗ σ(t) =
∫ t
0
f(τ)dτ (A.2)
Eq. (A.2) in combination with the associative and distributive property of the
convolution product yields Eq. A.3:∫ t
0
f(τ)⊗ g(τ)dτ = [f(t)⊗ g(t)]⊗ σ(t) =
= f(t)⊗ [g(t)⊗ σ(t)] = f(t)⊗
∫ t
0
g(τ)dτ
(A.3)
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and thus ∫ t
0
[f(τ)− f(τ)⊗ g(τ)]dτ = [f(t)− f(t)⊗ g(t)]⊗ σ(t) =
= f(t)⊗ σ(t)− f(t)⊗ g(t)⊗ σ(t) = f(t)⊗ [σ(t)− g(t)⊗ σ(t)] =
= f(t)⊗ [σ(t)−
∫ t
0
g(τ)dτ ]
(A.4)
After recalling these mathematical concepts, let us come back to Eq. (2.4).
Since the organ of interest gives volume tissue concentration Ct(t) rather than
mass concentration Q(t), it is possible to work with the quantity Ct(t), instead
of Q(t), by multiply both sides of Eq. (2.4) by tissue density ρ. In this way we
obtain Eq. (A.5):
ρ ·BF · Ca (t)− ρ ·BF · Cv (t) (A.5)
where
ρ · dQ (t)
dt
=
dCt (t)
dt
(A.6)
Because tissue density is closed to unity in most cases (and this is true in both
liver and lung), in the literature ρ is often neglected to simplify notations.
Therefore, we can rewrite Eq. (A.5) according to Eq. (A.7):
dCt (t)
dt
= BF · Ca (t)−BF · Cv (t) = BF · [Ca (t)− Cv (t)] (A.7)
By integrating Eq. (A.7), it is possible to obtain Eq. (A.8):
Ct(t) = BF ·
∫ t
0
[Ca(τ)− Cv(τ)]dτ (A.8)
After that, by substituting Cv(t) with its definition given in Eq. (2.1), it is
possible to rewrite Eq. (A.8) according to Eq. (A.9):
Ct(t) = BF ·
∫ t
0
[Ca(τ)− h(τ)⊗ Ca(τ)]dτ (A.9)
By exploitinig Eq. (A.4), it is possible to rewrite Eq. (A.9) in Eq. (A.10):
Ct(t) = BF · Ca(t)⊗ [σ(t)−
∫ t
0
h(τ)dτ ] (A.10)
Since in real time domains t is always equals or greater than zero, the function
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σ(t) is always unitary. Therefore, we can write Eq. (A.11):
Ct(t) = BF · Ca(t)⊗ [1−
∫ t
0
h(τ)dτ ] (A.11)
that according to the definition of R(t) (given in Eq. (2.8)) becomes Eq. (A.12):
Ct(t) = BF · Ca(t)⊗R(t) (A.12)
Finally, by applying the commutative principle, it is possible to obtain Eq. (2.9)
presented in the literature.
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Abbreviation Definition
1D Transverse manual registration
2CXM Two-compartment exchange model
2D Transverse manual registration
2I1CM Dual-input one-compartment model
3D Multi-slice manual registration
α Non-linear parameter affecting curve slope (Hill’s equation)
ϵ Residuals
ϵ¯ Residuals’ mean value
η White noise
µ Distribution mean
µϵ Mean of absolute residuals
µBF BF mean
µlCV lCV mean value
µs Mean BF values representative of each slice
µw Mean BF values representative of the whole tumour
ΩW Group of concentration values inside W
σ Distribution standard deviation
σϵ Standard deviation of residuals
σµϵ Standard deviation of µϵ values
σBF BF standard deviation
σlCV lCV standard deviation value
σi(ΩW ) Standard deviation of ΩW
τa transit time of CA from aorta to tissue in 2I1CM
τp transit time of CA from portal vein to tissue in 2I1CM
a AR coefficient
AATHM Adiabatic approximation to the tissue homogeneity model
aBF Arterial BF
AIRTUM Italian Association of Cancer Registries
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List of Abbreviations
ANOVA Analysis of variance
AR Autoregressive
AUC Area under the curve
BF Blood flow
BFA Baseline finding algorithm
BV Blood volume
CA Contrast agent
Ca(t) Arterial inflow
Cev CA concentration inside EV
Civ CA concentration inside IV
CRC Colorectal cancer
CT Computed tomography
CTp Computed tomography perfusion
CV Coefficient of variation
Cv(t) venous outflow
DCE Dynamic contrast enhanced
DICOM Digital Imaging and Communications in Medicine
DIMS Dual-input maximum slope
DPM Distributed parameter model
E Entropy
E[µϵ] Mean of µϵ values
E0 Baseline tissue concentration value (Hill’s equation)
EC50 Instant of half maximum tissue concentration (Hill’s equation)
EF Extraction fraction
EI Interval ending point
Emax Saturation concentration value of tissue (Hill’s equation)
EP Baseline ending point
Es Entropy of each slice
eTM Extended Tofts model
EV Extravascular space
Ew Entropy of the whole tumour
Fiv Plasma flow
FN False negative
FNR False negative ratio
FOV Field of view
FP False positive
FPR False positive ratio
FU Follow-up
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G1 Method to compute global baseline value considering a single slice
GUI Graphical user interface
h Probability density function of CA particles
HCC Hepatocellular carcinoma
HU Hounsfield units
IDT Indicator dilution theory
IQR Interquartile range
IV Intravascular space
k1a Arterial inflow rate constant in 2I1CM
k1b Portal inflow rate constant in 2I1CM
k2 Outflow rate constant in 2I1CM
ktrans Flow rate constant
L Length of the vascular bed
lCV Local coefficient of variation
MIUR Italian Minister of Education, Universities and Research
MRI Magnetic resonance imaging
MS Mean of the local standard deviation
MSM Maximum slope method
MTT Mean transit time
MVD Microvessel density
N Number of TCC data points
n.a. Not available
NAP Nominal acquisition protocol
NC Number of compartment
NSCLC Non-small cell lung cancer
OS Overall survival
p AR model’s order
pBF Portal BF
PCM Pharmacokinetic compartment models
PET Positron emission tomography
PFS Progression-free survival
PI Perfusion index
PS Permeability surface
Q Mass concentration of CA in tissue
R Impulse residual function
R2 Coefficient of determination
rµ µs range
rM Ms range
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RECIST Response Evaluation Criteria in Solid Tumor
ROI Region of interest
SEN Sensitivity
SF Standard fixed mode
SI Interval starting point
SIMS Single-input maximum slope
SNR Signal to noise ratio
SP Baseline starting point
SPEC Specificity
SS Variability of the local standard deviation
SSE Sum of squared error
SStot Total sum of data squares
std Standard deviation
T2σ 2− σ method thresholding value
TCC Time concentration curve
TEM Thresholded error maps
THM Tissue homogeneity model
TM Tofts model
TN True negative
TP True positive
TT Triangle method thresholding value
US Ultrasound
V1 Method compute voxel-based baseline value considering a single slice
V5 Method to compute voxel-based baseline value considering five slices
vev Interstitial space volume
VEGF Vascular endothelial growth factor
viv Plasma volume
W (x, y) Window of dimension w × w and centered in (x, y)
WHO World Health Organization
yAR AR signal
Yi TCC’s data point at the time instant i
Yˆi Fitting curve’s data point at the time instant i
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